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ABSTRACT 
On June 25-27, 2001 the UN General Assembly Special Session (UNGASS) on HIV/Aids 
was held in New York. During the session and the multilateral negotiations accompanying 
it, the UN addressed HIV/Aids at the General Assembly level for the first time as a single 
issue. The Special Session was chaired by Mr Harri Holkeri, Councillor of State from 
Finland. 
At the HIV/Aids Special Session, State Parties agreed on measures and targets to stop the 
HIV-epidemic by 2015. The General Assembly adopted the Declaration of Commitment on 
HIV/Aids “Global Crisis – Global Action”, which defines the priority areas of enhanced 
action to fight the HIV/Aids epidemic. The UN follows the implementation of the 
Declaration of Commitment through regular indicator reporting. Additionally, in 2006, a 
high level review meeting was held New York to follow the progress achieved. The next 
such review meeting will again be held at UN headquarters June 10-11, 2008. 
This report outlines the cross-sectorial HIV/Aids work done in Finland in 2006-2007. The 
report has been compiled under the guidance of the Ministry of Social Affairs and Health in 
cooperation with the Ministry for Foreign Affairs and the Civil Society/NGO sector. The 
National Public Health Institute HIV-unit has been responsible for data collection, analysis 
and report collation, drafting and coordination. 
All relevant branches of government have been consulted and encouraged to submit their 
input during the report preparation.  
In a global comparison and even compared to its EU-peers, HIV/Aids prevention, treatment 
care and support has been successful in Finland. Similar to many EU-countries, Finland 
fulfils and even exceeds most of the UNGASS Declaration of Commitment goals, even on 
the indicator level. 
However, despite the relatively favorable HIV/Aids-situation, sexually transmitted HIV-
infections have clearly increased in Finland during recent years. The reporting brought 
forward relevant future risks and need for improvement especially concerning long-term 
prevention work. Second generation behavioral surveillance among adult population would 
need to be further developed. 
National cross-sectorial coordination would probably require strengthening to prevent a 
future deterioration of the epidemiological situation. The findings of the UNGASS-
reporting process will be utilized in the development of future HIV/Aids action plans 
during 2008. 
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TIIVISTELMÄ 
Vuonna 2001 (Kesäkuu 25-27) järjestettiin YK:n yleiskokouksen 26. erityisistunto 
teemanaan HIV/Aids (United Nations General Assembly Special Session on HIV/Aids; 
UNGASS) New Yorkissa. Istunnon ja sen aikaisten monenvälisten neuvottelukierrosten 
aikana YK käsitteli ensimmäistä kertaa HIV/Aids:ia kaikkien jäsenmaiden yhteisenä asiana 
yleiskokouksen tasolla. Yleiskokouksen puheenjohtajana toimi valtioneuvos Harri Holkeri 
Suomesta. 
HIV/Aids- erityisistunnossa YK:n jäsenmaat sitoutuivat pysäyttämään HIV-epidemian 
etenemisen vuoteen 2015 mennessä. Istunnon loppuasiakirjassa (Declaration of 
Commitment on HIV/Aids ”Global Crisis – Global Commitment”), määritellään 
prioriteetit, joilla epidemian vastaisia toimia on tehostettava. YK seuraa loppuasiakirjan 
tavoitteiden toimeenpanoa tasaisin välein toimitettavan indikaattoriraportoinnin kautta. 
Lisäksi tavoitteiden saavuttamista tarkistetaan yleiskokouksen seurantakokouksissa, joista 
edellinen pidettiin vuonna 2006. Seuraava seurantakokous pidetään kesäkuussa 2008. 
Tässä raportissa käsitellään vuosina 2006-2007 Suomessa tehty poikkihallinnollinen  
HIV/Aids-työ. Raportti on koottu Sosiaali- ja terveysministerion johdolla, tiiviissä 
yhteistyössä Ulkoministeriön ja kansalaisjärjestökentän kanssa. Tiedot on koonnut, 
tulkinnut ja koonnut raporttimuotoon Kansanterveyslaitoksen HIV-yksikkö. 
Raportti on valmisteluvaiheessa käynyt useassa vaiheessa lausuntokierroksilla kaikkien 
oleellisten hallintosektoreiden ministeriöillä ja laitoksilla sekä laajalla järjestökierroksella. 
Myös kuntasektorille varattiin mahdollisuus lausuntojen antamiseen. 
HIV/Aids-epidemian hallinnassa Suomi on onnistunut sekä kansainvälisessä että EU-tason 
vertailussa erinomaisesti. Kuten monet muutkin EU-maat, Suomi täyttää ja useassa 
tapauksessa ylittää lähes kaikki UNGASS HIV/Aids deklaraation epidemian ehkäisyn 
tavoitteet, myös indikaattoritasolla.  
Vaikka HIV/Aids-tilanne Suomessa on hyvä monien mittareiden tasolla, seksivälitteiset 
tartunnat ovat viimeisten vuosien aikana selvästi lisääntyneet. Raportointi toikin esiin 
merkittäviä riskejä ja parantamisen tarvetta erityisesti ehkäisevän työn alueeella. Myös 
käyttäytymiseen liittyvää riskikäsitys- ja terveysseurantaa aikuisväestöllä tulisi kehittää.  
HIV/Aids-työn kansallinen poikkihallinnollinen koordinaatio vaatisi vahvistamista mikäli 
hyvä epidemiologinen tilanne halutaan tulevaisuudessa säilyttää. UNGASS-raportoinnin 
kautta esiin nousseita asioita onkin tarkoitus hyödyntää HIV/Aids-toimintaohjelman 
uudistamisprosessissa vuonna 2008. 
Asiasanat: HIV, Aids, Suomi, Ilmaantuvuus, Esiintyvyys, Maaraportti, UNGASS
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SAMMANDRAG 
Den 25-27 Juni, 2001, höll FN:s generalförsamling en specialsession om HIV/Aids (United 
Nations General Assembly Special Session on HIV/Aids; UNGASS) i New York.  Under 
specialsessionen och därtillhörande multilaterala konsultationer behandlade FN:s 
generalförsamling för första gången HIV/Aids som en separat gemensam fråga. Ordförande 
för specialsessionen var statsråd Harri Holkeri från Finland. 
Under specialsessionen förband sig FN:s medlemsländer att stoppa HIV-epidemin före år 
2015. Sessionen slutade med antagandet av en deklaration, Declaration of Commitment on 
HIV/Aids ”Global Crisis – Global Commitment” där medlemsländerna förbinder sig till 
specifika prioriteter för handling mot detta mål. FN följer upp deklarationen genom 
återkommande indikator-rapportering. Därtill följs målsättningarna genom 
uppföljningsmöten på hög nivå. Detta gjordes först år 2006, och följande möte kommer att 
anordnas i New York i Juni 2008. 
I rapporten beskrivs multisektorialt HIV/Aids-arbete i Finland 2006-2007. Rapporten är 
utformad under vägledning av Social- och hälsovårdsministeriet samt i samarbete med 
Utrikesministeriet och medborgarorganisationer. Materialet är samlat, tolkat och producerat 
till rapportform av Folkhälsoinstitutets (KTL) HIV-enhet. 
Under rapportens produktionsperiod har alla relevanta administrativa sektorer (inklusive 
kommunsektorn) samt ett stort antal medborgarorganisationer hörts i flera skeden och getts 
tillfälle att kommentera rapporten.   
I bekämpandet av HIV/Aids-epidemin har Finland lyckats väl både i internationell 
jämförelse och i relation till andra EU-länder. Liksom ett flertal andra EU-länder, uppfyller 
och i ett flertal avseende även överträffar Finland UNGASS HIV/Aids deklarationens 
målsättningar, även på indikatornivå. 
Även om situationen ser ut att vara under relativt god kontoll, finns det dock risker och 
hotbilder som borde åtgärdas. Antalet sexuellt överförda HIV-fall i Finland har ökat klart 
under de senaste åren. Rapporteringen påvisade speciellt resursbrister i preventivt 
HIV/Aids arbete, samt behov för förbättring av riskuppfattnings- och sexualhälso-
uppföljningsstudier bland vuxenbefolkningen. 
Den nationella koordinationen av preventivt HIV/Aids arbete skulle också kräva 
förstärkning och utveckling ifall det goda epidemiologiska läget skall kunna upprätthållas i 
framtiden. Dessa frågor kommer att uppmärksammas under utformningen av ett nytt 
nationellt HIV/Aids verksamhetsprogram under år 2008. 
Ämnesord: HIV, Aids, Finland, Insidens,  Prevalens, Landrapport, UNGASS 
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1. Status at a glance  
1.1. Inclusiveness of the stakeholders in the report writing process  
The report writing process was initiated in the spring of 2007, by a letter of consultation 
sent by the Ministry for Foreign Affairs (MFA) to the National Public Health Institute – 
(KTL) through the Ministry of Social Affairs and Health. This letter was prompted by the 
request of the Director of UNAIDS, Dr. Peter Piot for UNGASS reporting 2008. Following 
this, a coordination meeting of the abovementioned main governmental actors was 
commenced at the MFA on June 8, 2007. At this meeting, the main responsibilities of the 
actors were discussed and divided.  
As vice-chair (KTL) and chair (MoSAH) of the NAC, KTL and the MoSAH were assigned 
the main work of collection and analysis of indicator data. In the process, they would 
consult all significant stakeholders both at the data collection, report drafting and prior to 
final submission stages. It was decided, that the HIV-unit of KTL will assume the main 
coordinating and drafting responsibility in the report writing process, supported as needed 
by the MoSAH. 
In addition, KTL assumed responsibility for data collection and collation of the of the 
National Composite Policy Index (NCPI) questionnaires part A: 
I. Strategic Plan  
II. Political Support,  
III. Prevention,  
IV. Treatment, care and support and V. Monitoring and evaluation). 
The MFA assumed responsibility for delivery of the final report and collection and 
collation of Global Commitment and Action indicators. 
An important role of Civil Society NGO actors in the reporting process was recognized at 
the June 8 coordination meeting. It was decided to involve civil society not only as 
respondents at the report data collection stage, but also through two specific consultation 
and coordination activities. 
For the collation of the National Composite Policy Index (NCPI) questionnaires part B  
I. Human rights,  
II. II. Civil society participation,  
III. III. Prevention,  
IV. IV and Treatment, care and support),  
the Finnish HIV-network (a network of Finnish national and multilateral NGO/Civil 
Society actors; see attached list in section 11.2.6) was asked to act as the coordinator for 
responding to this part.
After completion of a first draft of the report, it was submitted to the NGO-actors and a 
hearing session of one half day was organized on November 19th. Feedback from the 
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NGO/Civil society actors was incorporated into a new draft, which was sent for final 
review on the 4th of December, 2007 to additional relevant NGO, civil society and 
governmental stakeholders. 
Finally, the feedback of the review was incorporated into the report after which it was 
submitted to UNAIDS in January 2008. 
1.2. Status of the epidemic 
In 2007, 184 new HIV cases were reported in Finland. Cumulatively 2258 HIV-cases had 
been reported in Finland (as reported by 2.1.2008). Of these 492 had developed AIDS, of 
which 281 had died. For the year 2006 the corresponding figures were 2089 (HIV-
infection), 459 (AIDS) and 273 (AIDS death). 
1.2.1. Surveillance of HIV/AIDS 
HIV-infection, AIDS and AIDS death are reportable diseases/conditions in Finland. 
Reporting and case linking is performed through comprehensive use of national personal 
social security insurance identity numbers, given at birth or at entry for legal long term 
immigration. The European Case definitions for HIV and Aids are followed in reporting. 
Access to free-of-charge HIV-testing is through publicly funded municipal health care 
centers (main primary care providers). If requested, testing can be performed anonymously. 
Anonymous testing is also available through several different NGO settings and the private 
sector.
By law, both diagnostic laboratories and treating physicians report cases to the Finnish 
National Public Health Institute (KTL), which maintains the National Infectious Disease 
Registry (NIDR) for passive surveillance purposes. The system records major transmission 
groups and has been in use without major changes since the mid-1980s. 
Voluntary targeted unlinked-anonymous studies are used as additional data sources to 
address prevalence in vulnerable groups. Blood and organ donations are universally 
screened for HIV and all expecting mothers are offered voluntary HIV-testing (opt-out 
regimen in place since 1998). 
1.2.2. The HIV epidemic 
The HIV/AIDS epidemic reached Finland in the mid-1980s. The epidemic has followed a 
western-European type of evolution with a consistently low annual incidence and 
prevalence rate of both HIV-infection and AIDS. Initially, the epidemic affected mostly 
men having sex with men (MSM), so that for many years, the majority of cases were in this 
transmission group. During the first 10-15 years of the epidemic HIV incidence and 
prevalence in Finland was among the lowest in a comparison of western European 
countries. By 2006-2007, the incidence rate has risen close to that of other Nordic 
Countries, but is still lower than in most old EU member states. 
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A feature of the Finnish HIV epidemic is that almost no IDU-associated HIV cases were 
recoded during the 1980s and the beginning of the 1990s. This is in sharp contrast to 
almost all other western European countries, including Sweden, Norway and Denmark, 
where large-scale outbreaks occurred in the 1980s. However, in 1998 the situation 
changed, when an outbreak was recorded among IDU mainly in the capital area. A strong 
prevention effort to counteract the outbreak was put in place, centering on development of 
Low Threshold Health Service Centers for IDU, providing health advice, referrals, small-
scale care, vaccinations, rapid testing and injection equipment exchange. These efforts 
seem to have had an effect, since the outbreak has subsided and the prevalence never rose 
above 5 % within the subgroup. 
During the late 1990s and especially after the year 2000, more and more cases of 
heterosexual transmission have been annually reported, and heterosexual transmission has 
for several years in a row been the largest transmission group. Approximately one third to 
one half of cases in this transmission category are reported among immigrants. 
In 2006, reported cases of sexual transmission increased approximately 30 % compared to 
the year before. In 2007, preliminary surveillance data indicates that this increase seems to 
have been sustained. 
1.2.3. AIDS and AIDS death 
AIDS and AIDS-deaths peaked in Finland in 1994 and 1995, at 43 cases and 31 deaths, 
respectively. Since then, cases have declined, especially AIDS deaths. In 2007, 8 AIDS 
deaths were reported and only 3 in 2007. The reduction in AIDS deaths despite an increase 
in HIV-cases corresponds to the comprehensive access to care and ARV-treatment. After 
an initial sharp decline in reported AIDS-cases after start of widespread access to ARV-
triple therapy in 1997, AIDS-cases have increased again since the turn of the century to 
approximately 25 cases annually. Most of these cases are diagnosed simultaneously as, or 
close to HIV-infection.  
1.2.4. Current HIV prevalence and incidence estimates:  
Figure 1 HIV Prevalence and Incidence 
Population HIV prevalence rate of approximately 2 / 10.000 population* 
Population HIV incidence rate of approximately 35 / million population* 
HIV prevalence among vulnerable groups. 
Estimated HIV prevalence among MSM: 4.5 % (2.6 - 7.3 %, CI 95 %) ** 
Estimated HIV prevalence among IDU: 1.4 % (0.5 – 3.2 %, CI 95 %) ** 
* based on passive reporting surveillance data (2007) 
** based on cross-sectional unlinked-anonymous sampling data (2006 and 2005) 
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1.3. Policy and programmatic response 
1.3.1. Main objectives of the Finnish HIV/AIDS prevention policy 
Prevention of new infections is the key target of policy measures. For those who become 
infected, there is guaranteed free access to medically indicated treatment and care.  
Support for full social empowerment of persons who have been infected to reduce their 
vulnerability is an essential part of prevention policies. Prevention activities are managed 
through national coordination and a multidisciplinary public/private partnership approach. 
1.3.2. Main target groups of national HIV/AIDS prevention policy 
• Youth are the most important target group, including the MSM group which must 
also be reached  
• Prevention of infection risks and drug use among injecting drug users are equally 
important. 
• Special attention needs to be directed to prisons, socially marginalised group, 
immigrants and sex workers 
• Prevention of Mother to child transmission MTCT must be comprehensive 
• Transmission within the healthcare sector must be completely eliminated, while 
simultaneously ensuring equal access to services for those living with HIV/AIDS 
1.3.3. Main approaches to HIV/AIDS prevention 
• HIV/AIDS prevention, treatment and care are integrated in a cross cutting way into 
multi-sectorial public health, social welfare and education programs on municipal, 
regional and national levels  
• Health education and promotion are the main modes of influencing the 
development of the future epidemic 
• Impact trough schools: health education as a standard compulsory subject for 
primary grades 7-9 as well as secondary grades I - II and includes sexual health and 
STD risk education 
• Effective treatment and support measures are an integral part of prevention 
• Support for full social empowerment of persons who have been infected to reduce 
their vulnerability is essential. 
• HIV testing practices and epidemiological surveillance systems generate relevant 
information for intervention planning 
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• The level of competence of social and healthcare professionals must be a 
maintained and expanded by continuous primary and work associated education and 
training 
• Legislation will respond with changes as needed if the HIV/AIDS situation changes 
• Management of the situation through coordination and a multidisciplinary action 
1.3.4. Political documents that exist with regard to HIV/AIDS prevention 
1. The Health 2015 Public Health Programme. Government resolution, Helsinki 2001. 
36 p. (Publications of the Ministry of Social Affairs and Health, ISSN 1236- 2050: 
2001:6) ISBN 952-00-0982-5. 
2. National HIV/AIDS policy for 2002-2006. Published in Helsinki, March 5, 2002. 
HIV Expert Group, Ministry of Social Affairs and Health. 
3. National HIV/AIDS prevention strategy for 2008-2012 (draft 2007, to be completed 
by 1.6.2008). HIV Expert Group, Ministry of Social Affairs and Health. 
4. Drug policy action programme 2004-2007. Government decision 2004. 
5. Promotion of sexual and reproductive health. Action programme 2007–2011. 
Helsinki 2007. 200 pp. (Publications of the Ministry of Social Affairs and Health, 
Finland. ISSN 1236-2050, 2007:17). ISBN 978-952-00-2376-8 (paperback), ISBN 
978-952-00-2377-5 (PDF) 
6. National Tuberculosis Control Programme 2006. Helsinki 2006. 144pp. 
(Publications of the Ministry of Social Affairs and Health, Finland, ISSN 1236-
2050, 2006:21) ISBN 952-00-2120-5 (paperback), ISBN 952-00-2121-3 (PDF) 
1.3.5. Funding for HIV/AIDS prevention, treatment, care and support 
The public financial resources allocated to HIV/AIDS prevention are divided between 
multiple actors and sectors. In many cases HIV/AIDS-prevention activities are linked to 
general health prevention and education activities. There is no specific budget line for the 
purpose and a comprehensive estimation of the resources used for HIV/AIDS has not been 
made. Prevention of health problems is according to the Law on Public Health 
(Kansanterveyslaki) the responsibility of the municipal government. Therefore, the 
responsibility for prevention, treatment and care lies within the municipally managed 
public national social services and health system providers. 
HIV/AIDS prevention, care and support are mainly integrated into the public healthcare 
social care/welfare and education activities on state, regional and municipal levels. No 
specific publicly budget line earmark funded HIV/AIDS-specific governmental 
organizations exists.  
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On a municipal level, responsible authorities are the municipal social welfare and health 
boards and the municipal health centers (publicly funded primary healthcare providers). 
For primary education the municipal school boards and the primary and secondary 
education system (Comprehensive school and High school system) has the main 
responsibility for health promotion and sexual health education, including HIV/AIDS 
prevention education in schools. 
Several national NGO and Civil Society organizations are actively involved in HIV/AIDS 
prevention and health education work. These are frequently partly or entirely funded 
through public/private partnerships with municipal and/or national funding agencies. 
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1.4. UNGASS indicator data: overview table 
1.4.1. National indicators 
Commitment and Action  
Indicator Description Value 
1 Domestic and international AIDS spending by categories and ﬁnancing 
sources  
Estimate not 
available 
2
National Composite Policy Index (Areas covered: gender, workplace 
programs, stigma and discrimination, prevention, care and support, human 
rights, civil society involvement, and monitoring and evaluation)  
Supplied in 
Annex 2 
National Programs  
Indicator Description Value 
3 Percentage of donated blood units screened for HIV in a quality 
assured manner1 100% 
4 Percentage of adults and children with advanced HIV infection 
receiving Antiretroviral treatment2 > 90 % 
5
Percentage of HIV-positive pregnant women who received 
antiretrovirals to reduce the risk of mother-to-child transmission2 > 95 % 
6 Percentage of estimated HIV-positive incident TB cases that received 
treatment for TB and HIV2 > 90 % 
7
Percentage of women and men aged 15-49 who received an HIV test 
in the last 12 months and who know their results3 > 95 % 
8
Percentage of most-at-risk populations that have received an HIV test 
in the last 12 months and who know their results4 > 95 % 
9 Percentage of most-at-risk populations reached with HIV prevention 
programs Not known 
10
Percentage of orphaned and vulnerable children aged 0–17 whose 
households received free basic external support in caring for the child5 > 99 % 
11 Percentage of schools that provided life skills-based HIV education in 
the last academic year6 > 95 % 
Data sources: 
1 Finnish Red Cross transfusion services 
2 Hospital Districts, MoSAH 
3 Primary healthcare providers 
4 Primary healthcare providers, Low threshold health service center sentinel surveillance network (KTL) 
5 MoSAH 
6 National Board of Education 
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Knowledge and Behavior 
Indicator Description Value 
12 Current school attendance among orphans and among non-orphans 
aged 10–14*7 > 99 % 
13
Percentage of young women and men aged 15–24 who both correctly 
identify ways of preventing the sexual transmission of HIV and who 
reject major misconceptions about HIV transmission*8 > 85 % 
14
Percentage of most-at-risk populations who both correctly identify ways 
of preventing the sexual transmission of HIV and who reject major 
misconceptions about HIV transmission  Not known 
15
Percentage of young women and men aged 15–24 who have had 
sexual intercourse before the age of 159
Girls aged 
14: 15 % 
Boys aged 
14: 15 % 
16
Percentage of women and men aged 15–49 who have had sexual 
intercourse with more than one partner in the last 12 months  Not known 
17
Percentage of women and men aged 15–49 who had more than one 
sexual partner in the past 12 months reporting the use of a condom 
during their last sexual intercourse*  Not known 
18
Percentage of female and male sex workers reporting the use of a 
condom with their most recent client  Not known 
19
Percentage of men reporting the use of a condom the last time they had 
anal sex with a male partner Not known 
20
Percentage of injecting drug users reporting the use of a condom the 
last time they had sexual intercourse10  39-67 % 
21
Percentage of injecting drug users reporting the use of sterile injecting 
equipment the last time they injected11  80-84 % 
7 MoSAH, National Board of Education 
8 Eurobarometer survey 2006 
9 School Health Survey 2006 and 2007 
10 “Risk”-study, Partanen et al. (2006) Publication series of the A-clinic foundation 52 
11 “Risk”-study, Partanen et al. (2006) Publication series of the A-clinic foundation 52, Low threshold health 
service center sentinel surveillance network (KTL) 
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Impact 
Indicator Description Value 
22
Percentage of young women and men aged 15–24 who are HIV infected12 0.03 % 
23
Percentage of most-at-risk populations who are HIV infected13
IDU: 1.4 % 
MSM: 4.5 % 
24
Percentage of adults and children with HIV known to be on treatment 12 
months after initiation of antiretroviral therapy14 > 90 % 
25
Percentage of infants born to HIV-infected mothers who are infected15 0 % 
1.4.2. Global Indicators
Indicator Description Value 
1
Amount of bilateral and multilateral ﬁnancial ﬂows (commitments and 
disbursements) for the beneﬁt of low- and middle-income countries16 20,5 M€ 
2
Amount of public funds for research and development of preventive 
HIV vaccines and microbicides17
Vaccines 
2006: 1.3 
M€ 
2005: 2.6 
M€ 
Long term 
investment 
6.6 M€ 
3
Percentage of transnational companies that are present in developing 
countries and that have workplace HIV policies and programs  
To be 
supplied by 
UNAIDS 
4
Percentage of international organizations that have workplace HIV 
policies and programs  
To be 
supplied by 
UNAIDS 
12 National infectious disease surveillance system 
13 MSM survey and prevalence study 2006, IDU LTHSC visitor prevalence studies 
14 Hospital Districts 
15 National infectious disease surveillance system 
16 Ministry for Foreign Affairs 
17 TEKES and SITRA 
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2. Overview of the 
HIV/AIDS epidemic in 
Finland in 2006-2007 
The HIV/AIDS epidemic reached Finland 
in the mid-1980s. The epidemic has 
followed a western-European type of 
evolution with a consistently low annual 
incidence and prevalence rate of both 
HIV-infection and AIDS. Initially, the 
epidemic affected mostly men having sex 
with men (MSM), so that for many years, 
the majority of cases were in this 
transmission group. During the first 10-
15 years of the epidemic HIV incidence 
and prevalence in Finland was among the 
lowest in a comparison of western 
European countries. By 2006-2007, the 
incidence rate has risen close to that of 
other Nordic Countries, but is still lower 
than in most old EU member states. In 
2006, 193 new HIV cases were reported, 
and in 2007 the same figure was 184 
cases (per 2.1.2008). 
A feature of the Finnish HIV epidemic is 
that almost no IDU-associated HIV cases 
were recoded during the 1980s and the 
beginning of the 1990s. This is in sharp 
contrast to almost all other western 
European countries, including Sweden, 
Norway and Denmark, where large-scale 
outbreaks occurred in the 1980s. 
However, in 1998 the situation changed, 
when an outbreak was recorded among 
IDU mainly in the capital area. A strong 
prevention effort to counteract the 
outbreak was put in place, centering on 
development of Low Threshold Health 
Service Centers for IDU, providing health 
advice, referrals, small-scale care, 
vaccinations, rapid testing and injection 
equipment exchange. These efforts seem 
to have had an effect, since the outbreak 
has subsided and the prevalence never 
rose above 5 % within the subgroup. 
During the late 1990s and especially after 
the year 2000, more and more cases of 
heterosexual transmission have been 
annually reported, and heterosexual 
transmission has for several years in a 
row been the largest transmission group. 
Approximately one third to one half of 
cases in this transmission category are 
reported among immigrants. 
In 2006, reported cases of sexual 
transmission increased approximately 30 
% compared to the year before. In 2007, 
preliminary surveillance data indicates 
that this increase seems to have been 
sustained. 
2.1. Access to VCT 
Access to free-of-charge HIV-VCT is 
provided through publicly funded 
municipal health care centers (main 
primary care providers).  In Finland, the 
majority of the outpatient primary care 
services are within the public sector, as 
are >95 % of the hospitals. More than 400 
municipalities are served by 
approximately 250 municipal primary 
health care centers, which all offer free-
of-charge HIV-testing services for 
municipal residents. If requested, testing 
can be performed anonymously. Testing 
is performed by licensed clinical micro-
biological and immunological 
laboratories which have to follow set 
quality control and monitoring schemes 
according to internationally agreed 
standards. 
Anonymous testing is also available 
through several different NGO settings. 
Injecting drug users are offered referral 
based and/or rapid point-of-care testing at 
IDU Low Threshold Health Service 
Centers (LTHSC). Similarly, there are 
NGO-based anonymous VCT services 
available using rapid testing schemes, 
provided by the Finnish AIDS Council. 
The Finnish Red Cross also provides free 
of charge HIV-testing.  
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HIV testing is available in correctional 
facilities under similar VCT conditions as 
in the civil sector. 
Private healthcare services offering HIV 
VCT are also available. 
2.2. HIV screening 
No risk-group based screening or routine 
population HIV-testing is employed in 
Finland. However, to ensure the safety of 
blood and organ transplantations and to 
prevent mother-to-child HIV 
transmission, all blood and organ 
donations are universally screened for 
HIV-infection (using antibody, antigen 
and NAT-technology) and all expecting 
mothers are offered HIV-testing (opt-out 
regimen in place since 1997). In both 
cases, results are confidential. 
Under existing law HIV-testing is not 
allowed as a prerequisite for employment, 
studies or for serving in military or 
paramilitary forces. Neither is involuntary 
screening performed in correctional 
facilities or for immigrant populations. 
Both are, however, offered as part of 
preventive medical care. 
2.3. Surveillance schemes: 
passive surveillance for 
incidence estimation 
and prevalence back-
calculation 
HIV-infection, AIDS and AIDS death are 
reportable diseases/conditions in Finland.  
Reporting and case linking is performed 
through comprehensive use of national 
personal social security insurance identity 
numbers, given at birth or at entry for 
legal long term immigration. Many other 
infectious diseases follow the same 
reporting scheme as HIV, but more 
information on disease status is collected. 
By law (Law on infectious diseases and 
associated decree18), both diagnostic 
laboratories and treating physicians report 
cases to the Finnish National Public 
Health Institute (KTL), which maintains 
the National Infectious Disease Registry 
(NIDR19) for passive surveillance 
purposes. 
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Microbiological laboratory
Notifiable microbe finding
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Notifiable disease
Primary Health Care
Physician-in-charge
Health Care District
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Reminder to notify
remote
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starting 2004)
feedback
copy of 
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Figure 2: National Infectious Disease 
Notification System – NIDR 
Data submission follows the schematic 
described in the figure. The system 
records major transmission groups and 
has been in use without major changes 
since the mid-1980s. 
2.4. Surveillance schemes 
II: sampling-based 
studies for prevalence 
estimation in specific 
groups 
Voluntary targeted unlinked-anonymous 
studies are used as additional data sources 
to address prevalence in vulnerable 
groups. They have been used to estimate 
HIV prevalence among IDU: s at an 
approximately bi-annual rate and more 
recently also been applied to prevalence 
estimation among MSM. 
18 Law on infectious diseases 25.7.1986/583 and 
associated decree 31.10.1986/786 
19 National Infectious Disease Registry (NIDR): 
www.ktl.fi/ttr
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2.5. HIV/AIDS in major and 
minor transmission 
groups in 2006-2007 
By the end of 2007 (data as reported by 
2.1.2008), cumulatively 2258 HIV-cases 
had been reported in Finland. Of these 
492 had developed AIDS, of which 281 
had died. For the year 2006 the 
corresponding figures were 2089 (HIV-
infection), 459 (AIDS) and 273 (AIDS 
death). For HIV and AIDS reporting, 
Finland follows the European case 
definitions for AIDS and HIV-infection 
from 1993. http://www.ktl.fi/portal/4792
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Figure 3: Annually reported HIV by 
Transmission Category 
Annually reported HIV infections have 
steadily increased in Finland since the 
beginning of the epidemic in the 1980s. 
The first known HIV-case in Finland 
stems from 1980 (retrospectively 
identified). 
In the beginning years of the epidemic, 
HIV-infection was very much associated 
with MSM and few cases in other 
transmission groups were recorded. In the 
1990s more heterosexually transmitted 
cases appeared, both among migrants 
coming from high-endemic areas but also 
among native Finns. By the late 1990s, 
the epidemic seemed to have stabilized at 
approximately 60-80 cases reported 
annually. 
A particular feature of the Finnish 
epidemic is the absence of an IDU-
associated epidemic during the 1980s. 
While all other Nordic countries 
experienced large outbreaks in this group 
during this time period, very few cases 
appeared in Finland, despite active case-
finding and even screening efforts among 
some vulnerable groups (notably prison 
inmates). 
In the late 1990s, however, this changed: 
in a few years beginning in 1998 more 
than 300 new cases were reported among 
IDU. Since then, strong prevention efforts 
seem to have been able to limit the 
outbreak and prevent the establishment of 
high prevalence and permanent 
endemicity in the group (se below chapter 
2.5.2 for further details). 
During the period of 2000 to current 
times, a clear trend of increased cases in 
the sexual transmission group is seen, 
both in the MSM and heterosexual 
transmission categories. 
In 2006, cases in the sexual transmission 
increased by approximately 30 % 
compared to the previous year, raising 
concerns of the need to improve 
prevention efforts for this transmission 
category. The same trend seems to 
continue in 2007. 
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Figure 4: Mean Age at HIV Diagnosis 
The age distribution among HIV cases on 
diagnosis has remained relatively high 
over the years. The mean age has risen 
from approximately 34 years to 40 since 
1995. Especially among men, the rise in 
mean age is significant. 
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Cases among women are on average 5 
years younger than men at HIV diagnosis.  
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Figure 5: Age Group Distribution at Diagnosis 
As seen by the age group chart, the 
increase in mean age is particularly due to 
the increase in the oldest age group, but 
partly also the group of 25-49 year old, 
where a strong increase was seen in 2006 
compared to previous years.  
The peak among youth (15-24 year old) 
seen in the years 1999 to 2001 is largely 
due to an outbreak among IDU during 
those years. 
AIDS in Finland follows the general 
epidemiology of other western highly 
developed countries. After a substantial 
lag compared to HIV-infection, the 
incidence of AIDS rose to its maximum 
level in 1994-1995, when 44 and 43 
cases, respectively, were reported.  
After 1996 and 1997 combination 
antiretroviral therapy including protease 
inhibitors became widely available in 
Finland and AIDS diagnoses dropped 
markedly. The lowest level was recorded 
in 1999, when only 11 cases were 
notified to the NIDR.  
Currently, approximately 25 AIDS cases 
are annually reported. Of these, over half 
are discovered simultaneously or within 1 
month of their HIV-diagnosis, and 
therefore probably largely represent long-
term, previously undetected infections. 
The level of underreporting of AIDS 
cases has not been formally estimated, 
but is not likely to be very high due to the 
few numbers of cases. It is known to be 
higher among immigrant populations, 
partly due to loss-to-follow-up due to 
further migration. There is no evidence of 
higher in AIDS incidence among 
permanent residents with immigrant 
background compared to native Finns. 
All Aids cases
0
5
10
15
20
25
30
35
40
45
50
Year
Ca
s
e
s
322626212421191611171924434425242517171777432100
2007200620052004200320022001200019991998199719961995199419931992199119901989198819871986198519841983198219811980
Figure 6: Annual Newly Reported AIDS-Cases 
in Finland 
Deaths are followed two ways for 
reported HIV cases. Deaths due to AIDS 
are reported to the NIDR similarly to 
AIDS and HIV-infection. In addition, 
cases are regularly (weekly) linked to 
death reports in the national Population 
Register, which records all causes of 
death among residents in Finland. 
Therefore, deaths due to AIDS and due to 
other causes can be distinguished.  
Mortality surveillance shows, that during 
the period of up to 1998, most deaths 
among HIV-infected were due to AIDS. 
Since then, however, the majority of 
deaths occur due to other reasons. In 
2006, only 3 AIDS-related deaths 
occurred, representing only 10% of all 
deaths among HIV cases. A large part of 
the reduction in AIDS-related death is 
probably due to wide coverage and good 
compliance of ARV-treatment. 
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Figure 7: Annual newly reported deaths among 
HIV-infected in Finland 
Non-AIDS related deaths in the group of 
HIV cases are overrepresented in the 
IDU-transmission category, which may 
currently underestimate the proportion of 
AIDS-related  
deaths. The proportion may change in the 
future.  
2.5.1. HIV infection: Sexual 
transmission 
Sexual transmission has increased its 
share and numbers among annually 
reported HIV cases in Finland. This trend 
is seen both in the transmission group of 
men who have sex with men (MSM) and 
among cases in the heterosexual group. 
HIV: Sexual transmission trends
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Figure 8: HIV Infection - Sexual Transmission 
Trends 
2.5.1.1. Men who have sex with men 
(MSM)
Among MSM the reversed trend is 
clearly visible, as cases diminished 
during the whole period of the 1990s, but 
have again slowly started rising in the 
present century (red trend line). 
The main crossing point of the trend was 
seen in 1998, when reported cases among 
MSM reached their lowest point of only 
13 cases. Since then annual figures have 
risen slowly but constantly, so that in 
2006 an all-time-high of 61 cases were 
reported in this group. 
Most cases in the MSM group are among 
individuals who are Finnish citizens at 
the time of diagnosis. 
The prevalence of HIV-infection among 
MSM was empirically estimated for the 
first time in 2006 using an anonymous 
survey and linked testing oral fluid mail-
in testing scheme. Among the 
approximately 400 study participants, 
HIV prevalence was found to be 4.5 % 
(CI 95, 3 – 7%). The estimate is biased by 
higher socioeconomic status, age and 
regional representativeness, but does 
provide evidence of significant 
prevalence at least in a part of the 
vulnerable subpopulation. 
2.5.1.2. Heterosexual transmission 
Similar to the MSM group, the trend of 
heterosexual transmission shows a strong 
rise in annually reported cases during the 
latest century. In 2006 a record number of 
94 cases were reported in this 
transmission category. 
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Figure 9: Heterosexual Transmission 
Approximately 63 % (n = 59) of cases 
reported in this category in 2006 were 
Finland 2008 UNGASS HIV/Aids country report– KTL B4 / 2008 
Report collation, drafting and coordination 
National Public Health Institute – KTL, HIV unit 
www.ktl.fi 29
among individuals with Finnish 
citizenship at diagnosis. This is slightly 
higher, but consistent with the proportion 
seen in previous years. 2007 figures are 
not adjusted for reporting delay. 
2.5.1.2.1. Men 
A slight majority of cases in the 
heterosexually transmitted category are 
seen among men. The sex ratio among 
the cases is 1:1.2. Among Finnish 
nationals at diagnosis, the ratio is on 
average higher, approximately 1:1.6. 
Among immigrant populations, the sex 
ratio is reversed, approximately 0.8:1. 
In 2006, 47 cases of HIV infection among 
men were recorded in the heterosexual 
transmission category. 
2.5.1.2.2. Women 
Women represent on average 
approximately 45 % of annually reported 
cases in the heterosexual transmission 
category. The growth in annually reported 
numbers for heterosexual transmission is 
also seen among women, but the trend is 
slightly less pronounced that that seen 
among men, especially if only Finnish 
citizens at date of diagnosis are 
considered. 
2.5.2. HIV infection: Injecting 
drug use 
Finland experienced its first domestic 
outbreak of HIV-infection among IDU 
only in the late 1990s, more than 10 years 
later than most western European 
countries. Even the countries closest 
benchmarks, the other Nordic countries of 
Sweden, Norway and Denmark 
experienced severe HIV epidemics 
among IDU in the mid- and late 1980: s. 
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Figure 10: Injecting Drug Use 
Prior to 1998, few IDU associated cases 
were reported, and most of them were 
reliably associated with likely 
transmission abroad. However, in 1998 a 
rapid increase in cases in this category 
was recorded. Since then, a total of 325 
cases (by November 9, 2007) in this 
category have been reported, most of 
which are linked to the original epidemic. 
In the last few years, however, the 
number of annually reported cases has 
strongly diminished, so that in 2006 only 
9 cases and in 2007 only 6 (by November 
9, 2007) cases were reported. 
Additional data from anonymous 
sampling based surveillance shows that 
the prevalence has remained low in the 
group, despite continuously high 
Hepatitis C prevalence. A prevalence 
study was last performed in 2005 and late 
2007. The 2005 data indicates a 
prevalence of approximately 1.4 % HIV 
infection among IDU. Preliminary 
analysis of 2007 data suggests that 
prevalence has remained low. 
2.5.3. Mother-to-child
transmission - MTCT 
The total number of cases reported to be 
due to MTCT since start of surveillance 
in 1980 is 14 cases. All but one of these 
cases have occurred prior to arrival to 
Finland. 
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Table 1: HIV-testing among Pregnant women in Finland 1998-2006 
All expecting mothers in Finland who participate in maternity care services (>> 99 % of 
pregnancies) are offered HIV-testing. Annually approximately 60.000 pregnant women are 
tested. Approximately 40 % of the women have had their first HIV diagnosis through the 
MTCT testing system. 
Since the start of the screening programme (1998) and associated efficient MTCT 
prophylaxis for both the mother and child, no children have been infected with HIV in 
Finland through this transmission route, when HIV infection has been diagnosed prior to 
delivery. In a follow-up study between 1993 and 2007 in the largest maternity ward in 
Finland, 96 healthy children without HIV-infection had been born to HIV infected women 
by November 200720. Only one child was infected during this period, and in this case the 
mother’s infection was only diagnosed after delivery. 
2.5.4. Blood and organ donations 
The total number of HIV infections due to blood or tissue products or due to organ 
transplants reported in Finland since 1980 is 14.  
Table 2: HIV testing among blood donations in Finland 
1998 1999 2000 2001 2002 2003 2004 2005 2006 
Donated 
units 
tested 349120 335751 330635 322357 312455 297292 285794 274870 278220 
HIV+ 0 0 0 0 2 2 0.0 1 2 
/100 000 0.00 0.00 0.00 0.00 0.64 0.67 0.00 0.36 0.72 
However, no cases of HIV infection due to domestic blood transfusions or blood products 
have been reported to have taken place in Finland after 1985. 
20 Päivi Lehtovirta, 2007.  Obstetric and Gynecological Aspects of HIV-infection in Finland. 79 p. University 
of Helsinki, Faculty of Medicine, Doctoral Thesis. Yliopistopaino, Helsinki. ISBN 978-952-92-2757-0. 
1998 1999 2000 2001 2002 2003 2004 2005 2006 
Tested 60055 5867
0
59112 57427 59112 60300 60060 59343 59659 
HIV + cases 5 7 8 13 12 13 8 16 13 
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2.5.5. Special considerations 
and vulnerable groups 
2.5.5.1. Youth
Among youth aged 15-24 years old, HIV-
infection is relatively rare. Totally, 304 
cases have been reported, 46 in the ages 
of 15-19 and 258 in the age group of 20-
24 years old. The prevalence in the age-
group is approximately 0.03 % based on a 
population of 260.00021 and taking into 
account deaths. 
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Figure 11: HIV-infection among youth 
Cases in these age groups occur mainly in 
the IDU (30.5 %), Heterosexual 
transmission (35.5 %) and MSM (13 %) 
categories.  In the younger (15 – 19 year 
old) age group, 54 % (n = 25) of the cases 
are among migrants, many of which may 
have been infected through MTCT. The 
peak of 1999-2001 was clearly associated 
with an outbreak among IDU. 
Surrogate markers 
Chlamydia and Hepatitis C virus 
infection among youth can be considered 
surrogate markers of sexual and injecting 
drug use associated HIV-risks among 
youth and are followed as indicators of 
risk changes. 
21 National Population register, 2006 
Hepatitis C infection among youth
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Figure 12: Hepatitis C infection among youth. *
adjusted for reporting delay
In the age-groups of youth, HCV-
infection has declined during the last 6-8 
years, indicating less risk associated with 
IDU (see later chapters for prevention 
programme).   
Chlamydia trachomatis infection among youth
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Figure 13: Chlamydia trachomatis infection 
among youth. * adjusted for reporting delay 
In contrast to Hepatitis C infection, 
Chlamydia infection is common among 
youth and shows no sign of clear decline, 
suggesting common risk for sexual 
transmission. Therefore, general STI 
prevention efforts are particularly 
targeted to youth and adolescents. 
2.5.5.2. Migrants
HIV cases according to citizenship at 
diagnosis
A significant proportion of HIV cases in 
Finland are seen among immigrant 
populations, as defined by citizenship 
status at the time of reporting. Of the total 
number of reported cases in Finland, 28.5 
% has been among immigrants. 
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Domestic and migrant HIV 
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Figure 14: Domestic and Migrant HIV 
infection. * Finnish Citizenship, § Foreign citizenship
While these cases do affect disease 
burden, the effect on the evolution of 
domestic epidemiology is less significant 
since the reported cases represent the 
epidemiology of the originating country.  
Transmission categories among migrants
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Figure 15: Migrant HIV-cases and 
Transmission Category 
The most common transmission category 
among migrants is heterosexual 
transmission. The proportion of cases for 
which there is no reported transmission 
category is high, probably due both to re-
migration before physician reporting 
and/or due to inability to identify the 
most likely way of transmission. 
The proportion of MSM cases among 
migrants has somewhat increased since 
the turn of the millennium.  
2.5.5.3. Travelers 
A significant proportion HIV cases have 
a travel association. Of cases among 
Finnish citizens, 38 % have been reported 
to be travel-associated (390 cases by 
2006). The absolute majority belongs to 
the sexual transmission group. 
Travel associated HIV cases among Finnish citisens, 1980-2006 
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Figure 16: Travel Associated HIV-cases among 
Finnish Citisens, 1980 - 2006 
Travel associated cases are clearly linked 
to areas to which Finns travel frequently. 
General areas where cases have been 
reported to occur have changed somewhat 
over time, as shown by the below figure. 
The largest numbers of travel-associated 
cases in recent years are linked to travel 
to South-East Asia. 
2.5.5.4. Neighboring areas 
HIV-cases linked to neighboring areas 
with recently expanding epidemics have 
slowly increased, both due to travel and 
migration. In total, 32 cases linked to 
eastern European neighboring areas have 
been reported.  
2.5.5.5. Correctional facilities 
VCT applying rapid testing is offered as 
part of regular health care services in 
correctional facilities. Cases are reported 
using the same reporting system as the for 
the general public health service and are 
not identified separately, but separate 
monitoring of positive results collected in 
a cooperation between KTL and the 
prison health services. 
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Figure 17: HIV in Correctional Facilities 
2.5.5.6. Sex workers 
There is no specific information on the 
incidence or prevalence of HIV infection 
among sex workers in Finland. This 
group is not included in routine reporting 
in the regular passive surveillance 
system, although the association is 
sometimes reported. However, rapid HIV 
testing offered in low threshold services 
by NGO service providers does not 
indicate that prevalence would be 
especially high. 
However, due to high-prevalence 
epidemics in neighboring areas where a 
significant proportion of sex worker 
temporarily working in Finland originate 
from, there is a potential for high 
prevalence in this group in the future. 
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3. National cost estimates 
for HIV/Aids 
As HIV/Aids prevention, treatment, care 
and support activities are to a large extent 
integrated into general primary, 
secondary and tertiary health care, the 
total spending or resources allocated 
cannot be reliably estimated without a 
major effort. 
Even direct costs and the disease burden 
are challenging to estimate reliably over 
any longer time-periods. Recently, the 
European Center for Disease Prevention 
and Control (ECDC) commissioned a 
joint pilot study22,23 to perform a rough 
estimate on disease burden due to a 
number of important infectious diseases 
in Europe. One of the diseases covered 
was HIV-infection and Aids.  
While the ECDC study was a pilot with 
several limitations, especially in 
comparability across countries and years, 
it applied a standard composite 
methodology to estimate disease burden 
(Disability Adjusted Life Years), which 
could be used to make national estimates. 
Assessments of disease burden are often 
based on singular health metrics, such as 
incidence, prevalence or mortality data 
alone. However, as diseases and their 
consequences are heterogeneous in terms 
of morbidity and mortality it is difficult to 
get an overall estimate of disease burden. 
22 van Lier E, Havelaar A, Nanda A, . The burden 
of infectious diseases in Europe: a pilot study. 
Euro Surveill 2007;12(12)[Epub ahead of print]. 
Available online: 
http://www.eurosurveillance.org/em/v12n12/1212
-222.asp
23 van Lier E, Havelaar A. The burden of 
infectious diseases in Europe: a pilot study. 
(Printed matter) RIVM report 215011001/2007. 
RIVM, P.O. Box 1, 3720 BA Bilthoven. 
Available online: 
http://rivm.nl/bibliotheek/rapporten/215011001.ht
ml
Composite health measures attempt to 
overcome this by combining mortality, 
incidence (and/or prevalence) and the 
sequelae associated with a disease. The 
Disability Adjusted Life Years (DALYs) 
is such a composite measure that can be 
helpful in estimating disease burden. 
In addition to composite measures, direct 
current costs of an epidemic and future 
predictions can be estimated using 
average standard estimates of costs/case. 
While both methods are relatively crude 
and contain significant uncertainty and/or 
bias in several regards, they do provide 
some guidance on the scale of current and 
future disease burden and costs. 
National resource allocation for HIV/Aids 
prevention, treatment, and care and 
support activities can be estimated only 
for a small minority of activities. These 
mainly consider very targeted activities 
which have a separately distinguishable 
budget. The majority of HIV/Aids 
prevention, treatment, care and support 
activities in Finland are too integrated 
into other activities to allow for direct 
resource allocation estimation. 
3.1. Disease burden 
associated with 
HIV/Aids 
The method used in this report is based 
on the above mentioned report, which in 
turn is an application of the methodology 
first described by Murray and co-workers 
in the Global Burden of Disease (GBD) 
project24,25 
24 Murray CJ, Acharya AK. Understanding 
DALYs (disability-adjusted life years). J Health 
Econ 1997; 16(6):703-30.Murray CJ, Lopez AD.  
25 Global mortality, disability, and the 
contribution of risk factors: Global Burden of 
Disease Study. Lancet 1997; 349(9063):1436-42. 
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3.1.1. Disability Adjusted Life 
Year (DALY) estimates 
Estimating Disability Adjusted Life 
Years lost was done using the following 
equation:  
DALY = YLL + YLD  
YLL is the number of years of life lost 
due to mortality and YLD is the number 
of years lived with a disability, weighted 
with a factor between 0 and 1 for the 
severity of the disability. The YLL due to 
a specific disease in a specified 
population is calculated by summation of 
all fatal cases (d) due to the health 
outcomes (l) of a specific disease, each 
case multiplied by the expected 
individual life span (e) at the age of 
death:
Figure 18: YLL formula
YLD is calculated by the product of the 
duration of the illness (t) and the severity 
weight (w) of a specific disease, 
accumulated over all cases (n) and all 
health outcomes (l):  
Figure 19: YLD Formula
Applying the DALY methodology 
involves making several choices on 
details of the analysis, which should 
reflect value choices that are relevant to 
the decision-maker.  
Value choices, such as disability 
weighting, age-weighting and 
discounting, imply that life years are 
assigned different value depending on the 
age and the health state they are in.  
Disability weighting means that each 
outcome of a disease is assigned a 
different value (severity weight) on a 
scale from 0 (perfect health) to 1 (death), 
(see original pilot study for some 
examples). 
For this report, the following (value) 
choices were made in as in the pilot 
study:  
• to use incidence rather than 
prevalence data;   
• to use HIV-infection, Aids and 
Aids death as outcomes;  
• not to apply discounting and age-
weighting;  
For this report, the following differences 
were applied compared to the pilot study 
• use of the historical yearly 
average lifetime in Finland to 
calculate life expectancy and YLD 
rather than the life expectancy of a 
standard life table; 
• use of the historical yearly 
average lifetime of Aids death 
cases for the calculation of  YLD 
• to estimate annual disease burden 
since 1980 
• Different duration of illness and 
severity weights for HIV-infection 
and Aids during the time-periods 
of 1980 – 1996 and 1997 – 2006 
depending on the scenario applied 
(see below). 
For DALY based burden of disease 
estimations, two different scenarios were 
applied:  
Scenario 1. Disease burden under 
the assumption of equal access to 
HAART (ARV treatment) since 
1997 
YLL = ? dl x el
 l 
YLD = ? nl x tl x wl
 l 
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Scenario 2. Disease burden under 
the assumption of no access to 
HAART (ARV treatment)  
Since effective ARV treatment has been 
practically universally available in 
Finland since 1997, a longer time of 
living with disease but a lower severity 
weight was used in scenario 1 in the 
estimations compared to the original pilot 
report. The factors used were the 
following: 
Table 3: Scenario 1, Equal Access to HAART 
Scenario 1  1980-1996   1997-   
Avg duration 
(y) severity Avg duration (y) severity 
*YLD factors used (HIV): 10 0.136 17.2 0.2 
** YLD factors used 
(Aids): 2 0.505 5.36 0.38 
To simulate for scenario 2 the real 
incidences (as annual cases reported) of 
Aids and Aids death were replaced with 
modeled figures between 1997 and 2007. 
YLD factors used for this scenario were 
the same throughout the period and 
similar to the time-period of 1980-1996 
in scenario 1. 
In the model of scenario 2, Aids cases 
were estimated based on the average of 
the prior 4 years of the relative ratio of 
HIV of and Aids cases. Aids death cases 
were similarly weighted to be based on 
reported HIV cases. In the model this 
resulted in an annual HIV/Aids ratio of 
0.47-0.52 and an HIV/Aids death ratio of 
0.41-0.42. 
HIV/Aids: Disability Adjusted Life Years (DALY) in Finland
(With HAART since 1997)
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Figure 20: Disease Burden under scenario 1 
(real data) 
While the model is very simple, it 
incorporates a possibility to compare the 
impact of ARV-treatment on a relatively 
conservative estimate of the evolution of 
the epidemic in case treatment had not 
been available or applied. 
Calculations using real reported data 
collected through the passive reporting 
system show that the cumulative disease 
burden over the entire epidemic in 
Finland until 2006 adds up to 16221 
Disability Adjusted Years of Life 
(DALY) lost due to HIV/Aids.  
This is not the only conclusion that can 
be drawn from the DALY estimates. 
Examining the changes that occur when 
effective ARV-treatment became 
available shows the clear saving in terms 
of life lost that treatment brings. Even 
though the value of the YLD measure 
(Years Living with Disability) increases 
due to longer estimated life after 
diagnosis, the YLL measure (Years Lost 
due to Death) strongly decrease, leading 
to a much reduced total DALY. 
The result would suggest that treatment is 
highly cost-effective in terms of reducing 
the loss of productive life, although 
estimating the magnitude would require 
availability of a parallel matched cohort 
who did not receive treatment. As this is 
not available, modeling was applied to 
get some idea on DALY savings (see 
below). 
It should be noted that the estimates 
include several factors of uncertainty. 
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Especially the estimates of average 
duration of disease and the severity factor 
are uncertain, particularly for the time-
period where effective ARV-treatment 
has been widely available.  
The representation of the DALY-estimate 
as an annually calculated value is also not 
necessarily the best way and should be 
interpreted with a degree of caution. It 
does, however, reflect an objective 
estimate of the DALY for reported cases. 
A further uncertainty stems the fact that 
the model applies no discounting for 
future years lost. 
HIV/Aids: Disability Adjusted Life Years (DALY) in Finland
(modelled NO HAART)
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Figure 21: Disease Burden under scenario 2 
(data modeled for 1997-2006) 
Disease burden was also modeled for a 
situation where ARV would not have 
become widely available in 1997. This 
was primarily done as a thought 
experiment and should be interpreted 
with due caution. In the model several of 
the data are relatively crudely estimated, 
which may bias the interpretation 
significantly.  
However, assumptions made on annual 
incidence of Aids and Aids death in no-
ARV scenario during 1997-2006 were 
conservative and based on the assumption 
that neither rate weighted to HIV-
incidence increases (or decreases) 
significantly. Some conclusion may 
therefore be drawn, bearing in mind the 
limitations of the scenario analysis. 
Comparison of disease burden with 
and without ARV 
HIV/Aids: Disability Adjusted Life Years (DALY) in Finland
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Figure 22: DALY in Finland ARV and No 
ARV Scenarios 
Comparing the no-ARV model with the 
estimate of disease burden based on real 
data clearly shows how large the effect of 
treatment is: compared to the no-ARV 
model, application of efficient ARV was 
estimated to have saved close to 16.000 
DALY in the last 10 years (table and 
figure), which is as much as the total of 
the epidemic disease burden calculated 
based on reported HIV, Aids and Aids 
death incidence. 
Table 4: Comparison Disease Burden with and without ARV 
Comparison DALY 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 total
ARV Available 586 644 751 907 676 707 726 739 692 803 16221
No ARV model 1273 1404 2660 2601 2314 2323 2355 2276 2506 3484 32185
Difference (DALY 
Saved) 687 760 1909 1693 1638 1615 1630 1537 1814 2681 15964
A more detailed examination of the no-
ARV model reveals that treatment 
availability increases the HIV YLD 
estimate, but this is clearly compensated 
by the large reduction in the Aids YLD 
and Aids death YLL estimate, as 
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demonstrated in the table below. Positive 
values represent savings compared to no 
ARV availability. 
Table 5: DALY savings due to ARV 
Comparison 
difference 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 total
?YLD HIV -150 -167 -302 -298 -269 -269 -271 -263 -290 -402 -2680
?YLD Aids -3 7 49 35 25 21 15 19 16 42 227
?YLL Aids 839 920 2162 1957 1881 1863 1886 1781 2088 3041 18418
?DALY 687 760 1909 1693 1638 1615 1630 1537 1814 2681 15964
The scenario analysis suggests that using 
a DALY indicator, effective ARV 
treatment is highly cost-effective in 
Finland compared with no ARV 
treatment. 
3.1.2. Direct cost estimates 
Due to the integration of HIV/Aids care 
into the regular public health care system, 
estimations of direct costs incurred per 
case and year are close to impossible to 
produce. Such an exercise would require 
an in-depth analysis throughout the 
country, since the resources used for 
HIV/Aids public health care in different 
regions of the country vary so widely. 
To gain some sort of estimate of current 
and projected costs due to HIV/Aids care, 
standard monthly, annual and total 
published costs per case can be used. If 
different case costs, different assumptions 
on the development of incidence and 
variable lifetime estimates are used for 
such modeling, realistic total estimates 
can be made to illustrate the cost effects 
changes in epidemiology can have over 
long time periods.  
Such scenario building is particularly 
useful to demonstrate potential savings 
that could be achieved by diminishing 
incidence or increased costs associated 
with increasing incidence. 
3.1.2.1. Parameters, assumptions and 
limitations of the cost 
modeling 
For this report a conservative direct 
healthcare cost model using the following 
parameters for the epidemic and its future 
development were used: 
Table 6: Parameters, Assumptions and Limitations of the Direct Cost Modeling 
Parameter Values modeled Properties 
Annual average 
cost per case 
10.000 € Single approximate estimate, based on 
published values26,27
Lifetime for a 
case 
mean 13 years, stdv +/- 10 
years
Single-sidedly cut normal distribution 
according to model 
Annual 
incidence 
scenarios (HIV 
cases) 
Scenario 1: 100 cases/year 
Scenario 2: 200 cases/year 
Scenario 3. 500 cases/year 
Diminished (prevention effect), Current and 
Growth scenario 
26 Hutchinson AB; Farnham PG; Dean HD; Ekwueme DU; del Rio C; Kamimoto L; Kellerman SE. The 
economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of 
continuing racial and ethnic differences. J Acquir Immune Defic Syndr.  2006; 43(4):451-7 
27 Valenti WM. Costs of HIV care: evolution and update. AIDS Reader. 2007;17:242-244. 
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For the scenarios, equal access to 
treatment and care was assumed for all 
cases. Cost estimated are only direct 
health care costs, and do not include 
social welfare costs or loss of 
productivity and other indirect societal 
costs or losses associated with HIV/Aids. 
A fixed average annual direct health care 
cost-per-case of 10.000 €/case/y was used 
to keep the model as simple as possible. 
This is a gross simplification, since true 
per-case costs will vary according to 
disease stage, the size of the epidemic and 
the development of treatments, their 
outcome predictions and unit prices for 
medications and services. However, the 
figure is based on relatively recent 
estimates in a western setting. 
Lifetime of cases was modeled to follow 
a partly one-sided normal distribution 
over a 50 year period, with an average 
lifetime of 13 years and a standard 
deviation of 10 years. However, the 
normal distribution was modified to 
include a biased proportion of 10 % cases 
which die of Aids within 1 year of HIV 
diagnosis (figure). This is a conservative 
estimate which is heavily dependent on 
the proportion of late diagnoses. 
The mean lifetime of 13 years may be an 
underestimate under current ARV-
treatment access. It was chosen as a 
conservative estimate, and does reflect 
the fact that a substantial proportion of 
cases (10% annually) in Finland indeed 
are diagnosed late.  
To reflect the large variation in post-HIV 
diagnosis lifetime, a wide variability 
reflected by a standard deviation of +/- 10 
years was included in the model. 
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Figure 23: PLWHA Lifetime post HIV 
diagnosis 
Costs were modeled for annual and 
cumulative epidemic costs under three 
non-variable HIV incidence scenarios: an 
annual incidence of 100, 200 and 500 
cases over a time period of approximately 
40 years. To keep the model simple, the 
incidence was kept fixed over time in all 
three scenarios. 
Modelling the Direct Cost of the HIV/Aids Epidemic
Mean PLWHA lifetime 13 years, stdev 10 y,
Cost level 10 k€/PLWHA/year
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Figure 24: Modeling the Direct Cost of the 
HIV/Aids Epidemic 
In the scenarios, costs of cases from 
previous years were cumulatively 
included in accordance to the lifetime 
normal distribution model. Under this 
model, annual costs slowly increase as 
the size of the PLWHA population grows. 
Eventually a steady-state is achieved, 
when annual deaths equal annual 
incidence. For the purpose of this report, 
the model is set to start from the year 
2006 adjusted to a level of 1474 PLWHA 
under the annual incidence of 200 cases 
(scenario 2). This point was chosen as it 
closely resembles the actual estimated 
levels recorded that year and the current 
incidence level. 
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From this point, the epidemic and its 
costs were annually modeled until the 
year 2048 under the three fixed incidence 
scenarios. 
It is clear that the model carries several 
simplifications which are unrealistic. 
Especially the use of a set annual 
incidence simplifies the model greatly. 
Nevertheless, the 3 different incidence 
scenarios do allow a comparison to be 
drawn between outcomes in situations 
where:  
A, Scenario 1) a situation where 
prevention would cut incidence to half the 
current level;
B, Scenario 2) the epidemic would 
evolve further in Finland at the current 
level (approximately 200 cases annually); 
and
C, Scenario 3) there would be a strong 
increase in incidence. 
The incidence levels were chosen to be 
conservative but different enough to 
demonstrate significant differences in 
both annual and cumulative costs. 
3.1.2.2. Comparison of costs modeled 
under different epidemic 
scenarios 
The following comparison of the 
scenarios allows drawing some 
conclusions on the consequences of 
changes in HIV/Aids epidemiology and 
could therefore be helpful for policy 
guidance. 
Table 7: Health care costs (undiscounted) and size of steady-state PLWHA  
population under different scenarios 
 Annual 
health care 
cost 2006 
(M€)
Annual 
cost 2015 
(M€) 
Annual cost 
2040 (steady 
state; M€) 
Total costs 
2006-2040 
(M€)
PLWHA 
population 
at steady-
state 
Scenario 1 
(100 cases/year) 7.5 12 14.2 476 1400 
Scenario 2 
(200 cases/year) 15 24 28.4 952 2800 
Scenario 3 
(500 cases/year) 37.5 60 71 2,381 7000 
The comparison shows, that even a 
relatively moderate increase in annual 
incidence can have a very large cost-
impact even in annual costs. In the 
Finnish setting, an evolution 
approximating that from scenario 1 to 
scenario 2 has taken place between 1998 
and 2007. This translates to a more than 
doubling of the estimated direct health 
care costs. 
Scenario 3 is not unrealistic either, and 
especially its long-term costs are very 
high. 
An issue which was not modeled at all in 
the estimation of costs, is the indirect 
impact of HIV/Aids as loss of 
productivity due to disability caused by 
the disease.  
Loss-of-productivity costs have been 
estimated in the literature, and have been 
as high as 4 times the cost of treatment by 
Hutchinson et al.28. In this study, lifetime 
28 Hutchinson AB; Farnham PG; Dean HD; 
Ekwueme DU; del Rio C; Kamimoto L; 
Kellerman SE. The economic burden of HIV in 
the United States in the era of highly active 
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direct medical cost per case was 180900 
USD whereas the productivity losses 
were 662100 USD. 
Considering the still high disease burden 
and the high direct health care and 
indirect productivity loss costs of 
HIV/Aids, strongly suggests that even 
relatively expensive prevention 
interventions, if effective, are highly cost-
effective. 
The burden of disease- and cost modeling 
strongly suggest that strengthening of 
those prevention activities which are 
known to be effective is well advised and 
will lead to significant savings over time. 
In the models above, burden of disease 
and costs were only crudely modeled for 
all cases, but the models could be easily 
extended to subcategories. This would, 
for example, allow an estimation of the 
cost-effectiveness of targeted 
interventions, such as among IDU. 
antiretroviral therapy: evidence of continuing 
racial and ethnic differences. J Acquir Immune 
Defic Syndr.  2006; 43(4):451-7  
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4. National response to 
the HIV/AIDS epidemic  
The national response to the HIV/AIDS 
epidemic is outlined in several policy 
documents of which the most important is 
the National HIV policy. This was given 
as a non-binding guidance document 
issued by the HIV-expert group of the 
MoSAH in 2002 and ran through 2006. 
Currently a new policy framework 
document is under development, and is 
scheduled to be issued during 2008. 
The policy outlined 8 key action areas as 
the following: 
I. Prevention of new infections 
is the cornerstone of 
preventive measures 
II. Effectiveness of treatment and 
support measures is an 
integral part of prevention 
III. It is essential to support the 
full social empowerment of 
persons who have been 
infected and to reduce their 
vulnerability 
IV. HIV tests and epidemiological 
follow-up systems generate 
information to be used in the 
planning of future measures 
V. International cooperation is a 
prerequisite for conquering the 
HIV epidemic 
VI. The education of professional 
staff must be expanded and 
the level of competence must 
be maintained 
VII. Legislative reform may 
become necessary as the HIV 
situation changes 
VIII. Management of the situation 
calls for improved 
coordination and a 
multidisciplinary approach. 
4.1. Prevention 
Prevention of new infections is the first 
key action area and objective of the 
current HIV policy document.  
According to the Law on Public Health 
(Kansanterveyslaki), prevention of health 
problems and health promotion is the 
responsibility of the municipal 
governments and is funded by municipal 
taxation. Therefore, the responsibility for 
HIIV/AIDS prevention, treatment and 
care also lies within the municipally 
managed public national social services 
and health system providers. 
HIV/AIDS prevention, care and support 
are mainly integrated into the public 
healthcare social care/welfare and 
education activities on state, regional and 
municipal levels. No specific publicly 
budget line earmark funded HIV/AIDS-
specific governmental organizations 
exists.  
On a municipal level, responsible 
authorities are the municipal social 
welfare and health boards and the 
municipal health centers (publicly funded 
primary healthcare providers). For 
specialized HIV care and treatment, 
municipalities usually purchase services 
fro their residents from regional and 
university hospitals organized into 
Hospital Districts. 
For primary education the municipal 
school boards and the primary and 
secondary education system (primary and 
secondary school system) have the main 
responsibility for health promotion and 
sexual health education, including 
HIV/AIDS prevention education in 
schools. 
In the Finnish system, cooperation 
between governmental and NGO/Civil 
society actors is actively pursued, 
especially for prevention activities. While 
NGOs and Civil Society are independent 
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in their activities, a large part of their 
funding comes from governmental or 
other public national sources. A 
particularly large funding agency is the 
national Slot Machine Association (Raha-
automaattiyhdistys; RAY), which is a 
government monopoly on gambling. All 
of the proceedings are used for publicly 
beneficial purposes, such as sports and 
exercise, culture and public health.  
The different ministries (such as the 
MoSAH and the MFA) also have their 
own project funding available for 
tendered or proposal based prevention 
projects. In addition, various forms of 
public-private partnerships are common, 
where a municipal or regional agency 
purchases a certain service or parts of it 
from an NGO or Civil society actor.   
Untargeted awareness campaigns and 
direct prevention activities directed 
toward the general population have not 
been seen as a priority area of HIV/AIDS 
prevention and especially not for 
achieving behavior change in the general 
public. Instead, targeting youth and 
building of a solid sexual health 
knowledge base at an early age among 
youth is seen as the main approach to 
achieving low risks at adult age. The 
main tool for achieving this is through 
health education in schools. 
In addition, targeted prevention efforts 
are applied to reach vulnerable groups 
such as MSM, IDU, sex workers and 
Immigrants.  
In the following, the main approaches and 
key targets groups of HIV prevention are 
described (as specified by the Key 
objectives of the HIV policy document). 
Key objectives: 1: The incidence of new 
HIV-infections, other STI and viral 
hepatitis infections will decline in all risk 
categories, 2: Knowledge and 
understanding of HIV transmission risks 
improves and attitudes do not declines 
among youth and 3: Programs and 
projects aiming at HIV-prevention will be 
evaluated through studies.
4.1.1. Youth 
Health education and promotion are the 
main tools of influencing the 
development of the future epidemic. The 
target of the activities is to ensure that all 
residents in Finland are aware of and 
understand true transmission risks and 
can take these into account in their 
behavior. Similarly important is ensuring 
that false beliefs and common 
misconceptions towards HIV risks and 
HIV-infected do not prevail.  
Under the prevention policies currently 
applied, HIV/AIDS risks are not dealt 
with in a vacuum, but need to be 
integrated in general activities such as 
dealing with sexual health, sexuality 
education, reproductive health and 
reduction of drug related harm. 
HIV/AIDS prevention activities are seen 
as a part of health promotion activities 
and are integrated in cross-cutting health 
education work. 
In specific activities, youth are the most 
important target group and MSM groups 
must also be reached. The best long-term 
impact is achieved through schools, as 
they reach almost the entire population in 
a comprehensive way.  
In Finland, health education was 
introduced as a standardized compulsory 
subject in 2005 for grades 7-9 in the 
primary level (ages 13-15) and grades 1-3 
of secondary level (ages 16-18) school 
system. The subject covers a standardized 
comprehensive health and healthy 
lifestyle curriculum and includes 
reproductive and sexual health, sexuality 
education (including non-judgmental 
dealing of homosexuality and other 
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sexual minorities) and STI risks, 
including HIV/AIDS risks. Prior to 2004, 
sexuality education and reproductive 
health was part of the school curriculum, 
but incorporated into other subjects. 
Schools also had more freedom in 
choosing how to implement the subject 
which led to wide variation in its content. 
For the currently applied sexual health 
and HIV/AIDS prevention policy model 
concerning youth, sexuality and 
reproductive health education start early, 
prior to puberty. This is to ensure that 
youth have the knowledge and tools they 
need at the age when issues of sexuality 
become timely due to their natural sexual 
development. Since there is large natural 
variation in the age when youth reach 
puberty and mature sexually, as well as 
between the development of girls and 
boys, it is important to ensure that 
sexuality and reproductive health 
education are available and repeated right 
before and throughout the period of 
adolescent puberty. 
According to the currently applied sexual 
health promotion approach, birth-control 
and STI prevention tools must be made 
available for youth through low threshold 
sexual heath services, i.e. youth clinics 
and school health services. Birth-control 
advice is offered to youth both through 
schools and the regular primary 
healthcare system. In a number of 
municipalities throughout the country, 
specialized youth clinics are also 
available.  
In 2006, the government issued a Sexual 
and Reproductive Health Action 
Programme29.
29 Promotion of sexual and reproductive health. 
Action programme 2007–2011. Helsinki 2007. 
200 pp. (Ministry of Social Affairs and Health, 
Finland. ISSN 1236-2050, 2007:17). ISBN 978-
952-00-2376-8 (paperpack), ISBN 978-952-00-
2377-5 (PDF) 
Several NGO organizations organize and 
maintain regular youth outreach activities 
and specialized service forms30. These 
services are most often either organized 
in cooperation with municipal healthcare 
actors or directly funded by municipal 
governments through service 
contracts31.For some services, central 
governmental support is also available. 
Among civil society actors, an important 
recent development has been the 
engagement of the Evangelical Lutheran 
Church of Finland youth sector. In 2006, 
the church youth association and the 
AIDS council together produced a guide 
called “A Miracle in the Eyes of God – 
on Sexuality, Physicality and Gender” 
targeted to confirmation trainees. The 
confirmation is a part of the process of 
accepting the message of the church and 
confirming ones membership of the 
parish. 
Approximately 90 % of fifteen-year-old 
youth (annually close to 24.000) 
participate in confirmation training 
organized by the local parishes. This is 
the highest rate of participation in any 
Lutheran Country, despite Finland 
otherwise being a very secularized 
society. Studies show that participation is 
part of youth culture and training camps 
are very popular among the youngsters. 
The “Miracle” training manual is targeted 
to youth leaders of the training camps, 
and they are themselves in the ages of 16-
18 year old.  The “Miracle” encourages 
open, positive and respectful discussions 
of sexuality, physicality and gender 
issues. 
30 Väestöliitto, AIDS-tukikeskus 
http://www.aidstukikeskus.fi , Diakonissalaitos, 
Suomen HIV/Aids hoitaja-yhdistys, EVL Kirkko 
31 Esim. Helsingin kaupunki ja Väestöliitto, A-
klinikkasäätiö ja Diakonissalaitos 
Finland 2008 UNGASS HIV/Aids country report– KTL B4 / 2008 
Report collation, drafting and coordination 
National Public Health Institute – KTL, HIV unit 
www.ktl.fi 45
4.1.2. Sexual minorities 
Among sexual minorities in Finland, 
MSM are the most relevant group 
needing special attention and targeted 
prevention messaging and support. In a 
recent study, HIV prevalence in at least a 
subset of this group was estimated to be 
close to 4.5 %, the highest recorded in 
any identifiable vulnerable subpopulation 
ever recorded in Finland. 
At the start of the HIV epidemic in the 
1980:ies NGO:s, such as the organization 
for sexual equality (SETA), have been 
actively involved in HIV/AIDS work, 
mainly through the establishment of the 
HIV-foundation (HIV-säätiö) which runs 
the Finnish AIDS Council (Aids-
tukikeskus).  
Nowadays, the AIDS-council is an 
independent NGO dedicated to 
HIV/AIDS prevention, service provision, 
training and advocacy work 
independently of SETA. It also has a 
broader scope covering several areas of 
sexual health and prevention of HIV-
infection and addresses both mainstream 
and vulnerable groups. 
The Finnish AIDS Council is run by the 
HIV Foundation. It aims to:  
• Prevent HIV infections.  
• Enhance the competence of social 
and health care professionals in 
handling HIV questions.  
• Support people with HIV 
infection, their families and 
friends, and those concerned 
about HIV.  
The services of the Finnish AIDS Council 
have been available since 1986. The 
organization is ideologically and 
religiously independent.  
The AIDS council has an active role in 
safe sex promotion among MSM. Its 
“safely among men” line of work has 
been well received and accepted among 
the MSM. However, the resources 
allocated to this work are relatively small 
compared to the estimated size of the 
target group. 
4.1.3. Travelers 
Travelers for leisure and business have 
recently been recognized as an important 
target group for enhanced prevention of 
especially sexual transmission. In 2007, a 
few training workshops mainly targeted 
for professionals in the travel and travel 
medicine field have been held, and a 
project for enhanced prevention in the 
group has started and will run through 
2008.  
Travelers are specifically mentioned as a 
target group in the drafts of the new HIV 
strategy document. The AIDS-council, 
the MoSAH, KTL and several other 
actors are planning a targeted awareness 
and prevention project with the aim of 
engaging travel agencies and workplace 
health providers in the work. 
4.1.4. Injecting drug use 
For HIV/AIDS and other infections with 
a transmission route involving direct 
blood contact, prevention transmission 
among IDU is an equally important 
aspect of comprehensive HIV/AIDS 
prevention efforts. In Finland HIV 
infection among IDU was rare until the 
end of the 1990s, when the first outbreak 
in this group was recorded. 
Finnish policy on dealing with drug use 
and the harm it induces is based on 
prevention of use and supply control of 
illicit drugs. However, it also 
pragmatically recognizes that blood-
borne infection risks must be addressed at 
the heart of the problem and not simply 
ignored. In the face of an outbreak of 
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HIV infection among injecting drug users 
(IDU) that started in 1998, changes 
enhancing prevention of infection risks 
were implemented. These include, but are 
not limited to, health promotion 
strengthening, vaccination coverage 
enhancement for hepatitis viruses, 
enhanced access to VCT for HIV, 
Hepatitis B (HBV) and Hepatitis C 
(HCV) as well as free injection 
equipment exchange.  
Figure 25: Excerpt from statute 
786/1986, Communicable Diseases 
Decree 
The new measures were introduced with a 
model that aims at lowering the threshold 
of the target group to access the services. 
These changes were introduced in 
governmental strategy and policy action 
programs during the period of 1998 
through 200732.
In 2004 injection equipment exchange 
was made explicitly legal and an 
obligation to provide such services was 
laid upon municipal health services. 
32 Governmental Strategy Documents on drugs 
1998 and 2000, Governmental Drug Policy Action 
Programme 2004–2007 
During the period of 1998 to 2007 a new 
concept combining social and health 
services was developed to tackle the HIV 
outbreak and drug use associated harm. 
Building on strong public–private 
partnerships, governmental and municipal 
actors have joined forces with 
NGOs/Civil Society actors to make an 
impact. 
A network of low threshold health 
promotion and service centers (LTHSC) 
now extends to close to 30 of the largest 
cities and municipalities.  
The LTHSC model emphasizes trust-
based voluntary participation and 
anonymous access. Services include 
small-scale health care provision, 
counseling and guidance to detoxification 
services, vaccinations, condom 
distribution, and exchange of injection 
equipment.  
Excerpt from statute 786/1986 Communicable Diseases Decree 
Section 6 (30.12.2003/1383) 
As duties referred to in the Communicable Diseases Act, the municipal body 
responsible for the prevention of communicable diseases and the health centre 
physician in charge of communicable diseases working under the body shall for 
their part, in addition to the duties laid down in the said Act: 
1) be responsible for the combat of communicable diseases in the area of 
operation of the health centre, including dissemination of information on 
communicable diseases, health education and health counseling, also health 
advice to injecting drug users and exchange of injecting equipment as 
necessary for the prevention of communicable diseases; 
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Figure 26: Network of LTHSC in Finland 
In addition to the fixed LTHSC, services 
have evolved to include Mobile LTHSC 
units, peer-to-peer and outreach work. 
In parallel to the primary prevention 
work, the response to the IDU HIV 
epidemic has benefited from the joint 
development of public – private sector 
partnership based specialized health 
services for HIV-positive IDUs. This 
includes combined antiretroviral therapy, 
a methadone maintenance program and 
social services.  
In the capital region the specialized 
services for HIV-positive IDU are 
provided at a single integrated center, the 
Munkkisaari Service Center. 
Examples of the funding and organization 
model used to provide services vary, so 
that in the capital city Helsinki services 
are provided by the A-Clinic Foundation 
and the Helsinki Deaconess Institute 
(HDL), but funding comes from both 
municipal and national government 
sources. On the other hand, in 
neighboring Espoo municipality, the 
stationary services are to mainly directly 
organised by the municipal health center, 
but mobile services are purchased from 
the Helsinki Deaconess Institute.  
IDU-associated HIV-infection
 and equipment exchange
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Figure 27: IDU associated HIV-infection and 
Injection Equipment Exchange 
LTHSC and the other targeted service 
models provide a very important and 
efficient access point for reaching out to 
users with prevention messages. More 
than 10.000 different clients are reached 
annually.  
In 2006, annual exchange of injection 
equipment exceeded 2 Million units. 
The programme has been a success: 
surveillance data show, that the HIV 
outbreak was rapidly curbed. Annual 
incidence has decreased and prevalence 
among users has never exceeded 1–2 %. 
There is a clear correlation between the 
increase in service provision and decline 
in the incidence of HIV.  
An evaluation of the effectiveness of the 
LTHSC model for prevention of IDU-
associated blood born infections is 
currently ongoing and is estimated to be 
completed in early 2008. 
4.1.5. Correctional Facilities 
Prison health is the responsibility of the 
prisons health services, which fall under 
the authority of the Criminal Sanctions 
Agency (Rikosseuraamusvirasto) which 
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is an agency under the Ministry of 
Justice. However, the MoSAH can give 
advice and guidance to the prison health 
services, if necessary. 
During imprisonment, prison health 
services offer services to inmates that to 
most parts equal those in the civil public 
health sector, but taking into account 
special needs of the inmates. 
HIV testing in prisons is available using 
the VCT concept. Automatic screening is 
not done, neither on entry nor at exit. 
However, the threshold of offering testing 
is low, and rapid HIV-tests are offered at 
several correctional facilities. 
ARV- and other HIV/AIDS treatment are 
available during imprisonment. 
A large part of inmates in the correctional 
system have an addiction disorder. Using 
illicit drugs during imprisonment is not 
allowed. Studies show, however, that 
drugs are being used during 
imprisonment, including injecting drugs. 
On entry, each inmate is given a package 
containing disinfectant materials, 
instructions and containers for 
disinfection of injection equipment. 
Leaflets on blood born and STI risks and 
protection are also given. During the 
imprisonment, additional disinfectants 
and condoms can be obtained from the 
prison health services. Injection 
equipment exchange services are not 
available within the correctional facilities. 
Addiction and detoxification health 
services are available in the Finnish 
correctional system. However, opiate 
maintenance or substitution therapy is 
available only if it has been started before 
imprisonment. 
A key NGO, Kriminaalihuollon tukisäätiö 
- KRITS (Probation Foundation 
Finland)33 is actively involved in 
development of harm reduction measures 
and social support for inmates and ex-
inmates. 
4.1.6. Sex workers 
Sex workers are at increased risk for both 
social marginalization and STI: s, 
including HIV-infection. In addition, sex 
work may in a subset of the group be 
linked to IDU and therefore introduce 
additional risks of infection to this group.  
Sex work is not explicitly illegal in 
Finland, but several regulations reduce 
the of sex workers possibilities to be open 
about their activities in contact with 
authorities, including social and health 
authorities. A part of sex work in Finland 
is tied to economic and/or organized 
crime migration, especially from the 
neighboring areas. 
While permanent residents can access 
public health care services, non-residents 
cannot, and social barriers may create 
high barriers for access even for 
residents. 
Therefore, special efforts have been put 
in place to ensure a lowering of the 
threshold for sex workers to access 
preventive social and health services. In 
many instances this means creating trust-
based services outside the regular local or 
national governmental social welfare and 
health services. NGO-based actors can in 
this regard provide the best access and 
help for sex workers.  
The main NGO providing such services 
in Finland is the Pro-Tukipiste34, which 
has outlets in the cities of Helsinki 
(capital) and Tampere. Pro-Tukipiste is a 
registered non-profit organisation which 
supports and promotes the civil and 
33 http://www.krits.fi
34 http://www.pro-tukipiste.fi
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human rights of individuals involved in 
sex work. Pro-Tukipiste follows and 
takes part in national and international 
discussions concerning prostitution and 
sex work, and also makes statements 
concerning issues related to prostitution 
policies. The association follows the 
treatment and the legal status of sex 
workers in Finland. 
Pro-Tukipiste maintains and runs 
professional social and health care service 
units and outreach units in Helsinki and 
Tampere.  
4.1.7. Migrants 
A significant proportion of HIV cases in 
Finland are seen among immigrant 
populations. While these cases do affect 
total disease burden, the effect on the 
evolution of domestic epidemiology is 
less significant since the reported cases 
reflect the epidemiology of the 
originating country.  
Over a long term perspective, however, 
the effect on prevalence may become 
greater, and warrants targeted prevention 
and support for integration to prevent the 
formation of continuously high 
prevalence among immigrant- and 
immigrant descendant populations. 
Migrants from high-endemic areas are 
therefore a group with special needs. 
People migrate to Finland for a variety of 
reasons including work, study, and family 
reasons, as well as refugees or asylum 
seekers.  
Those gaining permanent or long-term 
residence in Finland are covered by the 
national public healthcare system and 
have access to prevention, treatment and 
care though it. There is no HIV-screening 
policy associated with study, work or 
family immigration. 
The refugee and asylum seeker group is 
nowadays a minority group and has been 
estimated to account for less than 20 % of 
migration to Finland. The health of this 
group is under the responsibility of the 
Ministry of Interior immigration and 
refugee services.  
Upon entry, migrants in this group are 
offered health checkup services, 
including testing for infectious diseases 
such as TB and HIV. HIV testing is 
offered on a voluntary, VCT basis, and 
access to translators is provided. Migrants 
in this group are offered medical services 
according to clinically determined need.  
Due to cultural and societal reasons as 
well as language barriers, many migrants 
experience difficulties in accessing 
official health and social services in 
Finland, including HIV services. These 
barriers can sometimes be overcome or 
alleviated if help or services can be 
provided by NGO/Civil service actors. 
The Finnish AIDS Council (Aids-
tukikeskus)35, an NGO dealing with 
various aspects of HIV prevention and 
support work, have a specific migrant 
support line of work, which provides both 
direct help and support groups for 
migrants, but also training and materials 
for health professionals to prepare them 
for working with migrants in HIV 
prevention and care. 
4.1.8. Nosocomial transmission, 
including tissue and 
organ donations and 
assisted reproduction 
services 
Key objective 4: Nosocomial 
transmission and transmission through 
blood transfusion or blood products must 
be completely eliminated, while 
simultaneously ensuring equal access to 
35 http://www.aidstukikeskus.fi
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health services for those living with 
HIV/AIDS.
In the Finnish health system, patient-care 
personnel relation is based on trust. 
Therefore, while patients are actively 
encouraged to inform the care personnel, 
especially the treating physician, of all 
health conditions which affect health 
status and may influence care, there is no 
explicit legal obligation to inform health 
personnel about HIV status.  
Evidence shows, that within the health 
sector universal blood precautions are 
sufficient to prevent nosocomial 
transmission and protect personnel from 
infections. Health care guidelines 
stipulate that universal blood protection 
measures have to be used in all invasive 
procedures or procedures that may result 
in blood or tissue exposure. Disinfection 
and sterilization guidelines and standards 
ensuring elimination of nosocomial 
transmission through multiuse 
instruments and equipment are in place. 
For tissue and organ donations and 
assisted reproduction services, all 
performing units are responsible for 
ensuring prevention of nosocomial 
transmission in accordance to national 
standards. Prevention measures and the 
standards guiding their application are 
similar to all health care providers, 
including dental health providers and the 
entire private sector.  
Healthcare provision is monitored by the 
Agency of Medicines and Medical 
Devices, the provincial health authorities 
and the National Authority on 
Medicolegal Affairs. 
4.1.9. Blood donation and blood 
product mediated 
transmission 
In Finland, blood, plasma and blood 
component donation and blood product 
production services are run exclusively 
by the Finnish Red Cross and donations 
are exclusively based on voluntary 
donors. No compensation is given to 
donators. As blood donation is entirely 
voluntary, donators are confidentially 
pre-selected through the use of a 
standardized questionnaire used at all 
donation events. Exclusion criteria are 
based on known risks for blood born 
infections.  
In addition, all donations are screened 
prior to use for HIV and other blood born 
infectious using highly sensitive 
techniques. For HIV, both combined 
antibody/antigen detection and NAT-
screening techniques are used. 
Since the turn of the century, blood 
donation screening has revealed 
approximately 1 positive donation every 
second year, both among repeat and 
newly recruited donators. All positive 
donations are discarded prior to use. 
Furthermore, blood product 
manufacturing processes (for production 
of clotting factors etc.) employ methods 
which have been shown to inactivate 
HIV. 
Blood donations tested annually
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Figure 28: Blood Donations Tested Annually 
4.1.10. Mother to child 
transmission 
Key objective 5: All expecting women 
must be offered HIV testing and if found 
positive, offered to be informed of their 
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HIV-infection. All those who have been 
infected must be offered mother-to-child 
prevention measures through drug-
prophylaxis and other measures available 
according to best medical knowledge. 
Maternity and newborn child healthcare 
and health promotion is organized 
through a network of public municipally 
organized and funded maternity and child 
health centers. These centers offer 
specialist nurse, social support and 
welfare as well as physician services for 
the benefit of both the expecting mother 
and her child both during the pregnancy 
and after delivery. Almost all pregnant 
women utilize the services, which are 
available free of charge. 
As one part of the services, the expecting 
mother is routinely offered certain 
infectious disease tests as part of a 
national programme for unborn child 
health. The tests are voluntary, and 
include tests for syphilis, the carrier status 
of Hepatitis B and HIV-infection. HIV 
test offering is based on an opt-out 
scheme. Out of an annual level of close to 
60.000 pregnancies examined, only 0.4 % 
of pregnant mothers on average have 
refused testing. 
Table 8: Testing and test refusals in maternity centers 
 2000 2001 2002 2003 2004 2005 2006 2007 
Tests 58881 57141 58864 60226 60003 59312 59639 58740 
Refusals 132 287 84 73 57 31 20 17 
HIV+ 8 13 12 13 8 16 13 pending 
Annually, 5-16 HIV-positive mothers 
have been identified through the 
screening programme, of which the 
majority are cases that have already 
earlier been identified. 
All mothers with HIV-infection are 
offered mother to child transmission 
prophylaxis according to international 
best available praxis. Prophylaxis is also 
used for the newborn. A special training 
and instruction manual for maternity 
clinics is available for this purpose, also 
covering prevention of transmission 
through breast-feeding. 
4.2. Treatment and care 
In the Finnish HIV policy and strategic 
approach to tackle the epidemic, effective 
treatment and support measures are seen 
as an integral part of prevention. The 
assurance that access to the best existing 
treatment and care is available, and trust 
in a professional, compassionate, 
confidential and non-discriminating  
response within the health- and social 
care system, helps those who may fear 
that they have acquired HIV infection to 
seek testing and care.  
In the long run, the trust in the response 
from the system and the help it provides 
will help to maintain a low proportion of 
people not knowing of their infection and 
who may unknowingly transmit it further.  
A low number of unaware HIV-infected 
individuals is an important contributor to 
restricting the HIV epidemic. Therefore 
measures that actively encourage the 
seeking of care and testing are highly 
cost-effective. 
Key objectives: 6. All necessary 
clinically indicated care is guaranteed 
free of charge to those who have been 
infected. Access must be equally available 
throughout the country and covers all 
those who are eligible for social security 
benefits through national or European 
Union legislation or through multi- or 
bilateral international agreements, 7:
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National resources for HIV prevention 
and interruption of chains of transmission 
will be strengthened, 8: The application 
of post exposure prophylaxis drug 
treatment is developed. National 
guidelines are developed by organizing a 
national expert meeting with PLWHA 
representation, 13: All health- and social 
care professionals and other professional 
groups dealing with PLWHA gain a level 
of understanding enabling them to meet 
PLWHA in a professional and egalitarian 
way through their primary and vocational 
professional training or continuous 
education. 
The public health system in Finland is 
funded mainly by municipal taxation and 
a national obligatory social insurance 
system run by Kansaneläkelaitos – KELA 
(The Social Insurance Institution of 
Finland), which is an agency governed 
directly by the parliament (the national 
assembly). The social insurance provides 
benefits and covers many areas of social 
support services and health costs, 
including partial compensation for private 
medical care. Social insurance coverage 
is not tied to employment but legal 
residence status. 
A certain degree of co-payments still 
have to be provided for most primary, 
secondary and tertiary care, but various 
caps to these fees exist and the fees are 
also tied to economical status in a way 
that ensures that people with low 
economical resources are equally 
covered. 
For HIV/AIDS there is a special 
provision in the Act on Customer Fees 
within the Social- and Healthcare system 
(3.8.1992/734) which explicitly stipulates 
that access to HIV/AIDS medical 
treatment and care is free of all charges 
for all legal residents. This covers 
primary and specialist care, laboratory 
diagnostics and medication (incl. ARV-
drugs). 
Prevention of health problems is 
according to the Law on Public Health 
(Kansanterveyslaki) the responsibility of 
the municipal government. Therefore, the 
responsibility for prevention, treatment 
and care lies within the municipally 
managed public national social services 
and health system providers. On a 
municipal level, responsible authorities 
are the municipal social welfare and 
health boards. HIV/AIDS treatment, care 
and support are mainly integrated into the 
public healthcare social care/welfare on 
state, regional and municipal levels.  
Public health primary care in Finland is 
provided through publicly funded 
municipal health care centers. The 
majority of the outpatient primary care 
services are within the public sector, as 
are >95 % of the hospitals. More than 400 
municipalities are served by 
approximately 250 municipal primary 
health care centers, which all offer 
primary health services to municipal 
residents. For HIV care, there are special 
provisions given by guidelines issued by 
the Ministry of Social Affairs and Health, 
which enable seeking care in a non-
residential health center. These guidelines 
have been put in place to enable the 
maintaining of confidentiality for 
residents of small municipalities. 
However, the costs are referred back to 
the residential municipality. Clients of the 
municipal health services pay a relatively 
small annual co-payment for the use of 
the services. Children and certain social 
groups do not pay co-payments 
HIV VCT services are provided free of 
charge by all municipal health centers. 
Laboratory services are either provided 
by local laboratories or purchased by the 
municipal health center from health 
district level laboratory centers or private 
laboratory service providers. 
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For specialist care, municipal health care 
centers in turn refer their patients to 
regional or University central hospitals 
belonging to regional health districts. 
There are 21 such secondary and tertiary 
health districts providing specialist 
services. Municipalities or municipal co-
operations purchase specialist services as 
part of their public health service 
provision obligations. HIV-care is 
referred to the specialist care level due to 
the needed level of expertise.  
HIV specialist care is provided by all 
regional health districts, but some of the 
larger health districts have more expertise 
available and may at some instances 
provide subcontracting services to other 
districts. However, there is no formal 
decision to centralize HIV care and 
treatment, and municipalities and health 
districts can make their own choices on 
how to provide the services under their 
obligations. 
The largest center of the public health 
system providing specialist HIV/AIDS 
health services is the Helsinki and 
Uusimaa Hospital Districts (HUS) Aurora 
Hospital Infection Clinic. Some 
specialization is also available for 
infection dentistry and maternity care 
within the HUS area. 
In addition to public health care, 
HIV/AIDS care can be received through 
private health care services, but costs of 
these are not compensated from the 
national health insurance system. 
In the Helsinki area, the municipal health 
board and municipal health services have 
made a separate agreement with the 
Helsinki Deaconess Institute (a private 
health service provider) and the HUS 
Aurora Hospital Infection Clinic for 
provision of HIV/AIDS and addiction 
health services for HIV-infected injecting 
drug users. 
The development of necessary 
competence for dealing with HIV/AIDS 
issues throughout the social and health 
service field is a recognized challenge. 
Due to the low prevalence of HIV in 
Finland and concentration into 
metropolitan areas, most social and health 
professionals outside the areas of higher 
prevalence are unfamiliar with HIV/AIDS 
issues and are therefore poorly prepared 
to meeting PLWHA. 
Professional education curricula for 
health professionals (excluding infectious 
disease specialization) deal with general 
STI and blood borne infection issues, and 
HIV/AIDS is only dealt with as one of 
many conditions to consider. 
To improve the educational level and 
practical skills of professionals who may 
meet PLWHA in their work, continuous 
education seminars and workshops have 
been organized throughout the years by 
the Helsinki University Palmenia 
Continuing Education Center36 in 
cooperation with The National Public 
Health Institute - KTL, the MoSAH and 
several NGO and Civil Society actors. 
The Finnish association of HIV/Aids 
nurses (SHAS), the Finnish AIDS 
Council and the HUS Aurora Infectious 
disease unit has published an “HIV-care 
handbook” in 2007 with financial support 
from the Slot Machine association and 
the MoSAH. The handbook is mainly 
targeted to nursing professionals, but 
immediately gained wide popularity 
among the whole healthcare field. 
4.3. Support 
Key objective 9: Psychological and 
social support is available for all those 
PLWHA and their next of kin 
36 Palmenia Centre for Continuing Education, 
http://www.helsinki.fi/palmenia/english/index.htm
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Social and welfare support and 
psychological support due to health 
problems is provided by both the 
municipal social services and the 
municipal heath centers. These include 
support for accessing of sickness and 
disability benefits covered by the social 
insurance system, support for home care 
in case of need and access to crisis and 
long-term psychological support and 
mental care. Access to sickness and 
disability benefits (including the 
possibility to disability retirement 
benefits) and home care is nationwide.  
For psychological support there is more 
variation in the coverage, especially on 
the level of expertise on dealing with 
HIV/AIDS issues. 
Several national NGO and Civil Society 
organization are also actively involved in 
HIV/AIDS support work. These are 
frequently partly or entirely funded 
through public/private partnerships with 
municipal and/or national funding 
agencies or through direct purchasing 
agreements. 
4.4. Knowledge 
The starting point for the Finnish 
HIV/AIDS strategic approach is to ensure 
that all citizens and permanent residents 
have the knowledge and understanding 
needed to enable them selves to avoid 
exposure to true risks of HIV infection.  
At the same time, the approach should 
ensure that a similar high level of 
knowledge and understanding can be 
achieved regarding common misbeliefs 
and groundless fears towards HIV/AIDS 
risks and those living with the infection. 
The main means to achieve these goals is 
through a comprehensive coverage and 
high standard of the primary education 
system. Coverage of the Finnish primary 
and secondary educational system is very 
high, over 98 % of youth complete their 
compulsory education 12.
4.4.1. Finnish education system  
This section is adapted from chapter 10 in 
the publication “Koulutuksen määrälliset 
indikaattorit 2006” published by the 
Finnish National Board of Education 37
One of the basic premises of Finnish 
education policy is to guarantee everyone 
equal opportunities in education and 
training. This objective has required the 
formal education system to be clearly 
structured and all study tracks available in 
qualification-oriented education and 
training to be open from pre-primary 
education through to tertiary education. 
Education has always played a significant 
role for Finns in terms of guaranteeing 
upward social mobility. Finnish children 
start school in the year when they turn 
seven. Prior to this, each local authority 
(municipality) is obliged to provide 6-
year-olds with pre-primary education. 
Pre-primary education may be provided 
either in connection with school or as part 
of day care. Even though pre-primary 
education is not compulsory for children, 
the participation rate is 100%.  
Compulsory 9-year basic education is 
provided at comprehensive school, which 
is common for everyone and which is 
completed by virtually all Finnish 
children. In 2005, about 57,500 children 
started comprehensive school, while just 
below 63,800 students received their 
leaving certificates. Annually, only a few 
37 Finnish National Board of Education. 
International comparisons of some features of 
Finnish education and training, Chapter 10 in 
“Koulutuksen määrälliset indikaattorit 2006” 
edited by Timo Kumpulainen and Seija Saari. 
ISBN-13: 978-952-13-3092-6 (bound), ISBN-13: 
978-952-13-3093-3 (PDF). 
http://www.oph.fi/pageLast.asp?path=1,438,5089,
43978,44346
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hundred fail to obtain the comprehensive 
school leaving certificate. Those young 
people who wish to improve their leaving 
certificate or otherwise supplement their 
skills and knowledge may participate in 
additional education lasting one extra 
school year. About 1,600 young people 
chose this option in 2005, which is about 
2.5% of the whole age group. 
Upon completion of basic education, 
upper secondary level provides two main 
alternatives: general upper secondary 
school or vocational education and 
training. Both alternatives last three years 
and completion of the studies provides 
eligibility to apply for higher education. 
Those completing basic education apply 
for these two types of education through 
the national joint application system. This 
centralized application system contributes 
to ensuring that almost all basic education 
leavers apply for upper secondary studies 
and also continue their studies 
immediately upon completion of basic 
education. In 2004, 54% and 38% of 
basic education leavers moved on to 
upper secondary school and vocational 
education and training, respectively. 
Another 3% continued their studies in 
additional education. About 5% of basic 
education leavers did not continue to the 
next level immediately after finishing 
comprehensive school. 
At tertiary level, a new polytechnic 
system was created in Finland in the early 
1990’s to complement traditional 
university education. Using the OECD 
indicator covering tertiary graduates, 
where the number of completed degrees 
is set in proportion to the size of a typical 
age group graduating from tertiary 
education, about 50% of young people 
complete a tertiary degree. This ratio is 
clearly higher than the OECD average. 
4.4.2. Long-term strategic 
approach 
Untargeted awareness campaigns and 
direct prevention activities directed 
toward the general population have not 
been seen as a priority area of HIV/AIDS 
prevention and especially not for 
achieving behavior change in the general 
public.  
Instead, targeting youth and building of a 
solid sexual health knowledge base at an 
early age among youth is seen as the 
main approach to achieving low risks at 
both young and adult age. The main tool 
for achieving this is through health- and 
sexual education in primary and 
secondary level schools. 
The Finnish educational system achieves 
consistently outstanding marks in both 
national and international evaluations. 
The learning outcomes of Finnish basic 
education are among the best in the 
world. According to the OECD’s PISA 
survey, 15-year-old Finns are among the 
best in terms of reading literacy, 
mathematics and sciences. A particular 
strength of Finnish basic education is the 
fact that the proportion of poorly 
performing students is low. 
In the latest (the year 2006) PISA – The 
OECD Programme for International 
Student Assessment evaluation Finland 
scored as the number 1 ranked country 
for all OECD members and PISA partner 
countries. The theme of the evaluation 
was Science.  
According to the 2003 PISA definition, 
this area of the evaluation covers the 
students’: 
“Scientific knowledge and skills applied 
to real-life situations, as opposed to 
science linked to particular curricular 
components. Students are required to 
show a range of scientific skills, involving 
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the recognition and explanation of 
scientific phenomena, the understanding 
of scientific investigation and the 
interpretation of scientific evidence. 
Tasks are set in a variety of contexts 
relevant to people’s lives, related to life 
and health, technology and the Earth and 
environment.38”
In this regard the Finnish approach seems 
to give youth a solid ground for acquiring 
the necessary skills to make evidence 
informed choices in their daily lives and 
behavior, including sexual behavior.  
4.4.3. School health- and sexual 
education
Sexual education has been part of school 
education in curriculum for 14-15 year-
old pupils from the 1980s. Presently 
schools are obliged to implement a new 
national curriculum of health education 
including sexual education and 
prevention of sexually transmitted 
diseases. In addition to the curriculum on 
health education, sexual health issues are 
integrated into other school and study 
objects such as biology, media education 
and human development.  
The focus on sexual education in Finland 
is moving from a biological perspective 
to a wider orientation that includes 
emotional and social aspects of sexual 
health. Sex education material for 
teachers and school public health nurses 
are available also via the Internet. 
Adolescents' sexual knowledge and 
behavior is monitored every two years in 
connection with the national School 
Health Promotion Study. The data has 
been available since 1995 to evaluate the 
provision and effect of sexual education 
at national level. 
38 http://www.pisa.oecd.org -> what PISA 
produces -> PISA 2003 
There are active non-governmental 
organizations providing materials and 
services for sexual education of 
adolescents in Finland, e.g. the Family 
Federation of Finland (Väestöliitto) 
operates a Sexual Health Clinic - Open 
House Clinic for Adolescents, with active 
Internet service39.
4.4.4. School health surveys 
The National Research and Development 
Centre for Welfare and Health (STAKES) 
in cooperation with the University of 
Jyväskylä run the School Health 
Promotion Study, which is a large-scale 
population based health and health 
education survey for students at 8th and 
9th grades at comprehensive schools (14–
16-year-olds) and for 1st and 2nd grades in 
high school (16–18-year-olds). 
Data collection 
Data collection is performed in the end of 
April, in a biannual and geographically 
rotating fashion in the participating 
municipalities. The survey covers 
approximately 90 % of the Finnish 
municipalities. In even-numbered years 
the provinces of Southern Finland, 
Eastern Finland and Lapland are 
surveyed, whereas in odd-numbered years 
the survey covers the provinces of 
Western Finland, Oulu and Åland. 
The survey, which is an anonymous 
classroom questionnaire of 12 pages was 
distributed to 164 000 respondents in 
2005/2006. The response rate was 82 % 
in comprehensive school and 77 % in 
high school. 
39 http://www.vaestoliitto.fi
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Table 9: Participants in the School Health Survey 
The School Health Promotion study 1995–2006 
Year 
Participating 
Municipalities
Comprehensive 
schools 
High 
schools
Vocational 
schools Respondents 
1995 25 58 10 8 10081 
1996 96 255 155 77 53000 
1997 117 193 122 79 46000 
1998 136 285 159 78 59000 
1999 179 324 186 95 82200 
2000 156 334 200 88 79000 
2001 173 244 161 3 59000 
2002 150 416 219 - 82000 
2003 219 352 205 - 71600 
2004 145 432 222 - 84763 
2005 212 398 207 - 73900 
2006 148 431 228 - 88200 
The questionnaire covers living 
conditions, school as working 
environment, health-related behavior (e.g. 
nutrition, smoking, use of alcohol and 
drugs, sexual behavior) and health (e.g. 
diseases and symptoms, depressive 
mood). 
Among the subjects on sexual behavior 
and sexual health are questions on 
whether or not the respondent has had 
sexual intercourse, how many times ever 
and with how many partners one has had 
intercourse.  
The study questionnaire also includes a 
question on use of birth control and 
which method is used. 
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Figure 29: Adolescents and youth who have not 
had intercourse 
Results from the school health survey 
indicate that adolescents are relatively 
well aware of HIV/AIDS related risks. 
However, a proportion of students do 
start their sexual activity early, at the age 
of 14-15. 
The proportion of students who have not 
had their sexual debut (75-79 % have not 
had intercourse) has not changed 
significantly among comprehensive 
school classes 8-9 since 1997. It has 
increased in the older age groups of High 
school students in classes 1-2 (in 2007, 
60 % had not had intercourse compared 
to only 52 % in 1997). 
School health survey
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Figure 30: Sexual partners among 16-17 y old 
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Also, a larger number of students 
reported single sexual partners among 
High school respondents (44 % in 1997, 
55 % in 2007).  
School health survey: 
Comprehensive school class. 8-9, birth control usage
(20-23 % have had intercourse) at last intercourse
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Figure 31: Birth Control Use in 
Comprehensive School 
The main method of birth control both 
among 14-15 year old adolescents and 
among 16-17 year old youth is condom 
use. However, approximately 30-35 % of 
the younger group and over 40 % of the 
older group had not a condom at their last 
intercourse. Twenty and 10 % of the two 
groups, respectively, did not use any 
prevention at all. For the older group, the 
decline in the use of condoms correlates 
with a wider use of birth control pills. 
School health survey: 
secondary school class. 1-2, birth control usage 
(41-49 % have had intercourse) at last intercourse.
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Figure 32: Birth Control Use in Secondary 
School 
While the total proportion of those using 
birth control is high, it would be 
important to stress the importance of 
double protection by simultaneous use of 
condoms in the future. 
4.5. Behavior change 
There are few systematically conducted 
studies assessing sexual behavior and STI 
related risk taking among the general 
adult population. A few targeted studies 
among MSM and IDU have been 
conducted, but these are not necessarily 
even subpopulation wide, and are not 
always annually performed. 
Several health monitoring surveys with a 
wide sampling base are conducted in 
Finland, but these mainly address 
nutrition, various chronic diseases, 
smoking, drug and alcohol use, mental 
health and functional capacity/physical 
activity issues (i.e. AVTK, FINRISKI 
and HEALTH 2000)40.
However, none of the regularly conducted 
surveys cover sexual health issues, 
particularly not those that deal with 
sexual orientation, risk perception or risk 
taking. As a result, there are no adult 
population level data on key parameters 
such as sexual partner numbers or 
condom use, nor much any other risk 
indicator. 
Therefore, it is difficult to know anything 
specific on trends of risky behavior in 
Finnish adult populations. Studies among 
adolescents show no great changes over 
the years, but after the completion of high 
school there is no specific data available 
for adult populations. Partly this is 
explained by the strategic approach of 
reaching youth and an effective STI 
disease surveillance system which will be 
able to pick up changes leading to 
increased incidence. 
However, there is no guarantee that 
behavioral patterns and especially 
condom use frequencies recorded in 
school health surveys are permanently 
maintained in adult populations as the 
40http://www.ktl.fi/portal/4152,
http://www.ktl.fi/portal/11531
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youth mature. On the contrary, there is 
anecdotal evidence for an increase in 
complacency towards safe sex.  
Also, disease surveillance systems pick 
up only on hard outcome endpoints, i.e. 
only when risks have been realized and 
led to increased incidence. At this point, 
increased disease burden already leads to 
higher costs and suffering, which could 
have been avoided by recording increased 
risk behavior and putting in place 
effective interventions.  
Therefore, it is quite clear that a stronger 
emphasis has to be put on developing 
effective ways for risk behavior surveys 
in the very near future. 
4.6. Impact alleviation   
Impact alleviation consists of all 
measures that reduce the societal and 
personal burden of HIV/Aids. To ensure 
that this will be realized, the regulatory 
and legislative framework must support 
the objective. The HIV policy contains as 
a goal that legislation will respond with 
changes as needed if the HIV/Aids 
situation changes. 
4.6.1. Current legal framework 
for HIV/Aids  
There is no specific HIV/AIDS 
legislation, but several pieces of 
legislation cover issues that concern 
HIV/AIDS prevention. These include the 
following main statutes41.
Constitution 11.6.1999/731 
Protection against discrimination due to 
gender, race, minority status, sexual 
orientation, social and health status 
41 http://www.finlex.fi
Act on the Status and Rights of 
Patients 17.8.1992/785 
Protection against medical 
mismanagement and right to self-
determination within the healthcare 
system
Primary Health Care Act 
28.1.1972/66 
Free access to prevention and primary 
care for all legal residents 
Act on Specialized Medical Care 
1.12.1989/1062 
HIV and AIDS care is not specifically 
allocated to be dealt with within the 
specialized medical care system. In many 
municipalities care is however 
implemented this way to ensure necessary 
expertise. 
Act on Customer Fees within the 
Social- and Healthcare system 
3.8.1992/734 
Free of charge access to HIV treatment 
and care for all legal residents 
Covers care, laboratory diagnostics and 
medicines (incl. ARV-drugs) 
Personal Data Act and Personal 
Data File Decree 22.4.1999/523 
Identity protection 
Communicable Disease Act and 
associated decree 25.7.1986/583 
Surveillance and reporting of HIV and 
Aids cases, special protections against 
HIV status disclosure 
Act on Employee Contracts 
26.1.2005/55, Act on the Protection 
of Privacy in Working Life 
13.8.2004/759 
Protection against disclosure, 
discrimination due to health status 
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The employer may not exercise any 
unjustified discrimination against 
employees on the basis of age, health, 
disability, national or ethnic origin, 
nationality, sexual orientation, language, 
religion, opinion, belief, family ties, trade 
union activity, political activity or any 
other comparable circumstance. 
Penal Code 19.12.1889/39 
Knowingly transmitting HIV to another 
person or exposing another person to the 
risk of transmission of HIV is not 
specifically mentioned in the penal code 
as a felony. However, judicial practice 
has established these acts to be 
comparable to the offence of causing 
grave bodily harm. Under this 
interpretation a person can therefore be 
charged and sentenced.  
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5. National resource and 
funding estimates 
As is described in many subsections of 
this report, HIV/Aids prevention, 
treatment, care and support are integrated 
in many regular activities in society, 
rather than falling under separate 
programmes. Therefore direct resources 
allocated are close to impossible to 
identify by any level of accuracy. 
There are some targeted activities for 
which the resources allocated or used can 
be estimated. These, however, represent 
only a small fraction of the cumulative 
factual spending on HIV/Aids prevention, 
treatment care and support, and therefore 
cannot be used to make any meaningful 
comparisons with other health issues or 
between countries. 
5.1. Government   
Within the central government, the 
Ministry of Social affairs and Health 
(MoSAH) has a few budget lines for 
project- or programme based activities in 
the health field. In addition, the National 
Slot Machine Association, which is 
governmental monopoly, issues funding 
targeted for NGO health and social affairs 
activities. 
5.1.1. Central Government  
Of the national governmental funding 
appropriations issued by the MoSAH, 
there are two project budget lines which 
are relevant, the appropriations for 
“Prevention and control of infectious 
diseases” and the budget line for “Health 
Promotion”. In addition, the as the 
National Public Health Institute - KTL 
operates under the MoSAH, its HIV-units 
budget is derived from the governmental 
Social Affairs and Health budget. 
In addition to the identified funding, 
many appropriations under the MoSAH 
budget line indirectly support HIV/Aids 
work.  
Table 10: Examples of readily available government funding for national HIV/Aids 
issues* 
MoSAH budget lines 2006 2007 Project activity areas 
Prevention of infectious 
diseases 
(total: 1360 k€) nk 538 k€
STI and HIV/Aids 
prevention 
Health promotion 
(total: 9300 k€) 1171 k€ 1294 k€
Sexual health, health 
promotion among IDU 
National Public Health 
Institute – KTL (HIV-
unit budget) 298 k€ 317 k€
Surveillance, prevention, 
expert functions, co-
ordination, research and 
international cooperation 
*NOTE: these figures only serve as examples and should not be used as estimates of total NGO/Civil society spending 
levels on HIV/Aids, which have not been reliably estimated 
Funding by the National Slot Machine 
Association for HIV/Aids prevention 
activities is spread under various 
activities and cannot be reliably 
estimated. 
Finland 2008 UNGASS HIV/Aids country report – KTL B4 / 2008 
Report collation, drafting and coordination 
National Public Health Institute – KTL, HIV unit 
www.ktl.fi62
5.1.2. Municipal and Regional 
Government 
Although the regional and (especially) the 
municipal governments are largely 
responsible for both prevention and care 
and therefore also appropriate the bulk of 
the resources spent on HIV/Aids, their 
direct contribution is impossible to 
directly measure. 
The estimation of health care resources 
spent would require a detailed cost 
analysis, which would have to be done 
both on a municipal and hospital district 
level. 
In addition, the role of the educational 
system, especially the primary prevention 
activity in the form of health education 
and school health system which is 
provided by the municipal comprehensive 
school system is essential for the 
HIV/Aids prevention work.  
As for the health care system, the 
resources for HIV/Aids prevention within 
the educational system cannot be easily 
estimated. 
5.2. NGO: s and Civil 
Society 
Non-governmental Organisations (NGOs) 
and Civil Society working in the field of 
HIV/Aids are funded to a large extent by 
both governmental appropriations and/or 
by tendering contracts issued by 
municipal health authorities. National 
spending by the NGO/Civil society sector 
is as difficult as the government sector to 
estimate, but some published data or 
otherwise available can be shown as 
examples.  
Table 11: Examples of available data of NGO/Civil Society spending on HIV/Aids 
issues* 
Organisation Annual 
budget 
Activity area Main funding 
sources 
National Aids Council 1400 k€ 
HIV/Aids prevention, 
Service and Support 
MoSAH, Slot 
Machine Association 
Pro-tukipiste** 1100 k€ 
Support and help for sex 
workers
MoSAH, Slot 
Machine Association, 
City of Helsinki 
Helsinki Vinkki IDU 
LTHSC*** 800 k€ 
Health promotion and 
prevention of infectious 
diseases for Injecting 
Drug Users 
A-Clinic Foundation, 
MoSAH, Slot 
Machine Association, 
City of Helsinki 
*NOTE: these figures only serve as examples and should not be used as estimates of total NGO/Civil society spending 
levels on HIV/Aids, which have not been reliably estimated 
**   Unofficial figure; 2008 budget estimate 
*** Unofficial figure; 2005 funding 
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6. Best practices  
6.1. Integration of HIV and 
AIDS prevention, 
treatment and care into 
regular primary, 
secondary and tertiary 
level healthcare 
The integration of HIV/AIDS as a cross-
cutting issue in regular healthcare with as 
little specific actions as possible is in 
many ways a successful practice. As 
HIV/AIDS is more or less a health issue 
among others, there is no question on 
who has responsibility for tackling the 
problem, as it follows regular divisions of 
labor within society. 
According to the Law on Public Health, 
the responsibility to primary prevention, 
public health preventive medicine and 
testing services lies with the municipal 
level of government. The health services 
are typically provided by the municipal 
health centers. 
The Law on specialized care regulates the 
organisation and duties of the health care 
districts which run the regional and 
university central hospitals. According to 
the regulation, the provision of public 
health specialized care is the responsibilty 
of the hospital districts, and the 
municipalities purchase these services for 
their residents. PLWHA are generally 
referred to the specialist level for their 
care. 
This approach also lays a solid 
foundation for comprehensive coverage 
of HIV/AIDS services, as municipal 
health providers cannot point to some 
other, possibly unavailable national actor 
for picking up the responsibility or costs. 
6.2. Voluntary testing and 
counseling with a low 
threshold 
Voluntary testing and counseling is 
provided by all municipal health centers 
free of charge. This ensures that there is 
no cost limitation towards HIV-test 
seeking and that regional coverage is 
adequate. 
6.3. Efficient surveillance 
system enabling rapid 
response in changing 
situations 
The system in place for HIV/AIDS 
surveillance in Finland is one of the best 
performing passive reporting systems 
even using an international yardstick. The 
use of a double reporting system (lab and 
physician reporting), multiple reporting 
time-points (infection, AIDS, AIDS-
death), confidential and secure use of 
personal identifiers enabling report 
linking and case counting and the 
collection of a rather wide array of 
transmission group data ensures that 
epidemiological changes can be rapidly 
detected and responded on.  
An example of this was the outbreak 
among IDUs in 1998 which was 
identified within a few months of the first 
cases and almost immediately led to rapid 
prevention responses.  
Other tools which are useful for 
surveillance are the use of rapid HIV 
screening tests in diagnostic testing. This 
enables a good contact to those seeking 
testing and enables counseling to be 
performed while tests are developing. It 
has also significantly increased test 
uptake upon vulnerable groups, especially 
IDUs. 
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In addition to passive surveillance, 
sampling based studies among IDU and 
MSM populations are conducted to 
monitor trends in prevalence among 
vulnerable groups. Here the application of 
novel and innovative, oral fluid sampling 
devices for HIV-testing with integration 
into anonymous population surveys has 
provided valuable data on specific 
otherwise hard to reach populations. 
6.4. Integration of HIV/AIDS 
prevention into school 
health and sexual 
health education 
Health education, including sexual health, 
sexuality education, drug and alcohol use, 
STI and HIV/Aids issues reach close to 
100 % of all adolescent through the 
compulsory school subject of ages 13-18. 
6.5. Targeted prevention 
services for highly 
vulnerable groups 
Special targeted services (Low Threshold 
Health Service Centers – LTHSC) for 
IDUs include health promotion and 
advice, vaccinations, counseling, sexual 
and reproductive health services, small 
scale medical services, referrals, testing 
and injection equipment exchange 
services. Such services are provided at 
close to 30 sites across the country in a 
multitude of collaborative public-private 
co-operations. The A-clinic foundation 
and the Helsinki Deaconess Institute the 
largest service providers.  
Targeted low threshold services for sex 
workers are provided in two large cities 
(Helsinki and Tampere). The services are 
provided by an NGO actor, Pro-Tukipiste 
ry and funded by governmental and 
municipal actors. 
The Finnish AIDS Council provides 
preventive, training and support services 
targeted both to vulnerable groups such 
as MSM but also to youth, health 
professionals and PLWHA and their next 
of kin 
6.6. Involvement, private-
public partnership and 
direct governmental 
and municipal financing 
of civil society and 
NGO: s in prevention 
and support 
Most HIV prevention activities in Finland 
which are not directly run by the 
governmental or municipal health care or 
educational systems actively engage civil 
society and NGO: s. The National HIV 
Expert group has permanent 
representation from Civil Society and 
NGO members have been engaged in 
UNGASS and the EU Think Tank Civil 
society forum. 
Importantly, NGO: s and governmental 
actors have a good and working 
cooperation in substance work including 
day to day dialogue. Finnish HIV/AIDS 
NGOs are mainly directly funded by 
national funding agencies. 
In addition, several NGO: s have long- 
and short-term contract for special service 
provision with municipal bodies 
responsible for health issues. As an 
example, the IDU-LTHSCs in Helsinki 
are entirely run by two NGOs, the A-
Clinic Foundation and the Helsinki 
Deaconess Institute based on a service 
contract with the municipal health 
services in Helsinki, who provide the 
funding. In addition, the MoSAH 
provides national funding for certain 
development and monitoring activities. 
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6.7. Training and self-help 
manual production 
The Finnish association of HIV/Aids 
nurses (SHAS), the Finnish AIDS 
Council and the HUS Aurora Infectious 
disease unit has published an “HIV-care 
handbook” in 2007 with financial support 
from the Slot Machine association and 
the MoSAH. The handbook is mainly 
targeted to nursing professionals, but 
immediately gained wide popularity 
among the whole medical field, including 
physicians.
The role of nurses in HIV/AIDS work, 
especially in testing, counseling and 
positive prevention among PLWHA is 
very important in Finland. 
The Finnish Body Positive association 
has produced an “HIV self-help manual” 
6.8. A miracle in the Eyes of 
God – on Sexuality, 
Physicality and Gender: 
a guide for confirmation 
training of the Lutheran 
Evangelical Church 
The Finnish Aids Council in co-operation 
with the Evangelical Lutheran 
Association for Youth in Finland (NK) 
published January 18th 2007 a book 
called “A Miracle 
in the Eyes of God - 
On Sexuality, 
Physicality and 
Gender”. The book 
is targeted at group 
leaders of confir-
mation trainings.  
It was considered essential by the 
publishers to produce the book since its 
message could reach the majority of 
Finland's fifteen-year-olds. The 
publishers intended the book to provide 
support for those responsible for practical 
youth work in local parishes. In addition, 
the book complements the Evangelical 
Lutheran Church of Finland’s theme for 
youth work during years 2006-2007. The 
theme “Beautiful in the Eyes of God” 
focuses on growing up as a boy or as a 
girl, including also sexuality as one of the 
aspects. The Church Council had 
requested that NGOs, including NK, 
produce material for the Church’s various 
themes. The Church Council is not 
directly responsible for the materials 
produced by NGO: s, such materials are 
to be used as background in youth work.  
“A Miracle in The Eyes of God” 
encourages open, positive and respectful 
discussion of sexuality, physicality and 
gender issues. The book does not hesitate 
to touch upon difficult topics and does 
not offer any strict rules for the reader. 
When it comes to love, affection and their 
limits, this book challenges adolescents to 
reconsider their own responsibilities. The 
book offers a lot of concrete support and 
information for recognizing and dealing 
with emotions, accepting oneself, 
understanding sexuality, dating, and 
respecting our own bodies and the bodies 
and the physical and mental integrity of 
others. The book contains a lot of 
practical exercises, which help young 
people to face their own thoughts 
concerning sexuality, physicality and 
gender issues.  
The Finnish 
Aids Council 
produced the 
book in 
collaboration 
with experts 
from the 
Evangelical Lutheran Church of Finland. 
The book was published in Finnish in a 
run of 25,000 copies. Local parishes can 
order the book from NK free of charge. 
Furthermore, the book can be 
downloaded from the Finnish Aids 
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Council’s website. The Finnish Aids 
Council is a national NGO which was 
established 20 years ago. The Council 
provides support and psychosocial help to 
those who are already infected, their close 
friends and to those who suspect they 
could have been infected. In addition to 
support services the Council provides 
education and prevention services. 
HIV/AIDS material is produced and 
education services are especially provided 
to professionals working in the social and 
health care section. Additional target 
groups served in prevention are: 1) the 
migrant population, 2) men who have sex 
with men and 3) young people.  
NK (Nuorten Keskus) is a nationwide 
Christian service organization engaged in 
youth work. The foundation of its work is 
grounded in the teachings of the 
Evangelical Lutheran church. The aim of 
the organization is to strengthen a young 
person in his faith in God; to help him 
grow up into a physically and mentally 
well-balanced person and to motivate him 
to be active in the Church and society.  
Member organizations of the NK include 
Lutheran local parishes and Christian 
youth associations. The NK serves people 
between the ages of 15 to 29. 
Background: The Finnish System of 
Confirmation Training: A Unique 
National Custom  
In practice the goal of confirmation 
training is to lead young people in the 
direction of congregational fellowship 
and to help them to grow as Christians. 
During the period of confirmation 
training, young people’s questions about 
life are discussed and answered in 
accordance with the frame of reference 
provided by the Christian faith.  
Surveys show, that confirmation training 
is a part of Finnish youth culture. From a 
young person’s perspective it is not 
viewed as something which labels a 
person as religious. It is regarded as a 
natural part of going through one’s 
teenage years.  
The confirmation training offered by the 
Evangelical Lutheran Church of Finland 
is remarkable in having the highest rate of 
participation in any Lutheran country.   
Organization of Confirmation Training  
The Evangelical Lutheran Church of 
Finland comprises about 560 local 
parishes. Local parishes are responsible 
for conducting confirmation training. 
Approximately 90 % of Finland's fifteen-
year-olds attend confirmation training -
about 58,000 youngsters each year. 
Confirmation training lasts at least six 
months.  
The average confirmation class size is 25 
youngsters, three workers (a priest, a 
diaconal worker and a youth worker), and 
about five to seven group leaders. The 
mainstream trend in confirmation training 
is to conduct most of it in a camp. The 
length of the camp stay ranges from five 
to twelve days. In addition to the camp, 
confirmation training includes activities 
which aim to introduce the youngsters to 
the everyday life and the fellowship in the 
congregation.   
The Role of Group Leaders in 
Confirmation Training  
The training of group leaders for 
confirmation camps has become the core 
of youth work in many parishes. In 2006, 
approximately 24,000 young people took 
part in this training. The group leaders, 
aged 16 to 18, have a central role in 
confirmation training: as volunteers they 
run the confirmation camps together with 
workers from local parishes. Group 
leaders also work as volunteers in other 
forms of confirmation training. They act 
for an average of two to three years as 
group leaders.   
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6.9. International 
development policy and 
development 
cooperation 
Development policy means the principles 
and policies according to which Finland 
acts to improve the circumstances of 
developing countries and the living 
conditions of their inhabitants. 
Development policy is part of Finland’s 
foreign policy, but not only that: 
development policy also involves 
activities within Finland itself. 
As a responsible member of the 
international community, Finland 
promotes development and a more 
equitable division of the benefits of 
globalisation. This is our responsibility, 
but in this way we also construct the 
security, economic growth and the 
fundamental well-being of our own 
society. 
The main goal of Finland’s development 
policy is to contribute to the eradication 
of extreme poverty from the world. 
Development cooperation is a key 
instrument of development policy. It can 
be used to promote the strengthening of 
an environment conducive to 
development in the poorest countries in 
order to improve the premises for 
investments and trade and to achieve 
economic growth. 
Finland's development policy is steered 
by the government resolution on 
development policy from October 2007.42
The fight against HIV/AIDS has been 
included as one of the cross-cutting 
themes in the new Development Policy of 
the Government of Finland (approved by 
the Cabinet in 18 October 2007). HIV 
42 http://www.formin.fi
and AIDS are seen not only as a health 
problem but a broad social issue that 
affects the society as a whole.  
HIV and AIDS have been implemented 
as a mainstreaming issue for NGO’s43
development cooperation since 2004. 
During the year 2006 proximately 12 
percent of the total funds of MFA were 
channeled through specialized NGOs. 
Special attention has been directed to 
Children. Finland has approved the 
framework for the protection, care and 
support of orphans and vulnerable 
children living in a world with HIV and 
AIDS. 
There is number of highly specialized 
Finnish development cooperation and 
humanitarian aid NGOs44. Larger ones 
take actively and regularly part to build 
awareness on global HIV and AIDS 
trends towards Finnish civil society. Part 
of the budgets of NGOs is directed to 
awareness campaigns. In addition to this 
NGOs are involved in Advocacy work on 
HIV and AIDS related issues. HIV and 
AIDS was included as one of the cross-
cutting themes in the new Development 
Policy of the Government of Finland 
partly due to the advocacy given by 
development cooperation NGOs. 
43 Some development cooperation NGOs, World 
Vision Finland etc. have chosen HIV and AIDS as 
a special theme to be implemented 
44 Examples: Fida International, Finn Church Aid, 
Save the Children, Plan Suomi Säätiö, Suomen 
lähetysseura, World Vision Finland 
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7. Major challenges and 
remedial actions  
7.1. Progress made on key 
challenges reported in 
the 2005 UNGASS 
Country Progress 
Report 
Finland has achieved most of the 
UNGASS national targets set in 2001. 
The main changes since the 2005 report 
have to do with improved surveillance 
among MSM and IDU low threshold 
services. 
The main goals of equal and 
comprehensive access to prevention, 
treatment and care are to a large extent 
fulfilled, although regional differences 
have not been completely eliminated. 
Nevertheless, there are still challenges 
that need to be addressed as well as 
uncertainties that the current surveillance 
system cannot address. These still need 
further responses and development. 
7.2. Challenges faced 
throughout the 
reporting period of 
2006-2007 that 
hindered the national 
response and the 
progress towards 
achieving the UNGASS 
targets  
The main challenges with achieving all 
UNGASS targets have to do with the 
following issues: 
7.2.1. UNGASS Indicators 
There are several indicators for which the 
information was not possible to collect 
during the reporting year: 
9:    Percentage of most-at-risk 
populations reached with HIV 
prevention programs  
14:  Percentage of most-at-risk 
populations who both correctly 
identify ways of preventing the 
sexual transmission of HIV and 
who reject major misconceptions 
about HIV transmission  
16:  Percentage of women and men 
aged 15–49 who have had sexual 
intercourse with more than one 
partner in the last 12 months 
17:  Percentage of women and men 
aged 15–49 who had more than 
one sexual partner in the past 12 
months reporting the use of a 
condom during their last sexual 
intercourse
18:  Percentage of female and male 
sex workers reporting the use of a 
condom with their most recent 
partner 
19:  Percentage of men reporting the 
use of a condom the last time they 
had anal sex with a male partner 
These data are missing because these are 
no direct studies of sexual behavior, risk 
perception and risk taking among the 
general adult populations. The only data 
available in any more or less consistent 
fashion is that of youth attending schools, 
certain vulnerable groups and sentinel 
data from STI clinics. However, not all of 
this data is completely compatible with 
the UNGASS indicators, either.  
A similar missing feature is that studies 
or surveys monitoring the societal 
attitudes towards HIV, AIDS and 
PLWHA are not regularly performed. The 
few available data are spotty and 
inconsistently gathered.  
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Monitoring of behavioral and attitude 
indicators needs to be strengthened in the 
future to be able to respond and target 
misconceptions and risk taking. 
7.2.2. Division of work and 
responsibility between 
government and NGO 
actors
7.2.2.1. Integrated HIV/AIDS work 
A guiding principle for the Finnish AIDS 
policy and the strategic approach toward 
prevention, treatment and care is the 
integration of the activities into regular 
social health care, with as little special 
measures put in place as possible. There 
are no “AIDS-centers”, “AIDS-clinics” or 
“HIV/AIDS wards” in Finland that would 
segregate and separate HIV-cases from 
other patients. Municipal public social 
and health provider have a clear legal 
obligation to see to the needs of their 
residents in any health issue, including 
HIV/AIDS.
While this approach has many benefits, it 
is not without problems either. When the 
approach works best, it provides equal 
access and nondiscriminatory HIV/AIDS 
care compared to any other medical 
condition. It also sets clear boundaries to 
where responsibilities lie within the 
various levels of social welfare and health 
care actors. 
In a worst case scenario, however, the 
integration may lead to integration on 
paper only and factual negligence of 
HIV/AIDS specific issues that would 
have to be taken into consideration for 
proper organization of actions. This may 
happen for many reasons, but mainly 
because one of the following reasons: 
1) Perceived or real rarity of the 
issue at hand (HIV/AIDS); which 
may lead to: 
2) Prioritizing other social and health 
issues 
3) Therefore: lack of resources 
4) Therefore: lack of knowledge and 
understanding 
If a situation like the one that is described 
above develops, which may well be the 
case in the smaller municipalities in 
Finland; it may mean that if faced with a 
need for service provision for an HIV 
positive resident, the system may not be 
ready for the task. 
This may lead to an inappropriate, or in 
the worst case even judgmental response 
towards the person, or to a referring to the 
lack of resources for the provision of 
especially supportive social services. 
While those accessing the public health 
system may press forward and demand 
their legal right to service, this places a 
too high burden on the individual to be 
acceptable. 
A big part of the problem above is the 
large number of municipalities and the 
small size of many of them. It is clear that 
a municipality as small as 2-3000 
inhabitants and with the corresponding 
tax base cannot provide the same level of 
services as one of 500.000 inhabitants. In 
addition, Finland is a large country with 
long distances in the rural areas, which 
puts additional challenges to ensuring 
equal access for all. This creates great 
challenges for creating and managing 
functional cooperative models between 
many small municipalities. 
As the small municipality size leads to 
several problems, a process of creating 
larger units of an average of 20.000 has 
started. This is expected to improve 
access to services in the future. 
An additional challenge is that some of 
the groups vulnerable to HIV infection, 
especially the IDU, sex workers and 
sometimes even MSM, may be perceived 
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as marginal or “difficult to face” groups 
within the public social welfare and 
health system. For some of them who act 
on the boundaries of the legal and judicial 
system (especially migrant sex workers or 
illegal immigrants), there may be no legal 
access to services. 
This raises the threshold for access to 
services, frequently both among the 
providers and the clients, which in many 
ways has a negative long term public 
health effect. 
7.2.2.2. Engaging the 3rd sector actors 
One solution that has been frequently 
used to try to solve some of the above 
challenges is the engagement of and co-
operation of NGO and Civil Society 
actors together with government (local 
and national) actors. NGOs working for a 
certain defined cause frequently have 
better possibilities to develop expertise 
which can be utilized for the benefit of 
both the individuals in need and the 
community.  
NGOs also often have a better possibility 
to reach out and connect to vulnerable 
groups and may be perceived among the 
target groups as more trustworthy 
because of the lack of a direct 
“governmental” role. 
For these reasons, there is both a tradition 
and good practice of outsourcing of parts 
of the social and health services to the so 
called 3rd sector, i.e. different NGOs and 
non-profit civil society actors (1st sector 
is the public sector, 2nd is the private 
sector). While this approach has the many 
obvious benefits and at its best leads to 
excellent results, it is not without 
challenges.   
A main challenge for the NGO 
engagement is long term funding. Most of 
the actors receive their operational 
funding trough a mixture of short term 
contracts. These come from many 
different sources, which can be self-
initiated applications to a certain broad 
funding-program (national or 
international, EU-funding is often used) 
or tendered, i.e. competition based. The 
latter is most frequent when municipal 
actors outsource part of their activities. 
Municipal actors are public agencies and 
are required to follow competition 
legislation in their outsourcing work. 
Especially important in this regard is the 
Act on Public Contracts, 348/2007, which 
specifies the rules under which a public 
agency must operate their purchasing of 
goods and services. 
The constant need for re-applying for 
external funding leads to a diminished 
longevity for the work at hand. In practice 
the funding available may be mostly for 
short term projects and less for 
maintenance of long-term activities, 
which can severely counteract the actual 
goal of the program at hand. 
A special emerging challenge can be seen 
in evolving rules for tendering processes: 
within certain types of public funding 
agencies, the question of freely competed 
tenders has been raised in areas where 
typically more or less targeted funding 
has been utilized in the past. This means, 
that due to stricter EU community 
competition rules and national legislation 
(see above), some non-profit NGOs 
which have a long established and 
recognized expertise within a field, may 
be faced with having to compete on equal 
terms with for-profit civil society actors 
for a certain activity.  
This approach incorporates a great risk of 
losing the expertise if a new actor comes 
in with an aggressive bidding to gain a 
foothold in the field. Such a situation may 
for example develop if packaging of 
many different services is performed to 
be able to gain a strong position towards 
the tendering party. Especially in 
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situations where municipalities more and 
more outsource some of their public 
social and health care duties to privately 
owned and operated actors, this may very 
well happen. This puts a hard burden on 
the expertise of the outsourcing agency as 
well as on the bidding service provider to 
be able to produce and judge competitive 
bids.
It will be important to make sure that it is 
even in the future possible to ensure that 
tendering processes adequately take into 
account and judge the best expertise and 
experience available in competitive 
tendering processes, so that these factors 
can overrule the cost of the services in 
provider selection when there is a clear 
difference between bidders. 
7.2.2.3. Division of responsibilities 
Another challenge of outsourcing or 
NGO engagement is that over time the 
responsibilities laid down in the laws and 
regulations may become blurred. While 
the law on public health is clear on where 
the responsibility leis (i.e. within the 
municipal government), the perception 
among those who may fund the services 
may become such that they have fulfilled 
their legal duty by such funding, even if it 
would be inadequate. 
Therefore, external monitoring of the 
fulfillment of the legal responsibilities by 
municipal social and health actors would 
need to be strengthened. During the mid 
1990:s recession the National Board of 
Social Affairs and Health, which used to 
be responsible for monitoring of social 
and health service provision was 
decommissioned entirely. 
While the tasks of the former board were 
divided among other actors, such as the 
MoSAH, STAKES and the regional 
governments, the development of detailed 
common standards was largely 
abandoned and more freedom given to the 
local actors in decision making and 
standard setting according to local needs. 
There is a need to evaluate whether some 
clearer guideline setting would be needed 
in the future. 
7.2.3. Need for strengthened 
nationwide activity 
Certain areas of especially preventive, but 
to a certain degree also healthcare 
HIV/AIDS work would benefit from a 
nationwide approach. Currently the 
challenge in this regard is how to identify 
the correct actor which would have both 
the mandate and resources available for 
such activities. Since preventive health 
and social work is the responsibility of 
municipal governments, it is difficult to 
identify a single actor who could take on 
a nationwide common program. In the 
current governmental structure only the 
MoSAH, regional governments or 
municipal co-operation bodies45, advised 
and assisted by KTL and STAKES could 
take the lead in these activities. 
7.2.3.1. HIV/Aids expertise within the 
public health care  
The integration of HIV/Aids into regular 
primary, secondary and tertiary health 
care is not without problems. In practice, 
the existence of  adequate HIV/Aids 
expertise in health care becomes 
questionable especially in those regional 
health districts where the prevalence and 
number of PLWHA is low, because 
HIV/Aids constitutes such a minor 
section of a health care providers 
workload.  
Even in the health districts with the 
highest number of PLWHA in the 
country, the allocation of human 
resources for maintenance of HIV/Aids 
expertise has great difficulties to hold its 
own against more established fields of 
medicine.  
45 Lääninhallitukset, Kuntayhtymät, Kuntaliitto 
Finland 2008 UNGASS HIV/Aids country report – KTL B4 / 2008 
Report collation, drafting and coordination 
National Public Health Institute – KTL, HIV unit 
www.ktl.fi72
7.2.3.2. Social marketing and 
awareness campaigns 
A major issue in this regard is how to 
identify an appropriate actor which could 
be responsible for awareness campaigns. 
While there is little evidence of true 
behavior change through such social 
marketing, there is good evidence of its 
supportive role for maintenance of 
existing safe practices and as an attitude 
modifier. Currently no actor is self 
evident in co-ordination or funding of 
campaigning or social marketing 
activities. Again, a possibly could lie in 
the municipal co-operation bodies. 
However, relatively large resources 
would be needed to achieve this. 
7.2.3.3. Stigma and discrimination 
Issues of stigma (and to a certain degree 
discrimination) due to fears and false 
beliefs have not been entirely removed 
from the societal response to HIV/AIDS 
in Finland. Although little data is 
available on the public attitudes towards 
HIV-infected, anecdotal reports and 
isolated events point to the existence of 
negative attitudes especially towards 
questions on transmission of HIV/AIDS. 
A recent case of an individual who had 
sexually transmitted HIV to several other 
persons despite knowledge of his/her own 
infection received a lot of media 
coverage. In the Finnish legal system 
interpretation, such knowing exposure of 
others has been deemed as falling under 
criminal prosecution. 
Media coverage of the case resulted in a 
partial backlash in attitudes and has the 
problem of emphasizing the 
responsibility of the positive person and 
de-emphasizing the need of the other 
parties for self-protection. 
It is clear that there is a need to study the 
questions of HIV related attitudes and 
stigma. Also, it would be important to 
estimate the public health and societal 
effects of the current judicial practice.  
7.2.3.4. MSM work 
Men having sex with men are clearly 
among the most vulnerable groups for 
HIV/AIDS in Finland. The estimated 
prevalence (4.5 %) in this group is the 
highest of all subpopulations in the 
country. 
Despite this there are only little 
prevention resources available for 
targeted MSM work. The MoSAH and 
some other funding bodies have provided 
resources for some NGO: s (The AIDS 
council and the Pro-Tukipiste) for 
preventive MSM work, but the coverage 
and extent is far from sufficient to reach 
the whole population even in the capital 
area. 
Preventive work through these 
organizations should be vigorously 
supported to extend their coverage. In 
addition, other relevant organisations, 
both governmental and NGO/Civil 
society, could include risk reduction and 
safe sex promotion, including targeted 
non-heteronormative messaging, on their 
agendas. However, this would require a 
clear increase in available funding and 
making STD prevention a priority area. 
International estimates would suggest that 
approximately 2-7 % of the male 
population belong to this group, making it 
the single largest vulnerable group. In this 
regard there would probably be a demand 
for targeted health services for MSM. In 
some countries, health clinic specializing 
in this group exist and act as a natural 
route for health promotion and 
HIV/AIDS prevention work. 
STI clinics have their own role in MSM 
health promotion and certainly STI 
prevention work, but they may not be 
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able to fulfill the whole spectrum of 
MSM specific health issues. 
7.2.3.5. Strengthened youth work, 
including non-hetero-
normative health education 
and prevention 
Thanks to the school health survey, there 
is relatively good data available on both 
the knowledge level and the STI risks 
among adolescents and youth in 
comprehensive schools and high schools. 
However, after this level, data is much 
spottier, and only exists from small-scale 
studies. In addition, the data is currently 
missing completely for those youth who 
choose vocational schools after the 
comprehensive school level. This deficit 
has been clearly addressed in the MoSAH 
“Promotion of sexual and reproductive 
health action programme” of 2006. Data 
from university level students is almost 
completely missing, although it could be 
collected through university health 
services. 
While the addition of Health education as 
a standardized compulsory subject in 
schools is a positive development and has 
probably improved the level of 
knowledge among youth significantly, 
there is little knowledge on how the 
knowledge turns into preventive action 
especially after the age of 18. Chlamydia 
and Papillomavirus infections are 
common among youth, especially after 
the age of 19. 
Resources for school student health 
services have been significantly reduced 
in the last 10 years, and in most schools 
access to a school nurse is only available 
certain days of the week, and access to a 
school physician only once a month. 
There are few youth health clinics that 
would offer sexual health and STI 
prevention advice targeted specifically to 
youth. The services are in principle 
available through regular municipal 
health centers, but the “youth-
friendliness” varies greatly between 
municipalities. Few, if any health centers 
provide free access to condoms. Access 
to condoms and other birth control tools 
is widespread, but prices are relatively 
high, especially for condoms and may 
therefore represent a barrier for use. 
The establishment of much wider 
network of municipal free youth sexual 
health clinics should be considered as an 
alternative to current practices. There is 
an urgent need to try to influence sexual 
behavior in way that would reduce 
current levels of risk among youth. 
Another important issue which would 
need further emphasis in youth health 
education and promotion would be to 
develop the school health education 
curriculum further, so that more attention 
could be paid to young men who are 
having, or might have, sex with men.  
The health education materials and 
curiculums should be critically examined 
and renewed to more strongly also 
include a non-heteronormative angle to 
ensure that the information on 
transmission and safe sex practices will 
also be addressed to young MSM and 
non-heterosexual women. 
7.2.3.6. Positive prevention 
Sexual prevention among PLWHA is 
mainly conducted by peer organizations 
such as the Finnish Body Positive 
association and by specialized infection 
clinic staff (mainly nurses and social 
workers). Low threshold health service 
centers for IDU also have a role in this. 
However, little is known about the actual 
impact of positive prevention messaging 
or even on how it is practiced. There is a 
need for developing the concept further, 
maybe by much more concrete 
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collaboration between the PLWHA 
organizations and the health care actors to 
develop more standardized tools and 
methodology. 
7.2.3.7. Migrants
Migration as an issue is going through 
major changes in Finland. The population 
of migrants grows continuously, and the 
number of residents with a migrant 
background increases. Prevention work 
among migrant populations needs own 
approaches which also must be adapted to 
the specific and differing needs of the 
diverse migrant populations.  
The successful integration of these 
services into the homogenous social and 
health services in Finland represent a 
tremendous future challenge, especially 
as there is a real need to increase 
migration due to a shrinking workforce in 
Finland. 
An additional and highly vulnerable 
group is formed of illegal and/or 
trafficked migrants whose needs easily 
become overrun by legal barriers. The 
needs of this group need to be addressed 
foremost from a human rights framework. 
7.2.4. Neighbourhood area 
cooperation
The neighboring areas of Finland in the 
East and the South have experienced 
some of the most rapidly expanding HIV-
epidemics during the last 10 years. A lot 
of cross-border exchange to these areas 
(the Russian Federation and the Baltic 
States) occurs and is expected to grow 
extensively in the future. 
The widespread HIV-epidemics coupled 
to a still significant economic gradient 
between the areas represent a major 
challenge for HIV prevention in the area. 
Finland has a long tradition of 
Neighboring Area collaboration with the 
Russian Federation in the field of Health, 
and this should be further extended and 
supported in the future to ensure a 
beneficial outcome for the years to come. 
7.3. Concrete remedial 
actions that are 
planned to ensure 
achievement of agreed 
UNGASS targets 
Plans to enhance behavioral surveillance, 
through the incorporation of questions on 
sexual behavior and risk taking in 
national health surveys exist. Currently 
negotiations are under way to enable this 
to be achieved. 
Similarly, the d School health study is 
planned to be extended to vocational 
schools to reach a higher proportion of 
the youth population. 
Many of the other challenges will be 
addressed through the new National HIV 
Policy document which hopefully will be 
able to suggest solutions to at least part of 
the challenges. 
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8. Support from the 
country’s development 
partners  
Not applicable. Finland is a bilateral, 
regional and multilateral donor. 
9. Support for Global 
Commitments 
9.1. UN and bilateral 
development co-
operation 
Finland strongly supports UNAID in its 
work and financial contributions in the 
past years have been as follows 
Table 12: Contributions to UNAIDS by 
Finland
Year Amount Comment 
2005 7 M€ Incl. 1 M€ for GCW 
2006 8 M€ Incl. 1 M€ for GCW 
2007 8 M€  
Finland also contributes for HIV/AIDS 
work indirectly through non-earmarked 
donations to several UN agencies, as well 
for bilateral development cooperation 
work, for example with Mozambique.  
9.2. Global fund 
Finland joined the Global fund against 
AIDS, Tuberculosis and Malaria in 2006 
and has contributed (and pledged to 
contribute) as follows: 
Table 13: Contributions and Pledges to 
the Global Fund by Finland 
Year Amount Comment 
2006 3 M€  
2007 2.5 M€  
2008 2.5 M€ pledged 
2009 2.5 M€ pledged 
9.3. Regional activities 
In addition to the above development 
cooperation support, Finland has a 
longstanding tradition of various forms of 
neighboring area co-operation. Work is 
especially done in collaboration with 
Nordic countries and the Russian 
Federation in the field of HIV and AIDS 
prevention, control and treatment.  In 
addition, regional co-operation extends to 
the Baltic States of the European Union 
and to larger networks international 
regional networks with a Northern 
Dimension.  
This work cannot be categorized as 
bilateral financial flow from a DAC 
member country (Finland) to a low- and 
middle income country. It however 
contributes to the improvement of the 
HIV and AIDS situation in the co-
operating countries and their regions. 
Highlights of the regional co-operations 
can be found in projects in the Murmansk 
and Leningrad regions, the Republic of 
Karelia and the city of St. Petersburg. 
Regional collaboration work is especially 
done in the format of two larger co-
operation frameworks. 
9.3.1. Northern Dimension 
Partnership in Public 
Health and Social Well-
being (NDPHS) 
Web address: http://www.ndphs.org/
Finland in 2002 took 
the initiative to 
establish a regional 
partnership pro-
gramme. The 
Northern Dimension 
Partnership in 
Public Health and Social Well-being 
(NDPHS) is a cooperative effort of 
thirteen governments, the European 
Commission and eight intergovernmental 
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organisations. The NDPHS provides a 
forum for concerted action to tackle 
challenges to health and social well-being 
in the Northern Dimension area and 
foremost in north-west Russia. 
Founded on 27 October 2003 at a 
Ministerial-level meeting in Oslo, 
Norway, the Partnership works according 
to the provisions spelled out in the 
Declaration concerning the establishment 
of a NDPHS (the Oslo Declaration). This 
Declaration lays the foundation for the 
Partnership’s objectives, structure, role 
and practical functions, main priorities, 
financing methods and guidelines for 
future development. Being multinational 
and multi-stakeholder in its composition, 
the membership of the NDPHS is 
comprised of numerous Partner Countries 
and Partner Organizations (the Oslo 
Declaration also includes a definition of a 
Special Participant).  
The NDPHS is one of two existing 
Partnerships within the Northern 
Dimension (ND) policy that began in 
2000 with the European Council’s 
adoption of the 1st Northern Dimension 
Action Plan. From its beginning, when 
the ND policy was the main external, 
cross-border framework for the European 
Union’s relations with North-west Russia 
and the Baltic Sea and Artic regions, this 
policy has aimed at addressing the special 
regional development challenges of 
Northern Europe.  
In accordance with the Political 
Declaration on the Northern Dimension 
Policy and the Northern Dimension 
Policy Framework Document– both 
endorsed at the ND Summit in November 
2006 – from the beginning of 2007 the 
Northern Dimension policy changed its 
character to a joint endeavor of four 
partners, namely that of the European 
Union, Iceland, Norway and Russia.  
The mission of the NDPHS is to promote 
the sustainable development of the 
Northern Dimension area by improving 
peoples’ health and social well-being. 
The Partnership aims to contribute to this 
process by intensifying cooperation, 
assisting the Partners and Participants in 
capacity building, and by enhancing the 
extent of coordination between 
international activities within the 
Northern Dimension area. 
In working to achieve these objectives, 
the Partners focus on increasing political 
and administrative coherence between the 
countries in the Northern Dimension area, 
narrowing their social and economic 
disparities, and improving peoples’ 
overall quality of life. 
The Partnership has two main priority 
fields in which it aims to support 
cooperation and coordination.  
The first priority is to reduce the spread 
of major communicable diseases and 
prevent life-style related non-
communicable diseases. These diseases 
include HIV/AIDS, tuberculosis, sexually 
transmitted infections, cardiovascular 
diseases, resistance to antibiotics, as well 
as other major public health problems 
that arise from the use of illicit drugs and 
socially distressing conditions.  
The second priority is to enhance 
peoples’ levels of social well-being and 
to promote socially rewarding lifestyles. 
Here, an emphasis is placed on 
encouraging proper nutrition, physical 
exercise, safe sexual behavior, ensuring 
good social and work environments, as 
well as supporting alcohol, drug and 
smoke-free leisure activities. Within this 
priority field, special attention is placed 
on youth as the primary target group. 
Across both priorities, gender and 
children’s perspectives are taken into 
account. Equity and social inclusion are 
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treated as central elements in achieving 
the Partnership’s objectives, for which 
reason a strong interaction between the 
health and social sectors is promoted. 
People with disabilities and indigenous 
peoples are also recognized as vulnerable 
groups that have particular needs and 
therefore require special attention. 
Among the principal approaches taken, 
the Partnership supports the reorientation 
of and greater efficiency within the health 
and social care systems. Potentials to 
improve community-based social care 
and preventive social services are at the 
forefront of capacity building efforts in 
this respect. 
9.3.2. Health cooperation in the 
Barents Region 
Web address: 
http://www.barentshealth.org/
The Barents Health Co-operation 
Programme 
was laun-
ched in 
March 1999 
and marked 
new em-
phasis on 
health and medical-related issues in the 
Barents Euro-Arctic Region. In 2003, a 
new Barents Health and Social 
Programme was adopted. In 2005, a 
unique Barents HIV Programme was 
adopted.  
The official health cooperation in the 
Barents Region is developed by regional 
and national/federal health authorities in 
four countries, Norway, Sweden, Finland 
and Russia. A Working Group on Health 
and Social-relating Issues (WGHS) meets 
regularly to follow up the programme. 
The WGHS is operating in conjunction 
with the Barents Regional Council and 
the Barents Euro Arctic Council, as well 
as other international structures in the 
region, among them the Northern 
Dimension Partnership in Public Health 
and Social Well-being.  
In October 2003, a new and enhanced 
health and social programme for the years 
2004-2007 was adopted by the Barents 
Euro Arctic Council (BEAC). The 
Cooperation Programme on Health and 
Related Social Issues in the Barents Euro-
Arctic Region 2004-2007 has a stronger 
emphasis on social aspects, multilateral 
action and coordination than the first 
programme. Special attention will be paid 
to gender mainstreaming, children and 
young people, and to vulnerable groups in 
the population.  
Priority areas in the programme are 
defined as:  
1. Prevention and combat of 
communicable diseases  
2. Prevention of lifestyle related health 
and social problems and promotion 
of healthy lifestyles  
3. Development and integration of 
primary health care and social 
services  
The Cooperation Programme on Health 
and Related Social Issues in the Barents 
Euro-Arctic Region 2004-2007 has been 
developed with the Second Northern 
Dimension Action Plan and the Northern 
Dimension Partnership in Health and 
Social Wellbeing in mind, and is intended 
to constitute a key component of the 
Partnership.  
In February 2005, the Barents Working 
Group on Health and Social-related 
Issues (WGHS) adopted the Barents 
HIV/AIDS Programme. The new 
programme will help coordinate and 
strengthen international efforts in the 
fight against HIV and AIDS in the region. 
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9.3.3. Neighboring area 
cooperation funding 
mechanism
Finland provides funding for regional 
bilateral HIV/AIDS prevention through 
its Neighboring area cooperation funding 
mechanism (grants provided though the 
MFA). 
Web address: 
http://www.formin.fi/public/default.aspx?
nodeid=34823&contentlan=2&culture=en
-US
As examples of the activities of 
governmental (MFA, MoSAH, STAKES, 
KTL, regional governments), NGO: s and 
regional collaborators (financed by the 
MFA) the following could be highlighted: 
• Coordination of the HIV/AIDS in 
the Barents and EU Northern 
Dimension programme, 2005-
2007 
• Pilot project of the Barents 
HIV/AIDS programme in 
Murmansk to establish a Low 
Threshold Health Service Centre, 
2005-2007 
• Technical assistance to the 
HIV/AIDS Expert Group of the 
EU Northern Dimension 
partnership, 2005-2007 
• Prevention of HIV infection in the 
Republic of Karelia, 2007-2009 
• Psychological and social support 
to HIV infected women in 
Leningrad Oblast, 2007-2009. 
• Technical assistance to health 
professionals in the Baltic States 
based on the WHO/ILO 
guidelines on health services and 
HIV/Aids (ILO Geneva 2005) 
provided by Tehy ry, the Union of 
Health and Social Care 
Professionals and PSI. 
9.4. Support for HIV vaccine 
development and 
microbicide 
development 
Finland has supported HIV vaccine 
development nationally, providing both 
long-term investment support and 
specific project support for an SME 
drug/vaccine biotech startup company 
(FIT-Biotech LTD, Tampere). FIT-
Biotech develops DNA-vector vaccines, 
including candidate HIV-vaccines. 
Finland does not financially support IAVI 
or the International Microbicide 
Initiative. 
Long term investment support has been 
given by SITRA46 (the Finnish 
Innovation Fund) and short-term project 
support by TEKES47 (Finnish Funding 
Agency for Technology Innovation). 
Both are national government supported 
independent funding agencies. The 
annual and long term contributions for 
FIT-Biotech for vaccine development are 
as follows: 
Table 14: Vaccine and Microbicide 
Support
Agency/year Amount Comment 
SITRA 6.58 M€ Long-term 
investment 
TEKES
Year   
2006 1.26 M€ General 
vaccine 
development 
2005 2.58 M€ General 
vaccine 
development 
2003 2.89 M€ HIV-vaccine 
2002 2.16 M€ HIV-vaccine 
2001 0.19 M€ HIV-vaccine 
46 http://www.sitra.fi
47 http://www.tekes.fi
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10. Monitoring and 
evaluation environment
10.1. Overview of the current 
monitoring and 
evaluation (M&E) 
system
Monitoring and evaluation is performed 
in a multi sectorial fashion, where each 
responsible authority performs M&E 
activities as part of their annual business 
cycle. In addition, there are National level 
M&E activities for HIV/AIDS within the 
MoSAH, the National Public Health 
Institute and STAKES. 
The main monitoring instrument is 
outcome monitoring, i.e. surveillance of 
new HIV-infections, AIDS and AIDS 
deaths (see chapter 2, especially points 
2.1-2.3). In addition, STI and blood-borne 
infection surveillance data is used as 
surrogate markers. The numbers of 
performed HIV tests are surveyed 
annually. 
For IDU prevention, a separate action and 
service provision monitoring system is in 
place, collecting annual indicator data in 
low threshold service centers, such as 
visits, client numbers, equipment 
exchange numbers, vaccinations, test 
numbers, regional coverage etc. The 
above functions are mainly the 
responsibility of the National Public 
Health Institute – KTL and its sister 
institute, STAKES, together with a 
network of LTHSC sites. 
Some monitoring of behavioral aspects of 
prevention is in place. These are targeted 
mainly towards youth, where STAKES 
performs an annual school health survey 
in age groups 13-18 year olds. In this 
survey, standard questions on HIV-
associated issues are used, and are 
employed for monitoring issues such as 
age of sexual debut and condom use, as 
well as partner numbers. 
HIV/AIDS health care service provision 
monitoring is mainly performed 
regionally or locally and few HIV-
specific data are available nationally. 
10.2. Challenges faced in the 
implementation of a 
comprehensive M&E 
system  
The main challenge of the current 
monitoring and evaluation system is that 
while there are relatively comprehensive 
local and regional systems in place, they 
are general in nature. Another challenge 
is the highly autonomous organization of 
health care, which makes it difficult to 
impose national reporting and monitoring 
responsibilities for regional actors. 
An important challenge for compliance 
with UNGASS reporting is the poor 
suitability of certain indicators for 
countries with a well developed and 
established comprehensive public health 
system. This means that certain currently 
collected indicator data are less relevant 
for national actors and this provides a 
challenge for their accurate estimation.  
It is especially difficult is to estimate the 
proportion and actual figures of funds 
spent on HIV/AIDS prevention and 
treatment, since many of the activities are 
part of established functions which are 
not HIV-specific. 
A clear missing part of a comprehensive 
monitoring and evaluation system in 
Finland is the lack surveillance and direct 
studies of sexual behavior, risk 
perception and risk taking among general 
adult populations. The only data available 
in any more or less consistent fashion is 
Finland 2008 UNGASS HIV/Aids country report – KTL B4 / 2008 
Report collation, drafting and coordination 
National Public Health Institute – KTL, HIV unit 
www.ktl.fi80
that of certain vulnerable groups and 
sentinel data from STI clinics. 
A similar missing feature is that studies 
or surveys monitoring the societal 
attitudes towards HIV, AIDS and 
PLWHA are not regularly performed. The 
few available data are spotty and 
inconsistently gathered.  
Monitoring of behavioral and attitude 
indicators needs to be strengthened in the 
future to be able to respond and target 
misconceptions and risk taking. 
10.3. Remedial actions 
planned to overcome 
the challenges  
At the moment there is no national 
remedial funding or direct programmatic 
actions planned on a national level. 
However, there are plans to enhance 
existing structures towards more 
systematic behavioral and attitude data 
gathering and analysis.  
In the new HIV strategy under 
development, a clearer coordination and 
monitoring and evaluation role is 
proposed to be given to the MoSAH 
appointed NAC, i.e. the HIV expert 
group. 
However, this is subject to political 
decision and has not been decided on yet. 
10.4. The need for M&E 
technical assistance 
and capacity building  
There is a clear need for additional 
indicator development for applicability in 
European settings. The leading role for 
this should perhaps be given to the 
European Center for Diseace Control and 
Prevention (ECDC) in cooperation with 
WHO-Euro and possibly UNAIDS. 
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11. Contributors to the 
report
11.1. Main Government 
Contributors 
The contributors listed in this section are 
nationally responsible for data collection, 
analysis, co-ordination and reporting to 
UNAIDS. 
11.1.1. Ministry of Social Affairs 
and Health 
Web address: www.stm.fi
The Ministry of Social Affairs and Health 
aims to provide the population with a 
healthy environment, good health and 
functional capacity, and adequate income 
and social protection in different life 
situations. 
The Ministry directs and guides the 
development and policies of social 
protection, social welfare and health care. 
It defines the main course of social and 
health policy, prepares legislation and key 
reforms and steers their implementation, 
and handles the necessary links with the 
political decision-making process.  
The general aims of social welfare and 
health care and the measures that will be 
taken in order to fulfil these aims are 
adopted in a Target and Action Plan for 
Social Welfare and Health Care that is 
drawn up for the whole period of office of 
each government. Thus the development 
of social welfare and health services is a 
part of the political decision-making. The 
Plan is a kind of co-operation contract 
between the local authorities 
(municipalities) and the state. The 
preparation, execution and follow-up of 
the Plan are the responsibility of a 
steering group composed of the 
representatives of, among others, the 
Association of Finnish Local and 
Regional Authorities, the Ministry of 
Social Affairs and Health and related 
authorities, and non-governmental 
organizations in its sector.  
There are five provinces in continental 
Finland plus the autonomous Province of 
Åland Islands. The State Provincial 
Offices are regional government 
authorities of the state. They guide and 
supervise social welfare and health care 
in the provinces, while the country's 431 
municipalities are responsible for the 
actual provision of services. At the end of 
2005 the Finnish population was about 
5.2 million. 
11.1.2. Ministry for Foreign 
Affairs
Web address: www.formin.fi
The Ministry 
for Foreign 
Affairs pro-
motes the se-
curity and 
welfare of 
Finland and 
the Finns, and works for a secure and fair 
world. 
The Ministry for Foreign Affairs 
concentrates on foreign and security 
policy, trade policy and development 
policy as well as on significant foreign 
policy issues and international relations in 
general. The Ministry also assists other 
branches of government in the 
coordination of international affairs. 
The Finnish Foreign Service – the 
Ministry and approximately one hundred 
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diplomatic and consular missions – 
focuses on serving Finns, the Finnish 
economy and society at large, the 
country’s political leadership and 
Parliament. 
Finland’s welfare is increasingly based on 
knowledge, creativity and innovation. 
The relatively small domestic market 
offers limited possibilities for success. It 
is therefore of the utmost importance to 
work more effectively at an international 
level. 
Finns also travel more than ever, for both 
business and pleasure. This creates 
growing challenges for Finnish 
diplomatic and consular missions abroad. 
11.1.3. National Public Health 
Institute - KTL 
Web address: www.ktl.fi
KTL protects and promotes the health of 
Finnish people 
The National Public 
Health Institute – 
KTL is a research 
and expert institute 
under the Ministry of 
Social Affairs and 
Health of Finland. 
KTL provides public decision makers, 
other stakeholders and the general public 
with reliable information on public 
health. 
The institute’s core functions are public 
health research and expert functions. KTL 
also operates functions for health 
monitoring and public health services, 
including the development, assessment 
and performing of laboratory research. 
The Institute participates in the 
dissemination of health information and 
health education through education and 
training activities. 
The eleven departments at the institute 
cover all aspects of public health from 
safe drinking water and vaccinations to 
genetics and mental health. KTL is 
responsible for the control of infectious 
diseases and for the prevention of chronic 
diseases in collaboration with the health 
care system. It has an important role in 
shaping Finnish public health work and 
health policies. KTL is very actively 
involved in numerous international 
collaborations. 
KTL is the only governmental institution 
with a unit within its organisation 
dedicated to HIV/Aids affairs. The HIV 
unit at the Department of Infectious 
Disease Epidemiology and Control is in 
responsible for national surveillance, 
expert advice, research and co-ordination 
under the guidance of the MoSAH. The 
unit has collated the UNGASS report and 
will publish it within the publication 
series of the institute. 
11.1.4. National Research and 
Development Centre for 
Welfare and Health – 
STAKES 
Web address: www.stakes.fi
STAKES is a sector research institute 
under the Ministry of Social Affairs and 
Health of Finland. Its core functions are 
research, development and information 
production. STAKES assesses changes 
affecting welfare and health, evaluates the 
outcomes of welfare policy and brings 
forth new alternatives. 
STAKES monitors and evaluates the 
functions and development in health care 
and social welfare, carries out health care 
and social welfare research, produces, 
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acquires and distributes information and 
know-how from national and 
international sources. It produces 
information and expertise for 
policymakers and other stakeholders and 
acts also as a statistical authority in the 
field of social welfare and health care. 
Statistics are compiled concerning 
various topics, e.g. social and health 
services (including reproductive health), 
alcohol and drugs, and social and health 
expenditure. 
The different divisions in STAKES work 
with issues such as evaluation of 
outcomes and equity of the service 
system, advanced client-centered 
services, facilitation of decision-making 
in the social services and health care, 
support to the preventive work, health 
care statistics and registers, information 
technology development and 
harmonisation. STAKES also includes 
the Finnish Office for Health Technology 
Assessment (Finohta) that promotes the 
use of good, evidence-based technologies 
in health care and develops the efficiency 
and effectiveness of health care. 
STAKES has a unit of International 
Development Co-operation (IDC) which 
has a strong role in especially 
neighboring area collaboration within the 
HIV/Aids sector. 
11.2. Main NGO/Civil society 
sector contributors 
The Contributors listed in this section 
have involved themselves actively in the 
data collection, evaluation and drafting 
during all steps of the reporting process. 
They are important players within the 
Finnish HIV/Aids field. 
11.2.1. The Finnish AIDS Council 
Web address: www.aidstukikeskus.fi
The services of the Finnish AIDS Council 
have been available since 1986. The 
organization is ideologically and 
religiously independent. The Finnish 
AIDS Council is run by the HIV 
Foundation. It aims to:  
• Prevent HIV infections.  
• Enhance the competence of social 
and health care professionals in 
handling HIV questions.  
• Support people with HIV 
infection, their families and 
friends, and those concerned 
about HIV.  
The Finnish AIDS Council is a national 
expert and service organization run by the 
HIV Foundation. Its work is in line with 
the Government Resolution on the Health 
2015 Public Health Program, according 
to which public health organizations are 
opinion leaders in health promotion, 
distributors of information, and providers 
and developers of services. The Finnish 
AIDS Council's guidelines comply with 
the guidelines of the Finnish national 
HIV/AIDS strategy.  
The Finnish AIDS Council's work is 
divided into two sectors: Services, and 
Prevention and Training. 
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11.2.2. The Finnish Body Positive 
Association (FBPA) 
Web address: www.positiiviset.fi
The Finnish Body 
Positive Association 
(FBPA) was founded in 
1989. FBPA is a peer 
organisation and the 
only association for 
people with HIV in 
Finland. The fundamental idea is by 
people with HIV for people with HIV.  
The main purposes of Finnish Body 
Positive Association are:   
• to promote the well being of its 
members and their families  
• to increase the self esteem of its 
members  
• to fight against discrimination of 
people with HIV and AIDS  
• to participate in the forming of 
AIDS policies in Finland  
• to offer correct and unprejudiced 
information about HIV and AIDS.  
FBPA has its office and drop-in centre in 
downtown Helsinki open six days a week. 
Its Treatment Action Group informs 
about the development and availability of 
new treatments. The International Group 
is in charge of international connections 
and relationships.  
The Women's Group has regular meetings 
centered on women's issues. Some 
members of FBPA give talks in schools, 
colleges and universities. FBPA is 
actively involved in community 
symposiums and seminars where HIV 
and AIDS are discussed.  
FBPA works in companionship with 
other communities and authorities active 
in the field of HIV. The most important 
Finnish companions are Finnish Aids 
Councils, Finnish AIDS Foundation, 
Finnish Red Cross, Diaconal Projects of 
Helsinki Deaconesses' Institution and 
Finnish HIV/AIDS Nurses' Association.   
Internationally FBPA is a member of 
NordPol, a coalition of Nordic 
organisations for people with HIV/AIDS. 
Some members of FBPA have been 
active in European Aids Treatment Group 
(EATG) and European Community 
Advisory Board (ECAB).  
FBPA is funded mainly by Raha-
automaattiyhdistys ry (Finnish Slot 
Machine Association) and the Ministry of 
Social Affairs and Health. FBPA also has 
its own fund raising activity. 
11.2.3. Pro-Tukipiste 
Web address: www.pro-tukipiste.fi
The main NGO providing services for sex 
workers in Finland is the Pro-Tukipiste, 
which has outlets in the cities of Helsinki 
(capital) and Tampere. Pro-Tukipiste is a 
registered non-profit organization which 
supports and promotes the civil and 
human rights of individuals involved in 
sex work. Pro-Tukipiste follows and 
takes part in national and international 
discussions concerning prostitution and 
sex work, and also makes statements 
concerning issues related to prostitution 
policies. The association follows and 
makes statements on the treatment and 
the legal status of sex workers in Finland. 
Pro-Tukipiste also maintains and runs 
professional social and health care service 
units and outreach units in Helsinki and 
Tampere.  
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11.2.4. The A-Clinic Foundation 
Web address: www.a-klinikka.fi
The A-Clinic Foundation is a non-profit, 
non-governmental organisation providing 
treatment services mainly through 
municipal public-private partnership. It is 
the leading substance abuse service 
provider in Finland with 
• 19 outpatient and inpatient service 
units: youth clinics, 
• Therapeutic communities 
• Low Threshold Health Promotion 
Service Centres for injecting drug 
users 
• Järvenpää Addiction Hospital 
• Activities in the areas of 
prevention, training, research and 
information provision. 
• Staff of 700 
For the last ten years the A-Clinic 
Foundation has been an active developer 
of low threshold services. Health and 
social advice centers provide needle 
exchange, medical services, condoms, 
Hepatitis vaccinations, HIV and Hepatitis 
testing and counselling. 
Working methods also include outreach 
and different peer work models. 
A-Clinic Foundation actively engages in 
societal dialogue with the specific aim of 
improving the conditions for 
underprivileged groups, including 
11.2.5. The Helsinki Deaconess 
Institute 
Web address: www.hdl.fi
The Helsinki Deaconess Institute is the 
biggest private sector provider of social 
services in the capital area of Finland. It, 
for instance, provides special services for 
HIV-positive intravenous drug users. 
The goal of the special services is to 
enhance the social wellbeing of the target 
group, increase their expected lifespan, 
make medical treatment available to 
everyone and hinder the spread of the 
HIV-epidemic in cooperation with other 
actors. The services consist of a Low 
Threshold Health Service Centre, Mobile 
Health Counselling Unit, short- and long-
term accommodation services and 
homecare.  
The creation and maintenance of a 
confidential relationship with the clientele 
is a precondition for the success of the 
special services. The essential operational 
principles are: keeping the threshold for 
entrance as low as possible, providing 
anonymous and comprehensive services. 
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11.2.6. The Finnish HIV-network 
The Finnish HIV-network is an informal 
forum of NGOs and municipal actors for 
sharing information and promoting 
awareness on HIV and AIDS in Finland. 
The network is also actively participating 
in the current political discussion related 
to HIV and AIDS issues. The network 
was established in 2000. The following 
organizations are members of the 
network:  
A-Clinic Foundation 
Caritas 
Church Council of the Evangelical 
Lutheran Church of Finland 
Family Federation of Finland 
FIDA International 
FILHA 
Finn Church Aid 
Finnish AIDS-Council 
Finnish Body Positive Association 
Finnish Christian Medical Society  
Finnish Evangelical Lutheran Mission 
Finnish Medical Association 
Finnish Red Cross 
Finnish UN Association 
Helsinki Deaconess Institute 
Hospital District of Helsinki and Uusimaa 
International Solidarity Foundation 
Kehys ry. 
Kepa, Service Centre for Development 
Cooperation 
Kotimaa 
National Public Health Institute 
National Research and Development 
Centre for Welfare and Health  
Plan Suomi ry. 
Pro-tukikeskus 
Save the Children 
Social Services Department of the City of 
Helsinki 
Stadia 
Student Union of the University of 
Helsinki 
Superliitto, Finnish Union of Practical 
Nurses 
Suomen hiv- ja aids-hoitajien yhdistys 
Taksvärkki 
Tehy, Union of Health and Social Care 
Professionals 
Trade Union Solidarity Centre of Finland 
UFF 
Unicef
Unifem 
Union of Multicultural Families ry. 
Vaasan kehitysmaaseura 
World Vision 
YouAct
YMCA Finland 
11.3. Other contributors 
These actors have given their separate 
direct individual feedback to the draft 
document. Most comments to substance 
have been incorporated, but with some 
necessary editing. Some comments were 
too broad or too specific to incorporate, 
or were discarded due to being outside 
the scope of the report. 
The Ministry of Justice 
World Vision 
Tehy, Union of Health and Social Care 
Professionals 
Helsinki City Health Center 
HUS Aurora Infection Clinic 
SETA 
Church Council of the Evangelical 
Lutheran Church of Finland48
In addition, the following actors were 
given the opportunity to comment on the 
report, but either had no comments or did 
not give a response to the request. 
The Ministry of Education 
The Ministry of the Interior 
The Ministry of Labour 
The Association of Finnish Local and 
Regional Authorities 
48 the Church Council provided as their input a 
Declaration outlining their view, role and effort in 
Global HIV/Aids work. The strong input and 
effort by the Lutheran Church is acknowledged, 
but publishing of the declaration is outside the 
scope of the report. The declaration is available 
upon request. 
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12. Annexes  
12.1. ANNEX 1: Consultation/preparation process for the country 
report on monitoring the progress towards the implementation 
of the Declaration of Commitment on HIV/AIDS  
The report writing process was initiated in the spring of 2007, by a letter of consultation 
sent by the Ministry for Foreign Affairs (MFA) to the National Public Health Institute – 
(KTL) through the Ministry of Social Affairs and Health. This letter was prompted by the 
request of the Director of UNAIDS, Dr. Peter Piot for UNGASS reporting 2008. Following 
this, a coordination meeting of the abovementioned main Governmental actors was 
commenced at the MFA on June 8, 2007. At this meeting, the main responsibilities of the 
actors were discussed and divided.  
As vice-chair (KTL) and chair (MoSAH) of the NAC, KTL and the MoSAH were assigned 
the main work of collection and analysis of indicator data. In the process, they would 
consult all significant stakeholders both at the data collection, report drafting and prior to 
final submission stages. It was decided, that the HIV-unit of KTL will assume the main 
coordinating and drafting responsibility in the report writing process, supported as needed 
by the MoSAH. 
In addition, KTL assumed responsibility for collation of the of the National Composite 
Policy Index (NCPI) questionnaires part A: 
V. Strategic Plan  
VI. Political Support,  
VII. Prevention,  
VIII. Treatment, care and support and V. Monitoring and evaluation). 
The MFA assumed responsibility for delivery of the final report and collection and 
collation of Global Commitment and Action indicators. 
An important role of Civil Society NGO actors in the reporting process was recognized at 
the June 8 coordination meeting. It was decided to involve civil society not only as 
respondents at the report data collection stage, but also through two specific consultation 
and coordination activities. 
For the collation of the National Composite Policy Index (NCPI) questionnaires part B  
V. Human rights,  
VI. II. Civil society participation,  
VII. III. Prevention,  
VIII. IV and Treatment, care and support),  
The Finnish HIV-network (a network of Finnish national and multilateral NGO-actors; see 
attached list in chapter 11.2.6 The Finnish HIV-network) was asked to act as the 
coordinator for responding to this part.  
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After completion of a first draft of the report, it was submitted to the NGO-actors and a 
hearing session of one half day was organized on November 19th. Feedback from the 
NGO/Civil society actors was incorporated into a new draft, which was sent for final 
review on December 5, 2007 to additional relevant NGO, civil society and governmental 
stakeholders. 
Finally, the feedback of the review was incorporated into the report after which it was 
submitted to UNAIDS in January 2008. 
Finland 2008 UNGASS HIV/Aids country report– KTL B4 / 2008 
Report collation, drafting and coordination 
National Public Health Institute – KTL, HIV unit 
www.ktl.fi 89
12.2. ANNEX 2: National Composite Policy Index questionnaire  
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Background
The following instrument measures one of the National Commitment and Action indicators,  the National 
Composite Policy Index (NCPI), designed to assess progress in the development and implementation of 
national AIDS policies and strategies. It is an integral part of the list of core UNGASS indicators and 
is to be completed and submitted as part of the 2007 UNGASS Country Progress Report.
This third version of the NCPI has been updated to reﬂ ect new AIDS programmatic guidance and to be 
consistent with new and agreed to policy and implementation measurement tools.13
NCPI data were also submitted in previous UNGASS reporting rounds in 2003 and 2005. Countries are 
strongly advised to conduct a trend analysis on the key questions and include a description of the ﬁ ndings 
in the 2007 Country Progress Report.14
STRUCTURE OF THE QUESTIONNAIRE
The NCPI is divided into two parts:
Part A to be administered to government ofﬁ cials.
Part A covers ﬁ ve areas: 
1. Strategic plan 
2. Political support
3. Prevention 
4. Treatment, care and support 
5. Monitoring and evaluation
Part B to be administered to representatives from nongovernmental organizations, bilateral 
agencies, and UN organizations.
Part B covers four areas: 
1. Human rights 
2. Civil society involvement
3. Prevention
4. Treatment, care and support
The overall responsibility for collating and submitting the information requested in the NCPI 
lies with the National Governments, through ofﬁ cials from the National AIDS Committee (NAC) (or 
equivalent) with support from UNAIDS and other partners.
PROPOSED STEPS FOR DATA GATHERING
1. Designation of two technical coordinators for the study (one for part A; one for part B)
 Technical coordinators should be given responsibility to undertake the desk review and carry out 
interviews to answer speciﬁ c questions. Preferably, the technical coordinator for Part A should be 
from the NAC (or equivalent) and for Part B should be a person outside the government. These 
persons should ideally be familiar with the issues and have a monitoring and evaluation background, 
and may request the assistance of consultants with a similar background.
Instructions
13 Policy and Planning Effort Index or children orphaned and made vulnerable by HIV/AIDS, UNICEF 2005; Scaling up Towards Universal Access, 
UNAIDS 2006; Setting National Targets for Moving Towards Universal Access, UNAIDS 2006; Practical Guidelines for Intensifying HIV Prevention; 
UNAIDS 2007
14 see Guidelines on construction of core indicators, UNAIDS 2002 and UNAIDS 2005, respectively, for the key questions in previous NCPI question-
naires
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2. Data gathering 
 Each section should be completed by (a) desk review and (b) interviewing key people most knowl-
edgeable about that topic:
• Strategic Plan and Political Support: the Director or Deputy Director of the National AIDS 
Programme or National AIDS Council, the Heads of the AIDS Programme at provincial and at 
district levels and UNAIDS
• Monitoring and Evaluation: Ofﬁ cers of the National AIDS Committee or equivalent, Ministry of 
Health, HIV focal points of other ministries.
• Human rights: Ministry of Justice ofﬁ cials, human rights commissioners, and representatives of 
human rights and other relevant nongovernmental organizations and legal aid centres/institutions, 
persons living with HIV. 
• Civil society participation: key representatives of major civil society organizations working in the 
area of HIV, persons living with HIV.
• Prevention and Treatment, care and support: Ministries and major implementing agencies/organiza-
tions in those areas, including nongovernmental organizations and persons living with HIV.
3. Data entry, analysis and interpretation 
 Once the NCPI is fully completed, the technical coordinators need to carefully review all responses 
to determine if additional consultations or review of more documents are needed. It is important to 
analyze the data for each of the NCPI sections and include a write-up in the Country Progress Report 
in terms of progress made in policy/strategy development and implementation of programmes to 
tackle the country’s AIDS epidemic. Comments on the agreements/discrepancies between overlap-
ping questions in Part A and Part B should also be included, as well as a trend analysis on the key 
NCPI data since 2003, where available. The NCPI ﬁ ndings need to be presented, discussed and 
agreed during the national UNGASS consultation workshop (see 4 below). It is strongly encouraged 
to enter the ﬁ nal agreed data in the Country Response Information System (CRIS). If this is not 
possible, an electronic version of the completed questionnaire should be submitted as an annex to 
the Country Progress Report.
4. Consultation workshop organized by the NAC (or equivalent)
 It is strongly recommended that the NAC (or equivalent) organizes a one-day broad consulta-
tion forum to discuss and endorse the major ﬁ ndings of the UNGASS Country Progress Report, 
including the results from the NCPI. It is expected that civil society organizations, including faith-
based organizations, people living with HIV, gender equality groups, women’s rights groups, human 
rights/legal advocacy organizations, and other major nongovernmental organizations are invited to 
participate.
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NCPI Respondents
[Indicate all respondents whose responses were compiled to ﬁ ll out (parts of) the NCPI in the below table; 
add as many rows as needed]
NCPI - PART A [to be administered to government ofﬁ cials]
Organisation Name/Position
Respondents to Part A
[indicate which parts each respondent was queried on]
A.I A.II A.III A.IV A.V
NCPI - PART B [to be administered to nongovernmental organizations, bilateral agencies, 
and UN organizations]
Organisation Name/Position
Respondents to Part B
[indicate which parts each respondent was queried on]
B.I B.II B.III B.IV
Note: In the NCPI answers, N/A stands for “Not Applicable”
Appendix 7
KTL - HIV unit
MoSAH
MoFA
M. Salminen, Head
M. Saarinen, Dir.
H. Mikkola, Advisor
NGO/CS HIV-network B. Rantakari, Chair
Finnish AIDS Council C. Björkenheim, Dir.
STAKES M. Anttila, S. Specialist
✔ ✔ ✔ ✔ ✔
✔ ✔ ✔ ✔ ✔
✔ ✔
✔ ✔ ✔ ✔
✔ ✔ ✔ ✔
✔ ✔ ✔ ✔
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National Composite Policy Index questionnaire 
Part A
[to be administered to government ofﬁ cials]
I. Strategic plan
1. Has the country developed a national multisectoral strategy/action 
framework to combat AIDS? 
(Multisectoral strategies should include, but are not limited to, those developed by Ministries such as 
the ones listed under 1.2)
Yes Period covered: [write in] Not Applicable (N/A) No
IF NO or N/A, brieﬂ y explain
IF YES, complete questions 1.1 through 1.10; otherwise, go to question 2.
1.1 How long has the country had a multisectoral strategy/action framework?
Number of Years: 
1.2 Which sectors are included in the multisectoral strategy/action framework with a speciﬁ c HIV 
budget for their activities?
Sectors included Strategy/Action framework Earmarked budget
Health Yes No Yes No
Education Yes No Yes No
Labour Yes No Yes No
Transportation Yes No Yes No
Military/Police Yes No Yes No
Women Yes No Yes No
Young people Yes No Yes No
Other*: [write in] Yes No Yes No
* Any of the following: Agriculture, Finance, Human Resources, Justice, Minerals and Energy, Planning, Public Works, Tourism, Trade and Industry.
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✔ 2002-2006
✔ ✔
✔ ✔
✔ ✔
✔
✔ ✔
✔ ✔
✔ ✔
✔ ✔
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IF NO earmarked budget, how is the money allocated?
1.3 Does the multisectoral strategy/action framework address the following target populations, 
settings and cross-cutting issues?
Target populations
a. Women and girls
b. Young women/young men
c. Speciﬁ c vulnerable sub- populations15
d. Orphans and other vulnerable children
Settings
e. Workplace
f. Schools
g. Prisons
Cross-cutting issues
h. HIV, AIDS and poverty
i. Human rights protection
j. PLHIV involvement
k. Addressing stigma and discrimination
l.  Gender empowerment and/or gender equality
a. Yes No
b. Yes No
c. Yes No
d. Yes No
e. Yes No
f. Yes No
g. Yes No
h. Yes No
i. Yes No
j. Yes No
k. Yes No
l. Yes No
1.4 Were target populations identiﬁ ed through a process of a needs assessment or needs analysis? 
Yes No
IF YES, when was this needs assessment /analysis conducted? Year: 
IF NO, how were target populations identiﬁ ed?
15 Sub-populations that have been locally identiﬁ ed as being at higher risk of HIV transmission (injecting drug users, men having sex with men, sex 
workers and their clients, cross-border migrants, migrant workers, internally displaced people, refugees, prisoners, etc.). 
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HIV/AIDS actions are integrated into the general budgets of all the sectors. For example, for the health and 
social welfare sector, both municipal, different district/regional level and national level funding budgeting guides
activities.
Budgets are fixed through a combination of earmarking and discretionary use at all levels, but most funds are 
allocated using annual and long term planning and monitoring systems.
For example, the National Public Health Institute receives its funding through the govermental annual MoSAH 
sector budget, but has relatively large freedom of internal fund allocation for different public health purposes. 
Plans and budgets are set annually, and yearly objectives and targets are set through an annual plan set up 
with the MoSAH.
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
2001, new assessment in progress
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1.5 What are the target populations in the country? [write in]
1.6 Does the multisectoral strategy/action framework include an operational plan?
Yes No
1.7 Does the multisectoral strategy/action framework or operational plan include:
a. Formal programme goals? Yes No
b. Clear targets and/or milestones? Yes No
c. Detailed budget of costs per programmatic area? Yes No
d. Indications of funding sources? Yes No
e. Monitoring and Evaluation framework? Yes No
1.8 Has the country ensured “full involvement and participation” of civil society16 in the develop-
ment of the multisectoral strategy/action framework?
Active involvement Moderate involvement No involvement
IF active involvement, brieﬂ y explain how this was done:
IF NO or MODERATE involvement, brieﬂ y explain:
1.9 Has the multisectoral strategy/action framework been endorsed by most external Development 
Partners (bi-laterals; multi-laterals)?
Yes No
16 Civil society includes among others: Networks of people living with HIV; women’s organizations; young people’s organizations; faith-based organi-
zations; AIDS service organizations; Community-based organizations; organizations of key affected groups (including MSM, SW, IDU, migrants, 
refugees/displaced populations, prisoners); workers organizations, human rights organizations; etc. For the purpose of the NCPI, the private sector 
is considered separately.
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✔
✔
✔
✔
✔
✔
✔
Civil society/NGO actors were an active part of the MoSAH HIV expert group which acts as the NAC and 
drafted the previous HIV policy. In addition to taking part of the drafting process, the HIV policy document was
sent out for review to various governmental and civil society/NGO actors before launching it in 2002.
A similar but even more involving process is currently in place to draft a new HIV strategy document.
✔NOT APPLICABLE. Finland is a Donor Country
MoFA development co-op strategy is endorsed
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1.10 Have external Development Partners (bi-laterals; multi-laterals) aligned and harmonized their 
HIV and AIDS programmes to the national multisectoral strategy/action framework?
Yes, all partners Yes, some partners No
IF SOME or NO, brieﬂ y explain
2. Has the country integrated HIV and AIDS into its general development plans 
such as: a) National Development Plans, b) Common Country Assessments/ 
United Nations Development Assistance Framework, c) Poverty Reduction 
Strategy Papers, d) Sector Wide Approach?
Yes No N/A
2.1 IF YES, in which development plans is policy support for HIV and AIDS integrated? 
a)____ b)____ c)____ d)____ e) other
2.2 IF YES, which policy areas below are included in these development plans?
 Check for policy/strategy included
Policy Area Development Plans
a) b) c) d) e)
HIV Prevention 
Treatment for opportunistic infections
Antiretroviral therapy
Care and support (including social security or 
other schemes)
AIDS impact alleviation
Reduction of gender inequalities as they relate 
to HIV prevention/treatment, care and/or support
Reduction of income inequalities as they relate 
to HIV prevention/ treatment, care and /or support 
Reduction of stigma and discrimination
Women’s economic empowerment 
(e.g. access to credit, access to land, training)
Other: [write in]
Appendix 7
✔
NOT APPLICABLE, see previous point 1.9
✔
✔ ✔ ✔
✔ ✔
✔ ✔
✔
✔ ✔ ✔
✔ ✔ ✔
✔ ✔ ✔
✔ ✔ ✔
✔ ✔ ✔
AS DONOR
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3. Has the country evaluated the impact of HIV and AIDS on its socio-economic 
development for planning purposes?
Yes No N/A
3.1 IF YES, to what extent has it informed resource allocation decisions?
Low High
0 1 2 3 4 5
4. Does the country have a strategy/action framework for addressing HIV and 
AIDS issues among its national uniformed services such as military, police, 
peacekeepers, prison staff, etc?
Yes No
 4.1 IF YES, which of the following programmes have been implemented beyond the pilot stage to 
reach a signiﬁ cant proportion of one or more uniformed services?
Behavioural change communication Yes No
Condom provision Yes No
HIV testing and counselling* Yes No
STI services Yes No
Treatment Yes No
Care and support Yes No
Others: [write in] Yes No
*What is the approach taken to HIV testing and counselling? Is HIV testing voluntary or 
mandatory (e.g. at enrolment)? Brieﬂ y explain:
5.  Has the country followed up on commitments towards universal access 
made during the High-Level AIDS Review in June 2006?
Yes No
5.1 Has the National Strategic Plan/operational plan and national AIDS budget been revised 
accordingly?
Yes No
Appendix 7
✔
✔
✔
✔ ✔
✔
✔
✔
✔
✔
The functions in point 4.1 are performed as part of regular public- and workers health care, prison social- and 
health care.
HIV testing and counselling guidelines do not differ from the civil sector, and are also based on VCT. There is no
mandatory testing in the military, police, peacekeepers or prison staff. There is an active policy of HIV risk 
communication and behavioural training for peacekeepers and HIV-testing promotion for returning staff. 
✔
NOT APPLICABLE. Access is universal and 
budgeted through the regular social and 
health care budget
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5.2 Have the estimates of the size of the main target population sub-groups been updated? 
Yes No
5.3 Are there reliable estimates and projected future needs of the number of adults and children 
requiring antiretroviral therapy? 
Estimates and projected needs Estimates only No
5.4 Is HIV and AIDS programme coverage being monitored?
Yes No
(a) IF YES, is coverage monitored by sex (male, female)? 
Yes No
(b) IF YES, is coverage monitored by population sub-groups?
Yes No
IF YES, which population sub-groups?
(c) IF YES, is coverage monitored by geographical area?
Yes No
IF YES, at which levels (provincial, district, other)?
Appendix 7
✔
✔
✔
✔
✔
MSM - men having sex with men
IDU - Injecting drug users
Heterosexual
MTCT - mother to child transmission
Immigrants
National, provincial and municipal. All monitoring activities are integrated into regular social- and health care 
monitoring schemes. National monitoring is less detailed than regional.
✔
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5.5 Has the country developed a plan to strengthen health systems, including infrastructure, human 
resources and capacities, and logistical systems to deliver drugs?
Yes No
Overall, how would you rate strategy planning efforts in the HIV and AIDS programmes 
in 2007 and in 2005? 
 2007 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
 2005 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
Comments on progress made since 2005:
Appendix 7
✔
✔
✔
Each of these components exist as part of the public health care system, 
therefore no need for development only due to HIV/AIDS is necessary. 
Development is done through general development of the system
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II. Political support
Strong political support includes government and political leaders who speak out often about 
AIDS and regularly chair important meetings, allocation of national budgets to support the AIDS 
programmes and effective use of government and civil society organizations and processes to support 
effective AIDS programmes.
1. Do high ofﬁ cials speak publicly and favourably about AIDS efforts in major 
domestic fora at least twice a year?
President/Head of government Yes No
Other high ofﬁ cials Yes No
Other ofﬁ cials in regions and/or districts Yes No
2. Does the country have an ofﬁ cially recognized national multisectoral AIDS 
management/coordination body? (National AIDS Council or equivalent)?
Yes No
IF NO, brieﬂ y explain:
2.1 IF YES, when was it created? Year: 
2.2 IF YES, who is the Chair?
[write in name and title/function]
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The Ministry of Social Affairs and Health (MoSAH) has set the HIV expert group which performs these functions.
1989
Chair:            Dr. Merja Saarinen, senior adviser, MoSAH
Vice-Chair:    Dr. Mika Salminen, Head of HIV unit, National Public Health Institute - KTL
✔
✔
✔
✔
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2.3 IF YES, does it:
have terms of reference? Yes No
have active Government leadership and participation? Yes No
have a deﬁ ned membership?
include civil society representatives?
IF YES, what percentage? [write in]
include people living with HIV?
include the private sector?
Yes
Yes
Yes
Yes
No
No
No
No
have an action plan? Yes No
have a functional Secretariat? Yes No
meet at least quarterly?
review actions on policy decisions regularly?
actively promote policy decisions?
provide opportunity for civil society to inﬂ uence decision-making?
strengthen donor coordination to avoid parallel funding and 
duplication of effort in programming and reporting?
Yes
Yes
Yes
Yes
Yes
No
No
No
No
No
3. Does the country have a national AIDS body or other mechanism that 
promotes interaction between government, people living with HIV, civil 
society and the private sector for implementing HIV and AIDS strategies/
programmes? 
Yes No
3.1 IF YES, does it include?
Terms of reference Yes No
Deﬁ ned membership Yes No
Action plan Yes No
Functional Secretariat Yes No
Regular meetings Yes No
Frequency of meetings:
IF YES, What are the main achievements?
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This entire function is integrated into the National Aids Council equaivalent, the MoSAH HIV expert group.
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
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IF YES, What are the main challenges for the work of this body?
4. What percentage of the national HIV and AIDS budget was spent on 
activities implemented by civil society in the past year?
Percentage:
5. What kind of support does the NAC (or equivalent) provide to implementing 
partners of the national programme, particularly to civil society organizations?
Information on priority needs and services Yes No
Technical guidance/materials Yes No
Drugs/supplies procurement and distribution Yes No
Coordination with other implementing partners Yes No
Capacity-building Yes No
Other: [write in]
6.  Has the country reviewed national policies and legislation to determine 
which, if any, are inconsistent with the National AIDS Control policies?
Yes No
6.1 IF YES, were policies and legislation amended to be consistent with the National AIDS Control 
policies?
Yes No
6.2 IF YES, which policies and legislation were amended and when?
Policy/Law: Year:
Appendix 7
The body has no set powers or budget of its own, but can only make recommendations or work out guididance 
documents.
However, the body has substantial indirect power through its members and can (and has done so in the past) 
strongly influence both policy making and even budgetary measures through both governmental and civil society
actors.
 Needle exchange policy, Law on Infectious diseases 2004
NOT KNOWN
✔
✔
✔
✔
✔
✔
✔
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Policy/Law: Year:
[List as many as relevant]
Overall, how would you rate strategy planning efforts in the HIV and AIDS programmes 
in 2007 and in 2005? 
 2007 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
 2005 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
Comments on progress made since 2005:
Appendix 7
✔
✔
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III. Prevention
1. Does the country have a policy or strategy that promotes information, 
education and communication (IEC) on HIV to the general population?
Yes No N/A
1.1 IF YES, what key messages are explicitly promoted?
 Check for key message explicitly promoted
Be sexually abstinent
Delay sexual debut
Be faithful
Reduce the number of sexual partners 
Use condoms consistently
Engage in safe(r) sex
Avoid commercial sex
Abstain from injecting drugs
Use clean needles and syringes
Fight against violence against women
Greater acceptance and involvement of people living with HIV
Greater involvement of men in reproductive health programmes
Other: [write in]
1.2 In the last year, did the country implement an activity or programme to promote accurate 
reporting on HIV by the media?
Yes No
2. Does the country have a policy or strategy promoting HIV-related 
reproductive and sexual health education for young people?
Yes No
2.1 Is HIV education part of the curriculum in 
primary schools? Yes No
secondary schools? Yes No
teacher training? Yes No
2.2 Does the strategy/curriculum provide the same reproductive and sexual health education for 
young men and young women? 
Yes No
Appendix 7
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✔
✔
✔
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2.3 Does the country have an HIV education strategy for out-of-school young people?
Yes No
3. Does the country have a policy or strategy to promote information, 
education and communication and other preventive health interventions for 
vulnerable sub-populations? 
Yes No
IF NO, brieﬂ y explain:
3.1 IF YES, which sub-populations and what elements of HIV prevention do the policy/strategy 
address?
 Check for policy/strategy included
IDU MSM Sex 
workers
Clients
of sex 
workers
Prison
inmates
Other sub-
populations*
[write in]
Targeted information on risk 
reduction and HIV education
Stigma & discrimination reduction
Condom promotion
HIV testing & counselling
Reproductive health, including 
STI prevention & treatment
Vulnerability reduction (e.g. 
income generation)
N/A N/A N/A N/A
Drug substitution therapy N/A N/A N/A N/A
Needle & syringe exchange N/A N/A N/A N/A
Overall, how would you rate policy efforts in support of HIV prevention in 2007 and in 
2005?
 2007 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
 2005 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
Comments on progress made since 2005:
Appendix 7
Included in HIV and STD strategies as well as Drug Policy Action programmes
✔
✔
✔ ✔ ✔ ✔ ✔
✔
✔ ✔ ✔ ✔ ✔
✔ ✔ ✔ ✔ ✔
✔ ✔ ✔ ✔ ✔
✔
✔
✔
✔
✔
YOUTH
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4. Has the country identiﬁ ed the districts (or equivalent geographical/
decentralized level) in need of HIV prevention programmes?
Yes No
IF NO, how are HIV prevention programmes being scaled-up?:
IF YES, to what extent have the following HIV prevention programmes been implemented in 
identiﬁ ed districts* in need?
 Check the relevant implementation level for each activity or indicate N/A if not applicable
HIV prevention programmes
The activity is available in
all
districts* in need
most
districts* in need
some
districts* in need
Blood safety
Universal precautions in health care settings
Prevention of mother-to-child 
transmission of HIV
IEC on risk reduction
IEC on stigma and discrimination 
reduction
Condom promotion
HIV testing & counselling
Harm reduction for injecting drug users
Risk reduction for men who have sex 
with men
Risk reduction for sex workers
Programmes for other vulnerable sub-
populations
Reproductive health services including 
STI prevention & treatment
School-based AIDS education for young 
people
Programmes for out-of-school young 
people
HIV prevention in the workplace
Other [write in]
* Districts or equivalent geographical/de-centralized level in urban and rural areas
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Overall, how would you rate the efforts in the implementation of HIV prevention 
programmes in 2007 and in 2005?
 2007 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
 2005 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
Comments on progress made since 2005:
Appendix 7
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IV. Treatment, care and support
1. Does the country have a policy or strategy to promote comprehensive HIV 
treatment, care and support? (Comprehensive care includes, but is not 
limited to, treatment, HIV testing and counselling, psychosocial care, and 
home and community-based care).
Yes No
1.1 IF YES, does it give sufﬁ cient attention to barriers for women, children and most-at-risk 
populations?
Yes No
2. Has the country identiﬁ ed the districts (or equivalent geographical/
decentralized level) in need of HIV and AIDS treatment, care and support 
services?
Yes No N/A
IF NO, how are HIV and AIDS treatment, care and support services being scaled-up?
Appendix 7
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IF YES, to what extent have the following HIV and AIDS treatment, care and support services been 
implemented in the identiﬁ ed districts* in need?
 Check the relevant implementation level for each activity or indicate N/A if not applicable
HIV treatment, care and support 
services
The service is available in
all
districts* in need
most
districts* in need
some
districts* in need
Antiretroviral therapy
Nutritional care
Paediatric AIDS treatment
Sexually transmitted infection 
management
Psychosocial support for people living 
with HIV and their families
Home-based care
Palliative care and treatment of common 
HIV-related infections
HIV testing and counselling for TB patients
TB screening for HIV-infected people
TB preventive therapy for HIV-infected 
people
TB infection control in HIV treatment 
and care facilities
Cotrimoxazole prophylaxis in HIV-
infected people
Post-exposure prophylaxis 
(e.g. occupational exposures to HIV, rape)
HIV treatment services in the workplace 
or treatment referral systems through the 
workplace
HIV care and support in the workplace 
(including alternative working 
arrangements)
Other programmes: [write in]
*Districts or equivalent de-centralized governmental level in urban and rural areas
3.  Does the country have a policy for developing/using generic drugs or 
parallel importing of drugs for HIV? 
Yes No
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4.  Does the country have access to regional procurement and supply 
management mechanisms for critical commodities, such as antiretroviral 
drugs, condoms, and substitution drugs?
Yes No
4.1 IF YES, for which commodities?: [write in]
5. Does the country have a policy or strategy to address the additional HIV- or 
AIDS-related needs of orphans and other vulnerable children (OVC)?
Yes No N/A
5.1 IF YES, is there an operational deﬁ nition for OVC in the country? 
Yes No
5.2 IF YES, does the country have a national action plan speciﬁ cally for OVC?
Yes No
5.3 IF YES, does the country have an estimate of OVC being reached by existing interventions?
Yes No
IF YES, what percentage of OVC is being reached? % [write in]
Overall, how would you rate the efforts to meet the needs of orphans and other 
vulnerable children?
 2007 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
 2005 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
Comments on progress made since 2005:
All above.
✔
✔
✔
✔
112
Appendix 7
IV. Monitoring and evaluation
1. Does the country have one national Monitoring and Evaluation (M&E) plan?
Yes Years covered: [write in] In progress No
1.1. IF YES, was the M&E plan endorsed by key partners in M&E?
Yes No
1.2. IF YES, was the M&E plan developed in consultation with civil society, including people living 
with HIV?
Yes No
1.3.  IF YES, have key partners aligned and harmonized their M&E requirements (including indica-
tors) with the national M&E plan?
Yes, all partners Yes, most partners Yes, but only some partners No
2. Does the Monitoring and Evaluation plan include?
a data collection and analysis strategy Yes No
behavioural surveillance Yes No
HIV surveillance Yes No
a well-deﬁ ned standardized set of indicators Yes No
guidelines on tools for data collection Yes No
a strategy for assessing quality and accuracy of data Yes No
a data dissemination and use strategy Yes No
3. Is there a budget for the M&E plan?
Yes Years covered: [write in] In progress No
3.1 IF YES, has funding been secured? Yes No
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
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4. Is there a functional M&E Unit or Department?
Yes In progress No
IF NO, what are the main obstacles to establishing a functional M&E Unit/Department? 
4.1 IF YES, is the M&E Unit/Department based
in the NAC (or equivalent)? Yes No
in the Ministry of Health? Yes No
elsewhere? [write in]
4.2 IF YES, how many and what type of permanent and temporary professional staff are working in 
the M&E Unit/Department?
Number of permanent staff:
Position: [write in] Full time / Part time? Since when?:
Position: [write in] Full time / Part time? Since when?:
Position: [write in] Full time / Part time? Since when?:
Position: [write in] Full time / Part time? Since when?:
Etc.
Monitoring and evaluation is performed in a multi sectorial fashion, where each responsible authority performs 
M&E activities as part of their annual business cycle. In addition, there are National level M&E activities for HIV/
AIDS within the MoSAH, the National Public Health Institute and STAKES
Not possible  to separately estimate N/A N/A
✔
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Number of temporary staff: 
4.3 IF YES, are there mechanisms in place to ensure that all major implementing partners submit 
their M&E data/reports to the M&E Unit/Department for review and consideration in the 
country’s national reports?
Yes No
IF YES, does this mechanism work? What are the major challenges?
4.4 IF YES, to what degree do UN, bi-laterals, and other institutions share their M&E results? 
Low High
0 1 2 3 4 5
5. Is there a M&E Committee or Working Group that meets regularly to 
coordinate M&E activities? 
No Yes, but meets irregularly Yes, meets regularly
IF YES, Date last meeting: [write in]
The mechanisms works relatively well. The major challenge is to identify the correct actors within the different 
sectors. This significantly slows down data collection.
✔
✔
✔
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5.1 Does it include representation from civil society, including people living with HIV?
Yes No
IF YES, describe the role of civil society representatives and people living with HIV 
in the working group?
6. Does the M&E Unit/Department manage a central national database?
Yes No N/A
6.1 IF YES, what type is it? [write in]
6.2 IF YES, does it include information about the content, target populations and geographical 
coverage of programmatic activities, as well as their implementing organizations?
Yes No
6.3 Is there a functional* Health Information System?
National level Yes No
Sub-national level
IF YES, at what level(s)? [write in]
Yes No
(*regularly reporting data from health facilities which are aggregated at district level and sent to national level; and 
data are analysed and used at different levels)
6.4 Does the country publish at least once a year an M&E report on HIV, including HIV surveillance 
data?
Yes No
Appendix 7
Provincial and health district, municipal
✔
✔
✔
✔
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7.  To what extent is M&E data used in planning and implementation?
Low High
0 1 2 3 4 5
What are examples of data use?
What are the main challenges to data use?
8.  In the last year, was training in M&E conducted
At national level? Yes No
IF YES, Number of individuals trained: [write in]
At sub-national level? Yes No
IF YES, Number of individuals trained: [write in]
Including civil society? Yes No
IF YES, Number of individuals trained: [write in]
Overall, how would you rate the M&E efforts of the AIDS programme in 2007 and in 
2005?
 2007 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
 2005 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
Comments on progress made since 2005:
One of the main indicators used are outcome indicators, i. e.  incidence and prevalence data on HIV-infection and
AIDS. These are actively followed and analyzed for use in policy guidance.
As an example, when the incidence of HIV among IDU suddenly rose in 1998, a very strong effort for policy 
change was put in place, introducing strong prevention methods including injection equipment exchange and 
eventually leading to radical legislative change.
Another example comes from behavioural surveillance: when school surveys showed very variable access to 
comprehensive sexuality and reproductive health education during a 10-year period (due to a relaxing of 
educational guidelines), curricula standards were changed to ensure similar content and access in all schools.
Data is scattered into many databases
✔
✔
✔
✔
✔
✔
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Part B
 [to be administered to representatives from nongovernmental organizations, 
bilateral agencies, and UN organizations]
I. Human rights
1. Does the country have laws and regulations that protect people living with 
HIV against discrimination? (such as general non-discrimination provisions 
or provisions that speciﬁ cally mention HIV, focus on schooling, housing, 
employment, health care etc.)
Yes No
1.1 IF YES, specify: [write in]
2. Does the country have non-discrimination laws or regulations which specify 
protections for vulnerable sub-populations? 
Yes No
2.1 IF YES, for which sub-populations?
Women Yes No
Young people Yes No
IDU Yes No
MSM Yes No
Sex Workers Yes No
Prison inmates Yes No
Migrants/mobile populations Yes No
Other: [write in]
IF YES, Brieﬂ y explain what mechanisms are in place to ensure these laws are implemented:
Appendix 7
                             Yes. Transsexuals. The laws protect against discrimination on the basis of gender, heatlh sta-
tus, social and economic status, sexual orientation, ethnicity and any other comparable property (Non-discrimina-
tion Act - Yhdenvertaisuuslaki and Constitution, Basic Rights and Liberties, Act on Gender Confirmation of a 
Transsexual). However, while Basic Rights and Liberties in the Constitution define rather comprehensively the 
equality, the separate act, in turn, limits certain rights just to specific subgroups such as ethnic minorities 
excluding e.g. sexual minorities.
Authorities such as Ombudsman, Ombudsman for Minorities and Ombudsman of Gender Equality ensure the 
implementation of laws. The Ombudsman of Gender Equality monitors the implementation of the equality 
between women and men and the Ombudsman of Minorities advances the status and legal protection of ethnic 
minorities and foreigners in Finland. The other vulnerable groups do not have an ombudsman for their cause. 
These authorities amy give recommendations and advice, which are not legally binding.
✔
✔
✔
✔
✔
✔
✔
Finland has general non-discrimination provisions, however, there are no 
provisions specifically mentioning HIV
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IF YES, Describe any systems of redress put in place to ensure the laws are having their 
desired effect:
3. Does the country have laws, regulations or policies that present obstacles to 
effective HIV prevention, treatment, care and support for vulnerable 
sub-populations?
Yes No
3.1 IF YES, for which sub-populations?
Women Yes No
Young people Yes No
IDU Yes No
MSM Yes No
Sex Workers Yes No
Prison inmates Yes No
Migrants/mobile populations Yes No
Other: [write in]
IF YES, brieﬂ y describe the content of these laws, regulations or policies and how they 
pose barriers:
No anwear
Answer given by the MoSAH/KTL: Migrants have in certain situations limited access to treatment. Complete access to the 
public health care system without private insurance coverage is dependent on legal long term residence status or subject to
bilateral and/or multilateral agreements between Finland and the migrants home country. However, emergency medical 
care is available for all, including illegal immigrants.
✔
✔
✔
✔
✔
✔
✔
✔
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4. Is the promotion and protection of human rights explicitly mentioned in any 
HIV policy or strategy?
Yes No
5. Is there a mechanism to record, document and address cases of 
discrimination experienced by people living with HIV and/or most-at-risk 
populations?
Yes No
IF YES, brieﬂ y describe this mechanism
6. Has the Government, through political and ﬁ nancial support, involved most-
at-risk populations in governmental HIV-policy design and programme 
implementation?
Yes No
IF YES, describe some examples
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Point 4. Original answer by the the Civil Society/NGO sector: NO
Point 5. Original answer by the the Civil Society/NGO sector: NO
Cases are being recorded if made officially with an authority (report of an offence), however, unofficial e.g. NGO 
database of cases of criminalization does not exist.
All following groups (independently or through interest groups) were represented in the process: PLWHAs, sex 
workers, women and migrants. In addition, the HIV expert team of the MoSAH includes representatives of civil 
society.
The challenge at the policy level is that the existent HIV-policy is only a proposal, the government has not ratified
it. HIV strategy has not bee turned into a programme (action plan).
State funds projects implemented by NGOs, Finland's slot machine association funds the basic operating 
conditions of NGOs as well as provides project support
✔ ✔
✔ ✔
✔
Point 4. Additional comments by the MoSAH and KTL. Human rights are indeed NOT mentioned specifically in the MoSAH 
2002-2006 HIV policy document. However, key objective 14. of the HIV-policy document states "Legislation will deb 
developed in response to the changing situation to ensure the RIGHTS and access to effective HIV prevention and treatment
PLWHA." (free unofficial translation). 
Human rights ARE explicitly mentioned In the 2004 MoFA international development assistance HIV/AIDS strategy. They 
are mentioned as a separate point of priority area 10. of the strategy.
Point 5. Additional comments by the MoSAH and KTL. Cases alleged discrimination can be addressed in several ways. In the
case of alleged discrimination or misconduct within the health care system, a complaint can be issued with the regional 
(provincial) authorities and will be duly processed. A Patient Ombudsman is available at health care units throughout the 
country for assistance in filing such complaints. If misconduct or discrimination is found to have taken place, punitive 
measures are available. On a national level, complaints can be filed with the Ombudsman for Justice or can also in the case
of the health care misconduct be dealt with by the National Authority for Medicolegal Affairs (Terveydenhuollon oikeus-
turvakeskus). Finally, cases of discrimination or misconduct can be filed and tried in civil courts. Proceedings are generally
public, but can be decided by the court to be non-public. Charges have led to punishments. Each of these mechanisms have 
been used in the past and the outcomes and proceedings are filed within the official government or judicial systems. 
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7. Does the country have a policy of free services for the following: 
HIV prevention services Yes No
Anti-retroviral treatment Yes No
HIV-related care and support interventions Yes No
IF YES, given resource constraints, brieﬂ y describe what steps are in place to implement 
these policies:
8. Does the country have a policy to ensure equal access for women and men, 
to prevention, treatment, care and support? In particular, to ensure access 
for women outside the context of pregnancy and childbirth?
Yes No
9. Does the country have a policy to ensure equal access for most-at-risk 
populations to prevention, treatment, care and support?
Yes No
9.1 Are there differences in approaches for different most-at-risk populations? 
Yes No
IF YES, brieﬂ y explain the differences:
Appendix 7
Law of Public Health (Kansanterveyslaki § 13), Patients' Bill of Rights legislation (Laki potilaan oikeuksista ja 
asemasta) and Communicable Disease Act (Tartuntatautilaki)
Act on Gender Equality (Tasa-arvolaki), Non-Discrimination Act (Yhdenvertaisuuslaki) ensure that all are treated 
equally, however, in practice the approaches vary depending on the special needs of each population.
✔
✔
✔
✔
✔
✔
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10.Does the country have a policy prohibiting HIV screening for general 
employment purposes (recruitment, assignment/relocation, appointment, 
promotion, termination)? 
Yes No
11.Does the country have a policy to ensure that AIDS research protocols 
involving human subjects are reviewed and approved by a national/local 
ethical review committee?
Yes No
11.1 IF YES, does the ethical review committee include representatives of civil society and people 
living with HIV?
Yes No
IF YES, describe the effectiveness of this review committee
12.Does the country have the following human rights monitoring and 
enforcement mechanisms?
– Existence of independent national institutions for the promotion and protection of human rights, 
including human rights commissions, law reform commissions, watchdogs, and ombudspersons 
which consider HIV-related issues within their work 
Yes No
– Focal points within governmental health and other departments to monitor HIV-related human 
rights abuses and HIV-related discrimination in areas such as housing and employment 
Yes No
– Performance indicators or benchmarks for 
a) compliance with human rights standards in the context of HIV efforts
Yes No
b) reduction of HIV-related stigma and discrimination
Yes No
Appendix 7
Point 10. Original answer by Civil society is NO. 
11.Including the medical research. Finland has not run through any other kind of research
NGOs receive research requests for data gathering (statistics and PLWHAs for interviews etc.). NGOs decide 
independently whether they cooperate or provide information.
Point 10. Original answer by Civil society is NO. 
✔ ✔
✔
✔ ✔
✔
✔
✔
✔
Point 10.
Additional comments by MoSAH and KTL: there is no law explicitly forbidding testing of HIV, but general laws of patient 
rights and codes of conduct (including the Helsinki declaration on medical ethics) restrict all medical testing to tests that are
aimed to BENEFIT the individual tested. This is also explicitly stated in the Law on Workers Health. In addition, all clinical 
microbiological tests are only allowed to be performed by licensed actors. These statutes therefore
point 11.1 
Additional comments by MoSAH and KTL: the Law on Medical Research (Laki lääketieteellisestä tutkimuksesta) specifies that 
for all medical research involving human subjects, the protocols must be reviewed and approved by an ethical committee prior 
to implementation. Ethical committees always have layman members, however, there is not a provision for disease specific
participation (such as by PLWHA). 
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IF YES, on any of the above questions, describe some examples:
13.Have members of the judiciary (including labour courts/ employment 
tribunals) been trained/sensitized to HIV and AIDS and human rights issues 
that may come up in the context of their work?
Yes No
14.Are the following legal support services available in the country?
– Legal aid systems for HIV and AIDS casework
Yes No
– Private sector law ﬁ rms or university-based centres to provide free or reduced-cost legal services 
to people living with HIV
Yes No
– Programmes to educate, raise awareness among people living with HIV concerning their rights
Yes No
15.Are there programmes designed to change societal attitudes of 
stigmatization associated with HIV and AIDS to understanding and 
acceptance?
Yes No
IF YES, what types of programmes?
Media Yes No
School education Yes No
Personalities regularly speaking out Yes No
Other: [write in]
Appendix 7
Answer given by the MoSAH and KTL: the Ombudsman of Justice can and has in the past given judgements in 
these issues. 
In practice, just NGOs have such programmes.
✔
✔ ✔
✔
✔ ✔
✔
✔
✔
✔
Pubic defenders office (yleinen oikeusasiatoimisto) provides services for 
people with scarce funds
Comment by MoSAH and KTL. NGOs are largely supported by governmental grants
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Overall, how would you rate the policies, laws and regulations in place to promote and 
protect human rights in relation to HIV and AIDS in 2007 and in 2005?
 2007 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
 2005 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
Comments on progress made since 2005:
Overall, how would you rate the effort to enforce the existing policies, laws and 
regulations in 2007 and in 2005?
 2007 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
 2005 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
Comments on progress made since 2005:
Appendix 7
On the policy level there have not been changes. The amount of laws and regulations prohibiting the 
discrimination is vast but not specific, e. g. PLWHAs are not specifically mentioned.
The efforts have been few. As said above government has not ratified the HIV-strategy nor is there a HIV 
programme to be implemented.
✔
✔
Comment by the MoSAH and KTL: It is correct that there is no specific programme. The HIV policy is an expert guidance 
document which should help in establishing good practices and guide efforts in all relevant sectors. For enforcement there are
mechanisms in place, such as the various Ombudsmen and the general judiciary system. In addition, there is the National 
Authority for Medicolegal Affairs which has jurisdiction in the area.
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II. Civil society17 participation
1. To what extent has civil society contributed to strengthening the political 
commitment of top leaders and national policy formulation? 
Low High
0 1 2 3 4 5
2. To what extent have civil society representatives been involved in the planning 
and budgeting process for the National Strategic Plan on AIDS or for the 
current activity plan (e.g. attending planning meetings and reviewing drafts)
Low High
0 1 2 3 4 5
3. To what extent are the services provided by civil society in areas of HIV 
prevention, treatment, care and support included 
a. in both the National Strategic plans and national reports?
Low High
0 1 2 3 4 5
b. in the national budget?
Low High
0 1 2 3 4 5
4. Has the country included civil society in a National Review of the National 
Strategic Plan?
Yes No
IF YES, when was the Review conducted? Year: [write in]
5. To what extent is the civil society sector representation in HIV-related efforts 
inclusive of its diversity?
Low High
0 1 2 3 4 5
List the types of organizations representing civil society in HIV and AIDS efforts: 
17 Civil society includes among others: Networks of people living with HIV; women’s organizations; young people’s organizations; faith-based or-
ganizations; AIDS service organizations; Community-based organizations; organizations of vulnerable sub-populations (including MSM, SW, IDU, 
migrants, refugees/displaced populations, prisoners); workers organizations, human rights organizations; etc. For the purpose of the NCPI, the private 
sector is considered separately.
Networks of people living with HIV
Women's organizations
Faith-based organizations
AIDS service organizations 
Organizations of vulnerable subpopulations (including MSM, SW, IDU, migrants, refugees/displaced populations, 
prisoners)
Human rights organizations 
✔
✔
✔
✔
✔
✔
This process is ongoing (2007)
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6. To what extent is civil society able to access
a. adequate ﬁ nancial support to implement its HIV activities?
Low High
0 1 2 3 4 5
b. adequate technical support to implement its HIV activities?
Low High
0 1 2 3 4 5
Overall, how would you rate the efforts to increase civil society participation in 2007 and 
in 2005?
 2007 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
 2005 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
Comments on progress made since 2005:
✔
✔
✔
✔
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III. Prevention
1. Has the country identiﬁ ed the districts (or equivalent geographical/
decentralized level) in need of HIV prevention programmes?
Yes No
IF NO, how are HIV prevention programmes being scaled-up?:
IF YES, to what extent have the following HIV prevention programmes been implemented in 
identiﬁ ed districts in need?
 Check the relevant implementation level for each activity or indicate N/A if not applicable
HIV prevention programmes
The service is available in
all districts*
in need
most districts*
in need
some districts*
in need
Blood safety
Universal precautions in health care settings
Prevention of mother-to-child transmission of HIV
IEC on risk reduction
IEC on stigma and discrimination reduction
Condom promotion
HIV testing & counselling
Harm reduction for injecting drug users
Risk reduction for men who have sex with men
Risk reduction for sex workers
Programmes for other most-at-risk populations
Reproductive health services including STI 
prevention & treatment
School-based AIDS education for young people
Programmes for out-of-school young people
HIV prevention in the workplace
Other programmes: [write in]
*Districts or equivalent geographical/de-centralized levels in urban and rural areas
Original answer by Civil society/NGO: 
For IDU but only on NGO level. However, in the urban setting districts change rapidly and launched information is
already outdated.
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
The answers to this table were given by the MoSAH and
KTL
Comment by MoSAH and KTL: 
HIV Prevention programmes are available and have a wide geographic coverage for most areas.
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Overall, how would you rate the efforts in the implementation of HIV prevention 
programmes in 2007 and in 2005?
 2007 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
 2005 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
Comments on progress made since 2005:
✔
✔
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IV. Treatment, care and support 
1. Has the country identiﬁ ed the districts (or equivalent geographical/
decentralized level) in need of HIV and AIDS treatment, care and support 
services?
Yes No
IF NO, how are HIV and AIDS treatment, care and support services being scaled-up?:
IF YES, to what extent have the following HIV and AIDS treatment, care and support services been 
implemented in the identiﬁ ed districts* in need? 
 Check the relevant implementation level for each activity or indicate N/A if not applicable
HIV and AIDS treatment, care and 
support services
The service is available in
all
districts* in need
most
districts* in need
some
districts* in need
Antiretroviral therapy
Nutritional care
Paediatric AIDS treatment
Sexually transmitted infection management
Psychosocial support for people living with 
HIV and their families
Home-based care
Palliative care and treatment of common 
HIV-related infections
HIV testing and counselling for TB patients
TB screening for HIV-infected people
TB preventive therapy for HIV-infected 
people
TB infection control in HIV treatment and 
care facilities
Cotrimoxazole prophylaxis in HIV-infected 
people
*Districts or equivalent geographical de-centralized governmental levels in urban and rural areas
Comment by MoSAH and KTL: Access to treatment, care and support is based on the public social welfare/support and health
care system and available throughout the country.
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
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HIV and AIDS treatment, care and 
support services
The service is available in
all
districts* in need
most
districts* in need
some
districts* in need
Post-exposure prophylaxis (e.g. 
occupational exposures to HIV, rape)
HIV treatment services in the workplace 
or treatment referral systems through the 
workplace
HIV care and support in the workplace 
(including alternative working 
arrangements)
Other programmes: [write in]
*Districts or equivalent geographical de-centralized governmental levels in urban and rural areas
Overall, how would you rate the efforts in the implementation of HIV treatment, care and 
support programmes in 2007 and in 2005?
 2007 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
 2005 Poor Good
 0 1 2 3 4 5 6 7 8 9 10
Comments on progress made since 2005:
2. What percentage of the following HIV programmes or services is estimated 
to be provided by civil society?
Prevention for youth <25% 25-50% 50-75% >75%
Prevention for vulnerable sub-populations
- IDU <25% 25-50% 50-75% >75%
- MSM <25% 25-50% 50-75% >75%
- Sex workers <25% 25-50% 50-75% >75%
Counselling and Testing <25% 25-50% 50-75% >75%
Clinical services (OI/ART)* <25% 25-50% 50-75% >75%
Home-based care <25% 25-50% 50-75% >75%
Programmes for OVC** <25% 25-50% 50-75% >75%
*OI Opportunistic infections; 
**OVC Orphans and other vulnerable children
The answers above are divided as follows: 
Treatment:              2005: 9, 2007: 9
Care and support:   2005: 8, 2007: 7
Treatment has always been good. Care and support has weakened as there are more PLWHAs and the amount
of nursing staff has not increased.
✔
✔
✔
The answers to this table were given by the
MoSAH and KTL
✔ ✔
✔ ✔
✔
✔
✔
✔
✔
✔
✔
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3. Does the country have a policy or strategy to address the additional HIV- 
and AIDS-related needs of orphans and other vulnerable children (OVC)?
Yes No N/A
5.1 IF YES, is there an operational deﬁ nition for OVC in the country? 
Yes No
5.2 IF YES, does the country have a national action plan speciﬁ cally for OVC?
Yes No
5.3 IF YES, does the country have an estimate of OVC being reached by existing interventions?
Yes No
IF YES, what percentage of OVC is being reached? % [write in]
✔
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United Nations A/RES/S-26/2
General Assembly Distr.: General2 August 2001
Twenty-sixth special session
Agenda item 8
01 43484
Resolution adopted by the General Assembly
[without reference to a Main Committee (A/S-26/L.2)]
S-26/2. Declaration of Commitment on HIV/AIDS
The General Assembly
Adopts the Declaration of Commitment on the human immunodeficiency
virus/acquired immunodeficiency syndrome (HIV/AIDS) annexed to the present
resolution.
8th plenary meeting
27 June 2001
Annex
Declaration of Commitment on HIV/AIDS
“Global Crisis – Global Action”
1. We, heads of State and Government and representatives of States and
Governments, assembled at the United Nations, from 25 to 27 June 2001, for the
twenty-sixth special session of the General Assembly, convened in accordance with
resolution 55/13 of 3 November 2000, as a matter of urgency, to review and address
the problem of HIV/AIDS in all its aspects, as well as to secure a global
commitment to enhancing coordination and intensification of national, regional and
international efforts to combat it in a comprehensive manner;
2. Deeply concerned that the global HIV/AIDS epidemic, through its devastating
scale and impact, constitutes a global emergency and one of the most formidable
challenges to human life and dignity, as well as to the effective enjoyment of human
rights, which undermines social and economic development throughout the world
and affects all levels of society – national, community, family and individual;
3. Noting with profound concern that by the end of 2000, 36.1 million people
worldwide were living with HIV/AIDS, 90 per cent in developing countries and
75 per cent in sub-Saharan Africa;
4. Noting with grave concern that all people, rich and poor, without distinction as
to age, gender or race, are affected by the HIV/AIDS epidemic, further noting that
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people in developing countries are the most affected and that women, young adults
and children, in particular girls, are the most vulnerable;
5. Concerned also that the continuing spread of HIV/AIDS will constitute a
serious obstacle to the realization of the global development goals we adopted at the
Millennium Summit of the United Nations;
6. Recalling and reaffirming our previous commitments on HIV/AIDS made
through:
• The United Nations Millennium Declaration, of 8 September 2000;1
• The political declaration and further actions and initiatives to implement the
commitments made at the World Summit for Social Development, of 1 July
2000;2
• The political declaration3 and further action and initiatives to implement the
Beijing Declaration and Platform for Action,4 of 10 June 2000;
• Key actions for the further implementation of the Programme of Action of the
International Conference on Population and Development, of 2 July 1999;5
• The regional call for action to fight HIV/AIDS in Asia and the Pacific, of
25 April 2001;
• The Abuja Declaration and Framework for Action for the fight against
HIV/AIDS, tuberculosis and other related infectious diseases in Africa, of
27 April 2001;
• The Declaration of the Tenth Ibero-American Summit of heads of State, of
18 November 2000;
• The Pan-Caribbean Partnership against HIV/AIDS, of 14 February 2001;
• The European Union Programme for Action: Accelerated action on HIV/AIDS,
malaria and tuberculosis in the context of poverty reduction, of 14 May 2001;
• The Baltic Sea Declaration on HIV/AIDS Prevention, of 4 May 2000;
• The Central Asian Declaration on HIV/AIDS, of 18 May 2001;
7. Convinced of the need to have an urgent, coordinated and sustained response
to the HIV/AIDS epidemic, which will build on the experience and lessons learned
over the past 20 years;
8. Noting with grave concern that Africa, in particular sub-Saharan Africa, is
currently the worst-affected region, where HIV/AIDS is considered a state of
emergency which threatens development, social cohesion, political stability, food
security and life expectancy and imposes a devastating economic burden, and that
the dramatic situation on the continent needs urgent and exceptional national,
regional and international action;
9. Welcoming the commitments of African heads of State or Government at the
Abuja special summit in April 2001, particularly their pledge to set a target of
1 See resolution 55/2.
2 Resolution S-24/2, annex, sects. I and III.
3 Resolution S-23/2, annex.
4 Resolution S-23/3, annex.
5 Resolution S-21/2, annex.
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allocating at least 15 per cent of their annual national budgets for the improvement
of the health sector to help to address the HIV/AIDS epidemic; and recognizing that
action to reach this target, by those countries whose resources are limited, will need
to be complemented by increased international assistance;
10. Recognizing also that other regions are seriously affected and confront similar
threats, particularly the Caribbean region, with the second-highest rate of HIV
infection after sub-Saharan Africa, the Asia-Pacific region where 7.5 million people
are already living with HIV/AIDS, the Latin American region with 1.5 million
people living with HIV/AIDS and the Central and Eastern European region with
very rapidly rising infection rates, and that the potential exists for a rapid escalation
of the epidemic and its impact throughout the world if no specific measures are
taken;
11. Recognizing that poverty, underdevelopment and illiteracy are among the
principal contributing factors to the spread of HIV/AIDS, and noting with grave
concern that HIV/AIDS is compounding poverty and is now reversing or impeding
development in many countries and should therefore be addressed in an integrated
manner;
12. Noting that armed conflicts and natural disasters also exacerbate the spread of
the epidemic;
13. Noting further that stigma, silence, discrimination and denial, as well as a lack
of confidentiality, undermine prevention, care and treatment efforts and increase the
impact of the epidemic on individuals, families, communities and nations and must
also be addressed;
14. Stressing that gender equality and the empowerment of women are
fundamental elements in the reduction of the vulnerability of women and girls to
HIV/AIDS;
15. Recognizing that access to medication in the context of pandemics such as
HIV/AIDS is one of the fundamental elements to achieve progressively the full
realization of the right of everyone to the enjoyment of the highest attainable
standard of physical and mental health;
16. Recognizing that the full realization of human rights and fundamental
freedoms for all is an essential element in a global response to the HIV/AIDS
pandemic, including in the areas of prevention, care, support and treatment, and that
it reduces vulnerability to HIV/AIDS and prevents stigma and related discrimination
against people living with or at risk of HIV/AIDS;
17. Acknowledging that prevention of HIV infection must be the mainstay of the
national, regional and international response to the epidemic, and that prevention,
care, support and treatment for those infected and affected by HIV/AIDS are
mutually reinforcing elements of an effective response and must be integrated in a
comprehensive approach to combat the epidemic;
18. Recognizing the need to achieve the prevention goals set out in the present
Declaration in order to stop the spread of the epidemic, and acknowledging that all
countries must continue to emphasize widespread and effective prevention,
including awareness-raising campaigns through education, nutrition, information
and health-care services;
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19. Recognizing that care, support and treatment can contribute to effective
prevention through an increased acceptance of voluntary and confidential
counselling and testing, and by keeping people living with HIV/AIDS and
vulnerable groups in close contact with health-care systems and facilitating their
access to information, counselling and preventive supplies;
20. Emphasizing the important role of cultural, family, ethical and religious factors
in the prevention of the epidemic and in treatment, care and support, taking into
account the particularities of each country as well as the importance of respecting all
human rights and fundamental freedoms;
21. Noting with concern that some negative economic, social, cultural, political,
financial and legal factors are hampering awareness, education, prevention, care,
treatment and support efforts;
22. Noting the importance of establishing and strengthening human resources and
national health and social infrastructures as imperatives for the effective delivery of
prevention, treatment, care and support services;
23. Recognizing that effective prevention, care and treatment strategies will
require behavioural changes and increased availability of and non-discriminatory
access to, inter alia, vaccines, condoms, microbicides, lubricants, sterile injecting
equipment, drugs, including anti-retroviral therapy, diagnostics and related
technologies, as well as increased research and development;
24. Recognizing also that the cost, availability and affordability of drugs and
related technology are significant factors to be reviewed and addressed in all aspects
and that there is a need to reduce the cost of these drugs and technologies in close
collaboration with the private sector and pharmaceutical companies;
25. Acknowledging that the lack of affordable pharmaceuticals and of feasible
supply structures and health systems continues to hinder an effective response to
HIV/AIDS in many countries, especially for the poorest people, and recalling efforts
to make drugs available at low prices for those in need;
26. Welcoming the efforts of countries to promote innovation and the development
of domestic industries consistent with international law in order to increase access to
medicines to protect the health of their populations, and noting that the impact of
international trade agreements on access to or local manufacturing of essential drugs
and on the development of new drugs needs to be evaluated further;
27. Welcoming the progress made in some countries to contain the epidemic,
particularly through: strong political commitment and leadership at the highest
levels, including community leadership; effective use of available resources and
traditional medicines; successful prevention, care, support and treatment strategies;
education and information initiatives; working in partnership with communities,
civil society, people living with HIV/AIDS and vulnerable groups; and the active
promotion and protection of human rights; and recognizing the importance of
sharing and building on our collective and diverse experiences, through regional and
international cooperation including North-South, South-South and triangular
cooperation;
28. Acknowledging that resources devoted to combating the epidemic both at the
national and international levels are not commensurate with the magnitude of the
problem;
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29. Recognizing the fundamental importance of strengthening national, regional
and subregional capacities to address and effectively combat HIV/AIDS and that
this will require increased and sustained human, financial and technical resources
through strengthened national action and cooperation and increased regional,
subregional and international cooperation;
30. Recognizing that external debt and debt-servicing problems have substantially
constrained the capacity of many developing countries, as well as countries with
economies in transition, to finance the fight against HIV/AIDS;
31. Affirming the key role played by the family in prevention, care, support and
treatment of persons affected and infected by HIV/AIDS, bearing in mind that in
different cultural, social and political systems various forms of the family exist;
32. Affirming that beyond the key role played by communities, strong partnerships
among Governments, the United Nations system, intergovernmental organizations,
people living with HIV/AIDS and vulnerable groups, medical, scientific and
educational institutions, non-governmental organizations, the business sector
including generic and research-based pharmaceutical companies, trade unions, the
media, parliamentarians, foundations, community organizations, faith-based
organizations and traditional leaders are important;
33. Acknowledging the particular role and significant contribution of people living
with HIV/AIDS, young people and civil society actors in addressing the problem of
HIV/AIDS in all its aspects, and recognizing that their full involvement and
participation in the design, planning, implementation and evaluation of programmes
is crucial to the development of effective responses to the HIV/AIDS epidemic;
34. Further acknowledging the efforts of international humanitarian organizations
combating the epidemic, including the volunteers of the International Federation of
Red Cross and Red Crescent Societies in the most affected areas all over the world;
35. Commending the leadership role on HIV/AIDS policy and coordination in the
United Nations system of the Programme Coordinating Board of the Joint United
Nations Programme on HIV/AIDS (UNAIDS); and noting its endorsement in
December 2000 of the Global Strategy Framework on HIV/AIDS, which could
assist, as appropriate, Member States and relevant civil society actors in the
development of HIV/AIDS strategies, taking into account the particular context of
the epidemic in different parts of the world;
36. Solemnly declare our commitment to address the HIV/AIDS crisis by taking
action as follows, taking into account the diverse situations and circumstances in
different regions and countries throughout the world;
Leadership
Strong leadership at all levels of society is essential for an effective response to the
epidemic
Leadership by Governments in combating HIV/AIDS is essential and their efforts
should be complemented by the full and active participation of civil society, the
business community and the private sector
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Leadership involves personal commitment and concrete actions
At the national level
37. By 2003, ensure the development and implementation of multisectoral national
strategies and financing plans for combating HIV/AIDS that address the epidemic in
forthright terms; confront stigma, silence and denial; address gender and age-based
dimensions of the epidemic; eliminate discrimination and marginalization; involve
partnerships with civil society and the business sector and the full participation of
people living with HIV/AIDS, those in vulnerable groups and people mostly at risk,
particularly women and young people; are resourced to the extent possible from
national budgets without excluding other sources, inter alia, international
cooperation; fully promote and protect all human rights and fundamental freedoms,
including the right to the highest attainable standard of physical and mental health;
integrate a gender perspective; address risk, vulnerability, prevention, care,
treatment and support and reduction of the impact of the epidemic; and strengthen
health, education and legal system capacity;
38. By 2003, integrate HIV/AIDS prevention, care, treatment and support and
impact-mitigation priorities into the mainstream of development planning, including
in poverty eradication strategies, national budget allocations and sectoral
development plans;
At the regional and subregional level
39. Urge and support regional organizations and partners to be actively involved in
addressing the crisis; intensify regional, subregional and interregional cooperation
and coordination; and develop regional strategies and responses in support of
expanded country-level efforts;
40. Support all regional and subregional initiatives on HIV/AIDS including: the
International Partnership against AIDS in Africa (IPAA) and the ECA-African
Development Forum African Consensus and Plan of Action: Leadership to
overcome HIV/AIDS; the Abuja Declaration and Framework for Action for the fight
against HIV/AIDS, tuberculosis and other related infectious diseases in Africa; the
CARICOM Pan-Caribbean Partnership against HIV/AIDS; the ESCAP regional call
for action to fight HIV/AIDS in Asia and the Pacific; the Baltic Sea Initiative and
Action Plan; the Horizontal Technical Cooperation Group on HIV/AIDS in Latin
America and the Caribbean; and the European Union Programme for Action:
Accelerated action on HIV/AIDS, malaria and tuberculosis in the context of poverty
reduction;
41. Encourage the development of regional approaches and plans to address
HIV/AIDS;
42. Encourage and support local and national organizations to expand and
strengthen regional partnerships, coalitions and networks;
43. Encourage the United Nations Economic and Social Council to request the
regional commissions, within their respective mandates and resources, to support
national efforts in their respective regions in combating HIV/AIDS;
At the global level
44. Support greater action and coordination by all relevant organizations of the
United Nations system, including their full participation in the development and
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implementation of a regularly updated United Nations strategic plan for HIV/AIDS,
guided by the principles contained in the present Declaration;
45. Support greater cooperation between relevant organizations of the United
Nations system and international organizations combating HIV/AIDS;
46. Foster stronger collaboration and the development of innovative partnerships
between the public and private sectors, and by 2003 establish and strengthen
mechanisms that involve the private sector and civil society partners and people
living with HIV/AIDS and vulnerable groups in the fight against HIV/AIDS;
Prevention
Prevention must be the mainstay of our response
47. By 2003, establish time-bound national targets to achieve the internationally
agreed global prevention goal to reduce by 2005 HIV prevalence among young men
and women aged 15 to 24 in the most affected countries by 25 per cent and by 25
per cent globally by 2010, and intensify efforts to achieve these targets as well as to
challenge gender stereotypes and attitudes, and gender inequalities in relation to
HIV/AIDS, encouraging the active involvement of men and boys;
48. By 2003, establish national prevention targets, recognizing and addressing
factors leading to the spread of the epidemic and increasing people’s vulnerability,
to reduce HIV incidence for those identifiable groups, within particular local
contexts, which currently have high or increasing rates of HIV infection, or which
available public health information indicates are at the highest risk of new infection;
49. By 2005, strengthen the response to HIV/AIDS in the world of work by
establishing and implementing prevention and care programmes in public, private
and informal work sectors, and take measures to provide a supportive workplace
environment for people living with HIV/AIDS;
50. By 2005, develop and begin to implement national, regional and international
strategies that facilitate access to HIV/AIDS prevention programmes for migrants
and mobile workers, including the provision of information on health and social
services;
51. By 2003, implement universal precautions in health-care settings to prevent
transmission of HIV infection;
52. By 2005, ensure: that a wide range of prevention programmes which take
account of local circumstances, ethics and cultural values, is available in all
countries, particularly the most affected countries, including information, education
and communication, in languages most understood by communities and respectful of
cultures, aimed at reducing risk-taking behaviour and encouraging responsible
sexual behaviour, including abstinence and fidelity; expanded access to essential
commodities, including male and female condoms and sterile injecting equipment;
harm-reduction efforts related to drug use; expanded access to voluntary and
confidential counselling and testing; safe blood supplies; and early and effective
treatment of sexually transmittable infections;
53. By 2005, ensure that at least 90 per cent, and by 2010 at least 95 per cent of
young men and women aged 15 to 24 have access to the information, education,
including peer education and youth-specific HIV education, and services necessary
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to develop the life skills required to reduce their vulnerability to HIV infection, in
full partnership with young persons, parents, families, educators and health-care
providers;
54. By 2005, reduce the proportion of infants infected with HIV by 20 per cent,
and by 50 per cent by 2010, by ensuring that 80 per cent of pregnant women
accessing antenatal care have information, counselling and other HIV-prevention
services available to them, increasing the availability of and providing access for
HIV-infected women and babies to effective treatment to reduce mother-to-child
transmission of HIV, as well as through effective interventions for HIV-infected
women, including voluntary and confidential counselling and testing, access to
treatment, especially anti-retroviral therapy and, where appropriate, breast-milk
substitutes and the provision of a continuum of care;
Care, support and treatment
Care, support and treatment are fundamental elements of an effective response
55. By 2003, ensure that national strategies, supported by regional and
international strategies, are developed in close collaboration with the international
community, including Governments and relevant intergovernmental organizations,
as well as with civil society and the business sector, to strengthen health-care
systems and address factors affecting the provision of HIV-related drugs, including
anti-retroviral drugs, inter alia, affordability and pricing, including differential
pricing, and technical and health-care system capacity. Also, in an urgent manner
make every effort to provide progressively and in a sustainable manner, the highest
attainable standard of treatment for HIV/AIDS, including the prevention and
treatment of opportunistic infections, and effective use of quality-controlled anti-
retroviral therapy in a careful and monitored manner to improve adherence and
effectiveness and reduce the risk of developing resistance; and to cooperate
constructively in strengthening pharmaceutical policies and practices, including
those applicable to generic drugs and intellectual property regimes, in order further
to promote innovation and the development of domestic industries consistent with
international law;
56. By 2005, develop and make significant progress in implementing
comprehensive care strategies to: strengthen family and community-based care,
including that provided by the informal sector, and health-care systems to provide
and monitor treatment to people living with HIV/AIDS, including infected children,
and to support individuals, households, families and communities affected by
HIV/AIDS; and improve the capacity and working conditions of health-care
personnel, and the effectiveness of supply systems, financing plans and referral
mechanisms required to provide access to affordable medicines, including anti-
retroviral drugs, diagnostics and related technologies, as well as quality medical,
palliative and psychosocial care;
57. By 2003, ensure that national strategies are developed in order to provide
psychosocial care for individuals, families and communities affected by HIV/AIDS;
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HIV/AIDS and human rights
Realization of human rights and fundamental freedoms for all is essential to reduce
vulnerability to HIV/AIDS
Respect for the rights of people living with HIV/AIDS drives an effective response
58. By 2003, enact, strengthen or enforce, as appropriate, legislation, regulations
and other measures to eliminate all forms of discrimination against and to ensure the
full enjoyment of all human rights and fundamental freedoms by people living with
HIV/AIDS and members of vulnerable groups, in particular to ensure their access to,
inter alia, education, inheritance, employment, health care, social and health
services, prevention, support and treatment, information and legal protection, while
respecting their privacy and confidentiality; and develop strategies to combat stigma
and social exclusion connected with the epidemic;
59. By 2005, bearing in mind the context and character of the epidemic and that,
globally, women and girls are disproportionately affected by HIV/AIDS, develop
and accelerate the implementation of national strategies that promote the
advancement of women and women’s full enjoyment of all human rights; promote
shared responsibility of men and women to ensure safe sex; and empower women to
have control over and decide freely and responsibly on matters related to their
sexuality to increase their ability to protect themselves from HIV infection;
60. By 2005, implement measures to increase capacities of women and adolescent
girls to protect themselves from the risk of HIV infection, principally through the
provision of health care and health services, including for sexual and reproductive
health, and through prevention education that promotes gender equality within a
culturally and gender-sensitive framework;
61. By 2005, ensure development and accelerated implementation of national
strategies for women’s empowerment, the promotion and protection of women’s full
enjoyment of all human rights and reduction of their vulnerability to HIV/AIDS
through the elimination of all forms of discrimination, as well as all forms of
violence against women and girls, including harmful traditional and customary
practices, abuse, rape and other forms of sexual violence, battering and trafficking in
women and girls;
Reducing vulnerability
The vulnerable must be given priority in the response
Empowering women is essential for reducing vulnerability
62. By 2003, in order to complement prevention programmes that address
activities which place individuals at risk of HIV infection, such as risky and unsafe
sexual behaviour and injecting drug use, have in place in all countries strategies,
policies and programmes that identify and begin to address those factors that make
individuals particularly vulnerable to HIV infection, including underdevelopment,
economic insecurity, poverty, lack of empowerment of women, lack of education,
social exclusion, illiteracy, discrimination, lack of information and/or commodities
for self-protection, and all types of sexual exploitation of women, girls and boys,
including for commercial reasons. Such strategies, policies and programmes should
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address the gender dimension of the epidemic, specify the action that will be taken
to address vulnerability and set targets for achievement;
63. By 2003, develop and/or strengthen strategies, policies and programmes which
recognize the importance of the family in reducing vulnerability, inter alia, in
educating and guiding children and take account of cultural, religious and ethical
factors, to reduce the vulnerability of children and young people by ensuring access
of both girls and boys to primary and secondary education, including HIV/AIDS in
curricula for adolescents; ensuring safe and secure environments, especially for
young girls; expanding good-quality, youth-friendly information and sexual health
education and counselling services; strengthening reproductive and sexual health
programmes; and involving families and young people in planning, implementing
and evaluating HIV/AIDS prevention and care programmes, to the extent possible;
64. By 2003, develop and/or strengthen national strategies, policies and
programmes, supported by regional and international initiatives, as appropriate,
through a participatory approach, to promote and protect the health of those
identifiable groups which currently have high or increasing rates of HIV infection or
which public health information indicates are at greatest risk of and most vulnerable
to new infection as indicated by such factors as the local history of the epidemic,
poverty, sexual practices, drug-using behaviour, livelihood, institutional location,
disrupted social structures and population movements, forced or otherwise;
Children orphaned and made vulnerable by HIV/AIDS
Children orphaned and affected by HIV/AIDS need special assistance
65. By 2003, develop and by 2005 implement national policies and strategies to
build and strengthen governmental, family and community capacities to provide a
supportive environment for orphans and girls and boys infected and affected by
HIV/AIDS, including by providing appropriate counselling and psychosocial
support, ensuring their enrolment in school and access to shelter, good nutrition and
health and social services on an equal basis with other children; and protect orphans
and vulnerable children from all forms of abuse, violence, exploitation,
discrimination, trafficking and loss of inheritance;
66. Ensure non-discrimination and full and equal enjoyment of all human rights
through the promotion of an active and visible policy of de-stigmatization of
children orphaned and made vulnerable by HIV/AIDS;
67. Urge the international community, particularly donor countries, civil society,
as well as the private sector, to complement effectively national programmes to
support programmes for children orphaned or made vulnerable by HIV/AIDS in
affected regions and in countries at high risk and to direct special assistance to sub-
Saharan Africa;
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Alleviating social and economic impact
To address HIV/AIDS is to invest in sustainable development
68. By 2003, evaluate the economic and social impact of the HIV/AIDS epidemic
and develop multisectoral strategies to address the impact at the individual, family,
community and national levels; develop and accelerate the implementation of
national poverty eradication strategies to address the impact of HIV/AIDS on
household income, livelihoods and access to basic social services, with special focus
on individuals, families and communities severely affected by the epidemic; review
the social and economic impact of HIV/AIDS at all levels of society, especially on
women and the elderly, particularly in their role as caregivers, and in families
affected by HIV/AIDS, and address their special needs; and adjust and adapt
economic and social development policies, including social protection policies, to
address the impact of HIV/AIDS on economic growth, provision of essential
economic services, labour productivity, government revenues, and deficit-creating
pressures on public resources;
69. By 2003, develop a national legal and policy framework that protects in the
workplace the rights and dignity of persons living with and affected by HIV/AIDS
and those at the greatest risk of HIV/AIDS, in consultation with representatives of
employers and workers, taking account of established international guidelines on
HIV/AIDS in the workplace;
Research and development
With no cure for HIV/AIDS yet found, further research and development is crucial
70. Increase investment in and accelerate research on the development of HIV
vaccines, while building national research capacity, especially in developing
countries, and especially for viral strains prevalent in highly affected regions; in
addition, support and encourage increased national and international investment in
HIV/AIDS-related research and development, including biomedical, operations,
social, cultural and behavioural research and in traditional medicine to improve
prevention and therapeutic approaches; accelerate access to prevention, care and
treatment and care technologies for HIV/AIDS (and its associated opportunistic
infections and malignancies and sexually transmitted diseases), including female-
controlled methods and microbicides, and in particular, appropriate, safe and
affordable HIV vaccines and their delivery, and to diagnostics, tests and methods to
prevent mother-to-child transmission; improve our understanding of factors which
influence the epidemic and actions which address it, inter alia, through increased
funding and public/private partnerships; and create a conducive environment for
research and ensure that it is based on the highest ethical standards;
71. Support and encourage the development of national and international research
infrastructures, laboratory capacity, improved surveillance systems, data collection,
processing and dissemination, and the training of basic and clinical researchers,
social scientists, health-care providers and technicians, with a focus on the countries
most affected by HIV/AIDS, particularly developing countries and those countries
experiencing or at risk of a rapid expansion of the epidemic;
72. Develop and evaluate suitable approaches for monitoring treatment efficacy,
toxicity, side effects, drug interactions and drug resistance, and develop
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methodologies to monitor the impact of treatment on HIV transmission and risk
behaviours;
73. Strengthen international and regional cooperation, in particular North-South,
South-South and triangular cooperation, related to the transfer of relevant
technologies suitable to the environment in the prevention and care of HIV/AIDS,
the exchange of experiences and best practices, researchers and research findings
and strengthen the role of UNAIDS in this process. In this context, encourage
ownership of the end results of these cooperative research findings and technologies
by all parties to the research, reflecting their relevant contribution and dependent
upon their providing legal protection to such findings; and affirm that all such
research should be free from bias;
74. By 2003, ensure that all research protocols for the investigation of HIV-related
treatment, including anti-retroviral therapies and vaccines, based on international
guidelines and best practices, are evaluated by independent committees of ethics, in
which persons living with HIV/AIDS and caregivers for anti-retroviral therapy
participate;
HIV/AIDS in conflict and disaster-affected regions
Conflicts and disasters contribute to the spread of HIV/AIDS
75. By 2003, develop and begin to implement national strategies that incorporate
HIV/AIDS awareness, prevention, care and treatment elements into programmes or
actions that respond to emergency situations, recognizing that populations
destabilized by armed conflict, humanitarian emergencies and natural disasters,
including refugees, internally displaced persons, and in particular women and
children, are at increased risk of exposure to HIV infection; and, where appropriate,
factor HIV/AIDS components into international assistance programmes;
76. Call on all United Nations agencies, regional and international organizations,
as well as non-governmental organizations involved with the provision and delivery
of international assistance to countries and regions affected by conflicts,
humanitarian crises or natural disasters, to incorporate as a matter of urgency
HIV/AIDS prevention, care and awareness elements into their plans and
programmes and provide HIV/AIDS awareness and training to their personnel;
77. By 2003, have in place national strategies to address the spread of HIV among
national uniformed services, where this is required, including armed forces and civil
defence forces, and consider ways of using personnel from these services who are
educated and trained in HIV/AIDS awareness and prevention to assist with
HIV/ AIDS awareness and prevention activities, including participation in
emergency, humanitarian, disaster relief and rehabilitation assistance;
78. By 2003, ensure the inclusion of HIV/AIDS awareness and training, including
a gender component, into guidelines designed for use by defence personnel and
other personnel involved in international peacekeeping operations, while also
continuing with ongoing education and prevention efforts, including pre-deployment
orientation, for these personnel;
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Resources
The HIV/AIDS challenge cannot be met without new, additional and sustained
resources
79. Ensure that the resources provided for the global response to address
HIV/AIDS are substantial, sustained and geared towards achieving results;
80. By 2005, through a series of incremental steps, reach an overall target of
annual expenditure on the epidemic of between 7 and 10 billion United States
dollars in low and middle-income countries and those countries experiencing or at
risk of experiencing rapid expansion for prevention, care, treatment, support and
mitigation of the impact of HIV/AIDS, and take measures to ensure that the
resources needed are made available, particularly from donor countries and also
from national budgets, bearing in mind that resources of the most affected countries
are seriously limited;
81. Call on the international community, where possible, to provide assistance for
HIV/AIDS prevention, care and treatment in developing countries on a grant basis;
82. Increase and prioritize national budgetary allocations for HIV/AIDS
programmes as required, and ensure that adequate allocations are made by all
ministries and other relevant stakeholders;
83. Urge the developed countries that have not done so to strive to meet the targets
of 0.7 per cent of their gross national product for overall official development
assistance and the targets of earmarking 0.15 per cent to 0.20 per cent of gross
national product as official development assistance for least developed countries as
agreed, as soon as possible, taking into account the urgency and gravity of the
HIV/AIDS epidemic;
84. Urge the international community to complement and supplement efforts of
developing countries that commit increased national funds to fight the HIV/AIDS
epidemic through increased international development assistance, particularly those
countries most affected by HIV/AIDS, particularly in Africa, especially in sub-
Saharan Africa, the Caribbean, countries at high risk of expansion of the HIV/AIDS
epidemic and other affected regions whose resources to deal with the epidemic are
seriously limited;
85. Integrate HIV/AIDS actions in development assistance programmes and
poverty eradication strategies as appropriate, and encourage the most effective and
transparent use of all resources allocated;
86. Call on the international community, and invite civil society and the private
sector to take appropriate measures to help to alleviate the social and economic
impact of HIV/AIDS in the most affected developing countries;
87. Without further delay, implement the enhanced Heavily Indebted Poor Country
(HIPC) Initiative and agree to cancel all bilateral official debts of HIPC countries as
soon as possible, especially those most affected by HIV/AIDS, in return for
demonstrable commitments by them to poverty eradication, and urge the use of debt
service savings to finance poverty eradication programmes, particularly for
prevention, treatment, care and support for HIV/AIDS and other infections;
88. Call for speedy and concerted action to address effectively the debt problems
of least developed countries, low-income developing countries, and middle-income
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developing countries, particularly those affected by HIV/AIDS, in a comprehensive,
equitable, development-oriented and durable way through various national and
international measures designed to make their debt sustainable in the long term and
thereby to improve their capacity to deal with the HIV/AIDS epidemic, including, as
appropriate, existing orderly mechanisms for debt reduction, such as debt swaps for
projects aimed at the prevention, care and treatment of HIV/AIDS;
89. Encourage increased investment in HIV/AIDS-related research nationally,
regionally and internationally, in particular for the development of sustainable and
affordable prevention technologies, such as vaccines and microbicides, and
encourage the proactive preparation of financial and logistic plans to facilitate rapid
access to vaccines when they become available;
90. Support the establishment, on an urgent basis, of a global HIV/AIDS and
health fund to finance an urgent and expanded response to the epidemic based on an
integrated approach to prevention, care, support and treatment and to assist
Governments, inter alia, in their efforts to combat HIV/AIDS with due priority to the
most affected countries, notably in sub-Saharan Africa and the Caribbean and to
those countries at high risk, and mobilize contributions to the fund from public and
private sources with a special appeal to donor countries, foundations, the business
community, including pharmaceutical companies, the private sector, philanthropists
and wealthy individuals;
91. By 2002, launch a worldwide fund-raising campaign aimed at the general
public as well as the private sector, conducted by UNAIDS with the support and
collaboration of interested partners at all levels, to contribute to the global
HIV/AIDS and health fund;
92. Direct increased funding to national, regional and subregional commissions
and organizations to enable them to assist Governments at the national, regional and
subregional level in their efforts to respond to the crisis;
93. Provide the UNAIDS co-sponsoring agencies and the UNAIDS secretariat with
the resources needed to work with countries in support of the goals of the present
Declaration;
Follow-up
Maintaining the momentum and monitoring progress are essential
At the national level
94. Conduct national periodic reviews with the participation of civil society,
particularly people living with HIV/AIDS, vulnerable groups and caregivers, of
progress achieved in realizing these commitments, identify problems and obstacles
to achieving progress, and ensure wide dissemination of the results of these reviews;
95. Develop appropriate monitoring and evaluation mechanisms to assist with
follow-up in measuring and assessing progress, and develop appropriate monitoring
and evaluation instruments, with adequate epidemiological data;
96. By 2003, establish or strengthen effective monitoring systems, where
appropriate, for the promotion and protection of human rights of people living with
HIV/AIDS;
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At the regional level
97. Include HIV/AIDS and related public health concerns, as appropriate, on the
agenda of regional meetings at the ministerial and head of State and Government
level;
98. Support data collection and processing to facilitate periodic reviews by
regional commissions and/or regional organizations of progress in implementing
regional strategies and addressing regional priorities, and ensure wide dissemination
of the results of these reviews;
99. Encourage the exchange between countries of information and experiences in
implementing the measures and commitments contained in the present Declaration,
and in particular facilitate intensified South-South and triangular cooperation;
At the global level
100. Devote sufficient time and at least one full day of the annual session of the
General Assembly to review and debate a report of the Secretary-General on
progress achieved in realizing the commitments set out in the present Declaration,
with a view to identifying problems and constraints and making recommendations
on action needed to make further progress;
101. Ensure that HIV/AIDS issues are included on the agenda of all appropriate
United Nations conferences and meetings;
102. Support initiatives to convene conferences, seminars, workshops, training
programmes and courses to follow up issues raised in the present Declaration, and in
this regard encourage participation in and wide dissemination of the outcomes of the
forthcoming Dakar Conference on access to care for HIV infection; the Sixth
International Congress on AIDS in Asia and the Pacific; the Twelfth International
Conference on AIDS and Sexually Transmitted Infections in Africa; the Fourteenth
International Conference on AIDS, Barcelona, Spain; the Tenth International
Conference on People Living with HIV/AIDS, Port-of-Spain; the Second Forum and
Third Conference of the Horizontal Technical Cooperation Group on HIV/AIDS and
Sexually Transmitted Infections in Latin America and the Caribbean, Havana; the
Fifth International Conference on Home and Community Care for Persons Living
with HIV/AIDS, Chiang Mai, Thailand;
103. Explore, with a view to improving equity in access to essential drugs, the
feasibility of developing and implementing, in collaboration with non-governmental
organizations and other concerned partners, systems for the voluntary monitoring
and reporting of global drug prices;
We recognize and express our appreciation to those who have led the effort to raise
awareness of the HIV/AIDS epidemic and to deal with its complex challenges;
We look forward to strong leadership by Governments and concerted efforts with the
full and active participation of the United Nations, the entire multilateral system,
civil society, the business community and private sector;
And finally, we call on all countries to take the necessary steps to implement the
present Declaration, in strengthened partnership and cooperation with other
multilateral and bilateral partners and with civil society.
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